introduct
autophagi
well
known
one
biogen
respons
variou
stress
possess
benefi
cial
role
surviv
littl
known
dynam
signifi
canc
septic
condit
hypothes
autophagi
induc
septic
condit
contribut
protect
tissu
damag
subsequ
lead
organ
dysfunct
confi
rm
whether
autophag
process
acceler
sustain
acut
phase
sepsi
also
determin
physiolog
role
method
sepsi
induc
cecal
ligat
punctur
clp
mice
examin
kinet
autophagosom
auto
lysosom
format
may
explain
statu
autophagi
western
blot
immunohistochemistri
electron
microscopi
investig
precis
role
autophagi
clpinduc
sepsi
chloroquin
autophagi
inhibitor
administ
clpoper
mice
blood
chemistri
patholog
liver
surviv
evalu
result
autophagi
demonstr
ratio
induc
time
cours
hour
clp
ratio
particularli
increas
liver
heart
spleen
autophagosom
format
becam
maxim
hour
declin
hour
clp
autolysosom
format
evalu
fusion
dot
immunohistochemistri
electron
microscopi
also
increas
procedur
furthermor
inhibit
autophagi
chloroquin
clp
procedur
result
elev
serum
ast
level
signifi
cantli
increas
mortal
mice
conclus
autophagi
induc
sever
organ
time
cours
clp
sepsi
model
process
gradual
complet
degrad
compon
data
suggest
autophagi
play
protect
role
organ
dysfunct
sepsi
result
express
percentag
control
sem
p
conclus
decreas
signifi
cantli
heart
rate
contractil
forc
speed
contract
relax
isol
perfus
rat
heart
probabl
play
role
pathophysiolog
cardiomyopathi
septic
shock
partial
revers
eff
ect
could
explain
left
ventricular
hypokinesia
patient
septic
shock
revers
refer
eff
ect
cdpcholin
microcirculatori
alter
endotoxemia
introduct
acut
myocardi
depress
septic
shock
common
myocardi
depress
mediat
circul
depress
substanc
incomplet
character
aim
studi
observ
eff
ect
model
perfus
rat
heart
method
profound
anesthesia
pentoth
wistar
rat
kill
exsanguin
sternotomi
heart
taken
connect
langendorf
column
apex
heart
hook
strength
sensor
biopac
student
laboratori
softwar
use
record
analys
heart
contract
contract
record
everi
minut
period
minut
control
measur
fi
rst
record
measur
four
paramet
heart
rate
contract
forc
speed
contract
relax
control
ngml
exposur
remov
express
variat
paramet
percentag
control
sem
pair
test
use
compar
heart
rate
contract
amplitud
speed
contract
relax
control
measur
remov
result
eight
rat
heart
wistar
weight
g
studi
see
tabl
heart
rate
introduct
tradit
whole
blood
experi
suggest
sepsi
caus
abnorm
red
blood
cell
rbc
deform
investig
cellular
level
employ
novel
biophys
method
observ
individu
rbc
membran
mechan
patient
septic
shock
method
collect
blood
sampl
patient
septic
shock
either
death
day
admiss
thermal
fl
uctuat
individu
rbc
record
allow
complet
analysi
rbc
shape
variat
time
mean
elast
cell
membran
quantifi
ed
sampl
collect
recruit
nine
patient
septic
shock
tabl
show
mean
rbc
thermal
fl
uctuat
sofa
score
conclus
rbc
thermal
fl
uctuat
analysi
allow
variat
rbc
elast
sepsi
quantifi
ed
cellular
level
could
identifi
specifi
c
trend
sepsi
sever
erythrocyt
elast
cell
demonstr
increas
decreas
fl
uctuat
independ
sofa
score
contrari
current
evid
suggest
rbc
deform
reduc
sepsi
refer
introduct
whole
blood
experi
suggest
cardiopulmonari
bypass
cpb
caus
red
blood
cell
rbc
trauma
chang
deform
may
contribut
postop
microcirculatori
introduct
neutrophil
gelatinaseassoci
lipocalin
ngal
known
sensit
biomark
acut
kidney
injuri
prevent
bacteri
iron
uptak
result
inhibit
overgrowth
previous
demonstr
protein
discharg
gut
lumen
crypt
cell
septic
condit
inhibit
growth
escherichia
coli
howev
remain
unclear
pathway
associ
upregul
ngal
therefor
design
present
studi
reveal
whether
patternrecognit
receptor
bacteria
tolllik
receptor
tlr
famili
play
pivot
role
ngal
secret
gut
crypt
cell
method
institut
approv
ileum
colon
male
mice
week
evert
wash
ca
mg
free
pb
buff
er
fi
time
tissu
incub
ca
mg
free
pb
contain
mm
edta
hour
isol
crypt
cell
gut
cell
suspens
fi
ltere
cell
strainer
twice
deposit
crypt
cell
centrifug
isol
crypt
cell
resuspend
pb
stain
amido
black
label
paneth
cell
crypt
cell
resuspend
ml
hbss
contain
fetal
bovin
serum
penicillinstreptomycin
crypt
cell
incub
without
tlr
ligand
lipopolysaccharid
ligand
cpgdna
ligand
incub
period
crypt
cell
deposit
elut
mrna
measur
express
ngal
tlr
mrna
use
realtim
pcr
result
collect
cell
stain
amido
black
lp
signifi
cantli
upregul
express
ngal
mrna
ileum
colon
crypt
cell
p
although
cpgdna
upregul
ngal
mrna
ileum
crypt
cell
appar
express
ngal
mrna
found
colon
crypt
cell
p
conclus
bacteri
stimul
pathway
play
pivot
role
express
ngal
mrna
gut
suggest
ngal
deriv
gut
crypt
cell
could
contribut
regul
intralumin
microfl
ora
critic
ill
refer
introduct
individu
infect
pandem
infl
uenza
viru
iav
experienc
uncompl
fl
u
howev
small
subset
patient
infect
rapidli
progress
primari
viral
pneumonia
pvp
minor
develop
ard
inherit
acquir
variabl
host
immun
respons
may
infl
uenc
suscept
outcom
iav
infect
howev
molecular
natur
human
factor
remain
larg
elus
method
report
three
adult
rel
autosom
domin
defi
cienci
son
histori
myelodysplast
syndrom
episod
mild
respiratori
infect
develop
pvp
rapidli
evolv
ard
die
age
respect
result
patient
heterozyg
novel
mutat
like
patient
defi
cienci
three
rel
absenc
peripher
nk
b
cell
monocytopenia
howev
high
number
plasma
cell
found
pauciclon
observ
peripher
blood
infect
normal
level
immunoglobulin
igg
antibodi
common
virus
microneutr
test
show
produc
normal
titer
neutral
antibodi
previou
annual
strain
result
suggest
clone
longliv
memori
b
cell
iav
expand
cell
produc
crossreact
antibodi
similar
recent
describ
fl
u
episod
strong
increas
cell
product
chemokin
well
strongli
elev
serum
cours
infect
conclus
defi
cienci
fi
rst
describ
mendelian
inborn
error
immun
underli
sever
iav
infect
primari
immunodefi
cienci
predispos
sever
iav
infect
may
debut
even
adult
without
histori
previou
sever
infect
massiv
cytokin
storm
may
explain
fatal
cours
infect
patient
introduct
adenosin
exert
antiinfl
ammatori
tissu
protect
eff
ect
system
infl
ammat
antiinfl
ammatori
properti
may
induc
immunoparalysi
imped
bacteri
clearanc
tissu
protect
eff
ect
might
limit
organ
damag
eff
ect
common
lossoffunct
variant
adenosin
monophosph
deaminas
gene
associ
increas
adenosin
format
patient
sepsi
unknown
method
prospect
cohort
geneticassoci
studi
eff
ect
presenc
gene
immun
function
multiorgan
dysfunct
mortal
septic
patient
studi
pneumosepsi
patient
n
control
without
infect
n
enrol
result
pneumosepsi
patient
control
similar
preval
mutat
gene
found
univari
logist
regress
analysi
show
tendenc
increas
mortal
patient
ct
genotyp
compar
patient
cc
genotyp
ci
moreov
carrier
ct
genotyp
tend
suff
er
multiorgan
dysfunct
ct
tt
respect
p
septic
carrier
ct
genotyp
ex
vivo
product
lpsstimul
monocyt
attenu
p
introduct
hypogammaglobulinemia
frequent
found
adult
patient
sever
sepsi
septic
shock
furthermor
seem
least
low
serum
level
igm
correl
higher
mortal
sepsi
mechan
hypogammaglobulinemia
septic
shock
yet
explain
hypothes
outfl
ow
immunoglobulin
extravascular
space
due
increas
capillari
permeabl
could
reduc
immunoglobulin
serum
concentr
directli
disrupt
endotheli
barrier
markedli
elev
sepsi
infl
ammatori
state
serum
level
correl
microvascular
leakag
endorgan
dysfunct
death
sepsi
method
prospect
nonintervent
studi
assess
correl
capillari
leakag
marker
serum
level
igg
igm
patient
communityacquir
sever
sepsi
septic
shock
admiss
blood
sampl
obtain
fi
rst
hour
admiss
hospit
result
mean
age
patient
femal
year
median
apach
ii
sofa
score
admiss
respect
mortal
rate
thirtyfour
percent
patient
level
igg
mgdl
median
concentr
hypoigg
group
pgml
statist
diff
erent
mannwhitney
p
rest
patient
normal
level
igg
pgml
concentr
igm
mgdl
found
four
patient
die
pearson
correl
test
show
correl
concentr
igg
correl
coeffi
cient
igm
correl
coeffi
cient
respect
statist
signifi
cant
p
conclus
present
hypothesi
increas
microvascular
leakag
respons
hypogammaglobulinemia
septic
patient
could
accept
studi
larger
number
patient
need
addit
necessari
explor
possibl
mechan
increas
catabol
consumpt
antibodi
inadequ
synthesi
immunoglobulin
could
also
respons
hypogammaglobulinemia
sepsi
introduct
septic
encephalopathi
frequent
complic
sever
sepsi
pathogenesi
mechan
fulli
understood
oxygen
suppli
util
critic
organ
function
especi
brain
tissu
extrem
depend
oxygen
glucos
disturb
oxygen
util
common
sepsi
number
mitochondri
dysfunct
describ
diff
erent
tissu
septic
anim
well
septic
patient
group
describ
mitochondri
dysfunct
brain
experiment
sepsi
method
experiment
sepsi
induc
endotoxemia
lp
mg
kg
ip
spraguedawley
rat
polymicrobi
fecal
periton
swiss
mice
brain
glucos
uptak
observ
vivo
endotoxem
rat
use
positron
emiss
tomographi
f
fl
uorodeoxyglucos
autoradiographi
cglucos
result
mice
polymicrobi
sepsi
present
hypoglycemia
hyperlactatemia
longterm
cognit
impair
observ
rapid
increas
uptak
fl
uoresc
glucos
analog
amino
dglucos
brain
slice
septic
mice
vitro
similar
increas
brain
glucos
uptak
observ
vivo
endotoxem
rat
remark
increas
glucos
uptak
start
hour
lp
inject
earlier
organ
brain
mice
experiment
sepsi
present
neuroinfl
ammat
mitochondri
dysfunct
oxid
stress
mitochondria
isol
septic
brain
gener
less
ro
vitro
fi
rst
hour
led
us
investig
role
nadph
oxidas
enzym
induc
innat
immun
respons
potenti
sourc
reactiv
oxygen
speci
experiment
sepsi
inhibit
nadph
oxidas
apocynin
acut
sepsi
prevent
cognit
impair
mice
data
indic
bioenerget
imbal
oxid
stress
associ
pathophysiolog
septic
encephalopathi
observ
new
metabol
phenotyp
brain
sepsi
character
rapid
increas
glucos
uptak
mitochondri
dysfunct
may
secondari
infl
ammat
hypoxia
introduct
pathophysiolog
brain
dysfunct
associ
sepsi
still
poorli
understood
potenti
mechan
involv
oxid
stress
neuroinfl
ammat
bloodbrain
barrier
alter
purpos
studi
metabol
alter
marker
mitochondri
dysfunct
clinic
relev
model
septic
shock
method
twelv
anesthet
midazolamfentanylpancuronium
invas
monitor
mechan
ventil
pig
alloc
sham
procedur
n
sepsi
n
periton
induc
intraabdomin
inject
autolog
fece
anim
studi
spontan
death
maximum
hour
addit
global
hemodynam
laboratori
assess
intracrani
pressur
cerebr
microdialysi
assess
baselin
hour
sepsi
induct
death
brain
remov
brain
homogen
studi
assess
marker
mitochondri
dysfunct
introduct
identifi
group
patient
high
risk
develop
infecti
complic
fi
rst
step
introduct
eff
ectiv
preemptiv
therapi
specifi
c
patient
group
quantifi
cytokin
gene
express
also
further
understand
traumainduc
immunosuppress
group
alreadi
demonstr
predict
immunolog
signatur
deriv
mrna
express
elect
thorac
surgic
patient
accur
predict
pneumonia
risk
method
total
ventil
polytrauma
patient
recruit
mrna
extract
paxgen
tube
collect
within
hour
initi
insult
hour
thelper
cell
subtyp
specifi
c
cytokin
transcript
factor
mrna
quantifi
ed
use
qpcr
ten
healthi
control
serv
compar
result
median
injuri
sever
score
iss
time
blood
demonstr
reduct
bet
increas
mrna
level
comparison
control
group
p
p
p
p
posit
correl
iss
whilst
introduct
measur
biomark
potenti
approach
earli
assess
predict
mortal
septic
patient
purpos
studi
ascertain
prognost
valu
proadrenomedullin
padm
measur
patient
admit
icu
hospit
diagnosi
sever
sepsi
septic
shock
year
method
cohort
studi
patient
year
sever
sepsi
accord
surviv
sepsi
campaign
icu
univers
hospit
demograph
clinic
paramet
padm
creactiv
protein
procalcitonin
studi
year
descript
compar
statist
analysi
perform
use
statist
softwar
packag
statistica
stat
soft
inc
medcalc
result
analyz
consecut
episod
sever
sepsi
septic
shock
icu
median
age
patient
introduct
sepsi
result
complex
interact
infect
microorgan
host
respons
often
lead
multipl
organ
failur
death
year
treatment
standard
earli
goalori
therapi
may
benefi
circul
biomark
earli
risk
stratifi
cation
aim
evalu
prognost
valu
presepsin
novel
marker
bacteri
infect
method
perform
nest
casecontrol
studi
random
control
albumin
italian
outcom
sepsi
albio
trial
enrol
patient
sever
sepsi
septic
shock
icu
itali
fifti
survivor
nonsurvivor
icu
discharg
select
match
age
sex
center
time
enrol
inclus
criteria
present
edtaplasma
sampl
collect
day
enrol
presepsin
immunechemiluminesc
assay
pathfast
presepsin
url
pgml
cv
mitsubishi
chemic
procalcitonin
assay
pct
elecsi
brahm
pct
url
ngml
cv
roch
diagnost
result
clinic
characterist
similar
two
group
except
wors
sofa
score
day
deced
presepsin
day
signifi
cantli
higher
deced
pg
ml
median
survivor
pgml
p
pct
diff
er
vs
ngml
p
presepsin
decreas
time
survivor
remain
elev
deced
vs
pgml
day
p
timesurviv
interact
pct
decreas
similarli
two
group
p
patient
earli
elev
presepsin
wors
sofa
score
higher
number
mof
hemodynam
instabl
lower
mean
arteri
pressur
baselin
hour
mortal
rate
day
vs
logrank
p
associ
presepsin
outcom
mark
patient
late
enrol
hour
septic
shock
earli
presepsin
better
prognost
accuraci
pct
auroc
vs
p
improv
discrimin
sofa
score
especi
septic
shock
conclus
earli
presepsin
measur
may
provid
import
prognost
inform
patient
sever
sepsi
septic
shock
may
crucial
import
earli
risk
stratifi
cation
introduct
infect
major
complic
postop
period
heart
transplant
ht
hospit
nosocomi
pneumonia
frequent
infect
period
object
studi
determin
epidemiolog
microbiolog
characterist
diseas
centr
method
descript
retrospect
studi
medic
record
ht
perform
singl
institut
follow
june
clinic
microbiolog
variabl
consid
centr
diseas
control
cdc
criteria
use
defi
ne
nosocomi
infect
invas
aspergillosi
consid
criteria
probabl
aspergillosi
accord
idsa
criteria
result
ht
infecti
episod
patient
eightyfi
patient
die
hospit
infect
second
caus
mortal
postop
period
dead
patient
common
locat
infect
pneumonia
n
infect
episod
bloodstream
n
urinari
tract
n
surgic
site
n
intraabdomin
infect
n
patient
pneumonia
treat
accord
knowledg
specifi
c
moment
thu
diff
erent
antibiot
use
durat
antibiot
therapi
day
nine
episod
pneumonia
accord
cdc
germ
isol
cultur
six
episod
polymicrobi
infect
frequent
microb
isol
e
coli
n
pneumonia
case
fumigatu
n
aureu
n
p
aeruginosa
n
p
mirabili
k
pneumonia
e
cloaca
e
faecali
c
glabrata
marcescen
one
case
pneumonia
suspect
confi
rmed
patient
despit
antibiot
treatment
maintain
media
day
widespectrum
treatment
target
therapi
know
antibiogram
length
icu
stay
day
hospit
stay
day
mechan
ventil
day
mortal
patient
pneumonia
conclus
nosocomi
pneumonia
frequent
infect
seri
despit
infect
confi
rmed
antibiot
therapi
maintain
suspect
case
found
high
incid
aspergillosi
limit
wide
durat
studi
consid
number
cvc
intub
surgeri
use
muscl
relax
steroid
independ
risk
factor
develop
vap
ventil
day
icu
length
stay
longer
vap
group
vs
vs
day
respect
lastli
hospit
mortal
rate
signifi
cantli
higher
vap
group
vs
p
conclus
incid
vap
sicu
siriraj
hospit
compar
previou
report
bundl
care
prevent
vap
includ
wean
ventil
muscl
relax
steroid
administ
accord
strong
indic
meticul
care
airway
implement
protocol
order
prevent
complic
result
develop
vap
refer
introduct
prospect
studi
determin
incid
sourc
etiolog
hospitalacquir
bloodstream
infect
habsi
indian
context
resist
pattern
also
review
method
singlecentr
prospect
studi
icu
habsi
defi
ned
accord
current
cdc
guidelin
hcap
catheterassoci
uti
cauti
skinrel
infect
caus
bsi
also
defi
ned
accord
recent
guidelin
analys
result
posit
sampl
sampl
n
habsi
microbiolog
analysi
show
gramneg
candida
gramposit
commonest
isol
klebsiella
mrsa
commonest
gramposit
sourc
habsi
show
crbsi
commonest
caus
correl
intern
data
ventilatorassoci
pneumonia
cauti
caus
bsi
respect
resist
pattern
among
gramneg
bacteria
show
multidrugresist
mdr
extrem
drugresist
xdr
isol
highest
see
tabl
introduct
catheterrel
bloodstream
infect
crbsi
complic
central
venou
cathet
cvc
attribut
morbid
mortal
cost
examin
patient
risk
factor
crbsi
adult
parenter
nutrit
pn
popul
studi
carri
tertiaryreferr
teach
hospit
studi
period
inpati
refer
pn
via
cvc
includ
prospect
collect
data
record
specifi
c
pn
record
crbsi
audit
group
met
quarterli
review
sepsi
episod
assign
diagnost
categori
crbsi
noncrbsi
patient
risk
factor
develop
crbsi
examin
use
logist
regress
model
take
account
dichotom
natur
outcom
odd
ratio
model
incorpor
demograph
clinic
data
test
statist
signifi
canc
introduct
mani
patient
develop
infect
follow
oper
decreas
immun
compet
demonstr
acut
neurolog
condit
strong
cytokinemedi
antiinfl
ammatori
respons
observ
stroke
patient
infect
although
infect
due
decreas
proinfl
ammatori
mediat
expect
well
investig
question
follow
experi
perform
method
twentytwo
urinari
bladder
cancer
patient
radic
cystectomi
lymphadenectomi
studi
blood
sampl
taken
day
day
oper
well
day
followup
solubl
receptor
level
sera
determin
hs
elisa
andor
elisa
plasma
acth
cortisol
valu
measur
ria
kit
result
patient
eight
deep
wound
urin
infect
found
day
six
urin
wound
infect
day
surgeri
surviv
patient
bacteri
contamin
wound
sampl
taken
end
oper
demonstr
day
circul
valu
lower
infect
patient
tnf
start
increas
day
day
never
reach
valu
unev
heal
group
solubl
tnf
receptor
acth
cortisol
concentr
demonstr
diff
erenc
day
day
start
increas
transient
reach
higher
level
septic
patient
conclus
low
proinfl
ammatori
respons
key
facilit
factor
develop
infect
measur
serum
level
oper
thu
predict
outcom
evalu
day
may
includ
direct
observ
hand
hygien
complianc
control
nurs
hand
cultur
healthcar
worker
hcw
base
guidelin
hand
hygien
health
care
clean
hand
alcoholbas
hand
rub
sterillium
prescrib
touch
patient
asept
procedur
bodi
fl
uid
exposur
risk
touch
patient
touch
hisher
surround
promot
hand
hygien
program
consist
lectur
webbas
selflearn
poster
locat
near
point
care
verbal
remind
control
nurs
new
observ
hand
hygien
control
nurs
day
hand
cultur
healthcar
provid
perform
septemb
consumpt
alcoholbas
hand
rub
product
volum
use
per
patientday
use
surrog
marker
hand
hygien
time
diff
erenc
hand
hygien
complianc
two
period
examin
use
chisquar
test
diff
erenc
hand
cultur
examin
use
student
test
time
trend
consumpt
alcoholbas
hand
rub
examin
use
linear
correl
p
consid
statist
signifi
cant
studi
approv
institut
ethic
review
board
result
survey
may
opportun
observ
hand
hygien
present
septemb
overal
complianc
improv
p
may
hcw
mean
colonyform
unit
cfu
hand
compar
cfu
hand
hcw
septemb
p
also
observ
initi
increas
use
alcoholbas
hand
rub
ml
per
patientday
may
maximum
ml
per
patientday
june
declin
ml
per
patientday
septemb
pearson
correl
coeffi
cient
p
conclus
implement
new
hand
hygien
program
icu
result
improv
hand
hygien
complianc
less
cfu
hand
hcw
signifi
cant
increas
use
alcoholbas
hand
rub
time
result
indic
constant
awar
vital
success
refer
introduct
icuacquir
infect
directli
relat
hospit
mortal
hand
hygien
eff
ectiv
lowcost
intervent
prevent
spread
bacteri
pathogen
includ
multidrugresist
organ
histor
complianc
hand
hygien
guidelin
physician
nurs
care
provid
poor
method
present
expect
infect
control
committe
pump
pump
everi
room
use
isopropyl
alcohol
perform
observ
hand
hygien
surgic
icu
march
octob
interven
chang
behavior
provid
monthli
feedback
specifi
c
provid
group
servic
made
use
unit
coordin
measur
complianc
individu
icu
result
overal
complianc
physician
nonphysician
feedback
physician
individu
servic
dramat
increas
hand
hygien
complianc
defi
ned
entri
exit
patient
room
studi
period
see
figur
conclus
physician
behavior
respons
monthli
feedback
specifi
c
individu
surgic
servic
use
unit
coordin
eff
ectiv
gather
larg
sampl
size
short
period
time
introduct
benefi
ts
univers
glove
gown
bugg
studi
clusterrandom
trial
evalu
use
wear
glove
gown
patient
contact
icu
primari
outcom
vre
mrsa
acquisit
secondari
outcom
includ
frequenc
healthcar
worker
visit
infect
rate
hand
hygien
complianc
advers
event
method
enrol
icu
state
icu
collect
nasal
perian
swab
patient
admiss
dischargetransf
baselin
period
unit
random
intervent
arm
requir
wear
glove
gown
patient
contact
intervent
toolkit
creat
base
site
feedback
complianc
report
swab
collect
complianc
fed
back
discuss
site
confer
call
weekli
basi
site
coordin
monitor
complianc
glove
gown
hand
hygien
frequenc
hcw
visit
review
patient
chart
advers
event
result
studi
period
swab
collect
baselin
period
abl
achiev
maintain
swab
complianc
rate
monthli
discharg
complianc
increas
begin
intervent
period
figur
observ
found
complianc
univers
glove
gown
observ
period
figur
nineti
chart
site
review
advers
event
conclus
divers
group
us
hospit
achiev
high
complianc
surveil
cultur
implement
univers
glove
gown
achiev
quickli
high
complianc
introduct
sepsi
account
high
mortal
surviv
sepsi
campaign
recommend
fi
rst
hour
resuscit
bundl
improv
patient
outcom
despit
bundl
poorli
perform
sever
organiz
cultur
barrier
recognit
guess
educ
organiz
intervent
icu
could
impact
septic
patient
outcom
order
test
hypothesi
carri
hospit
preintervent
survey
human
organiz
resourc
hor
avail
manag
septic
patient
aim
seek
barrier
potenti
aff
ect
correct
guidelin
implement
method
thirtynin
medic
ward
mw
emerg
depart
ed
enrol
everi
unit
ask
fi
preagre
hor
checklist
focus
main
requir
suggest
guidelin
result
analys
human
resourc
avail
see
bedtodoctor
ratio
signifi
cantli
p
increas
day
night
shift
bed
per
doctor
mw
median
otherwis
ed
staff
remain
roughli
doctor
duti
median
analysi
organiz
tool
tabl
point
low
percentag
hospit
diagnost
therapeut
protocol
sepsi
manag
hospit
empir
antibiot
therapi
guidelin
infect
sourc
erad
protocol
moreov
hospit
involv
infecti
diseas
expert
everi
case
sever
sepsi
septic
shock
conclus
guess
poor
avail
hor
show
hospit
could
role
guidelin
implement
patient
outcom
comparison
result
data
collect
clinic
checklist
focus
sepsi
bundl
complianc
patient
outcom
summari
could
confi
rm
hypothesi
aim
next
part
studi
refer
introduct
incid
patient
carri
esblposit
bacteria
icu
admiss
consid
problemat
howev
routin
cultur
identifi
ed
esblneg
patient
becom
colon
esbl
strain
icu
stay
selfdisinfect
siphon
prevent
bacteri
growth
antibacteri
coat
intermitt
heat
biofi
lm
format
electromechan
vibrat
place
sink
icu
aim
present
studi
evalu
eff
ect
intervent
method
intervent
studi
icu
intervent
involv
placement
selfdisinfect
siphon
biorec
patient
expect
icu
stay
day
januari
decemb
studi
sampl
throat
sputum
rectum
taken
admiss
twice
weekli
cultur
esbl
june
octob
sink
patient
room
cultur
regularli
esbl
intervent
april
multipl
repeat
cultur
taken
whenev
speci
antibiogram
bacteria
cultur
patient
sink
match
type
aflp
result
intervent
multipl
esblform
strain
found
sink
patient
room
eighteen
patient
esblneg
icu
admiss
becam
colon
diff
erent
esbl
strain
present
sink
admiss
room
figur
four
contamin
proven
aflpti
one
patient
die
esblposit
e
cloaca
pneumonia
intervent
sink
neg
esbl
strain
patient
becam
esbl
colon
icu
stay
conclus
wastewat
sink
like
sourc
esbl
colon
icu
patient
place
selfdisinfect
siphon
introduct
present
studi
investig
eff
ect
singl
dose
intraperiton
ip
igg
iggam
administr
variou
behavior
alter
cecal
ligat
perfor
clp
induc
sepsi
model
rat
method
femal
wistar
albino
rat
g
divid
fi
group
n
naiv
control
group
sham
oper
group
receiv
convent
antibiot
treatment
clp
group
receiv
clp
procedur
convent
antibiot
treatment
igg
iggam
group
also
appli
gkg
ip
igg
igam
therapi
minut
clp
procedur
ten
day
surgeri
anim
underw
three
behavior
task
open
fi
eld
test
evalu
locomotor
activ
elev
plu
maze
test
measur
level
anxieti
forc
swim
test
assess
possibl
depress
state
result
acquir
test
use
estim
eff
ect
immunoglobulin
therapi
behavior
chang
clpinduc
sepsi
rat
open
fi
eld
test
clp
group
show
signifi
cant
decreas
total
squar
pass
day
similarli
total
number
rear
groom
dramat
decreas
clp
group
comparison
control
sham
group
p
elev
plu
maze
test
number
entri
open
arm
decreas
clp
group
forc
swim
test
tendenc
increas
immobl
time
clp
group
although
data
statist
insignifi
cant
valu
indic
import
behavior
alter
improv
day
immunoglobulin
therapi
prevent
occurr
behavior
chang
especi
anim
iggam
group
conserv
valu
quit
near
control
group
measur
paramet
conclus
sepsi
even
though
treat
convent
antibiot
caus
neg
eff
ect
behavior
paramet
studi
igg
iggam
treat
anim
presenc
clp
show
behavior
chang
therefor
result
suggest
singl
dose
ip
igg
iggam
treatment
appli
immedi
sepsi
procedur
prevent
behavior
defect
observ
follow
sepsi
introduct
thrombomodulin
endotheli
cell
cofactor
glycoprotein
thrombincatalyz
activ
protein
c
recombin
human
solubl
thrombomodulin
rhstm
recent
develop
new
agent
uniqu
aminotermin
structur
exhibit
antiinfl
ammatori
activ
includ
sequestract
cleavag
highmobl
group
box
method
studi
patient
septic
dissemin
intravascular
coagul
dic
treat
rhstm
inj
asahi
kasei
pharma
co
tokyo
japan
patient
septic
dic
treat
ukgday
result
signifi
cant
result
improv
apach
ii
score
dic
diagnost
criteria
score
critic
ill
patient
treatment
use
rhstm
p
improv
platelet
count
ddimer
level
also
observ
studi
p
activ
antithrombin
also
signifi
cantli
increas
treatment
p
hospit
mortal
studi
conclus
rhstm
might
one
import
endogen
regul
coagul
act
major
inhibitor
thrombin
well
iii
new
agent
may
play
import
role
treatment
septic
dic
introduct
antithrombin
iii
iii
known
contribut
antiinfl
ammatori
respons
well
anticoagul
previou
introduct
sepsi
septic
shock
complex
infl
ammatori
syndrom
multipl
cellular
activ
process
involv
mani
humor
cascad
trigger
presum
endotheli
cell
play
pivot
rule
pathogenesi
sepsi
may
infl
uenc
infl
ammatori
cascad
also
upon
interact
excess
amount
infl
ammatori
mediat
function
cell
may
becom
impair
like
gener
dysfunct
endothelium
key
event
pathogenesi
sepsi
hmgcoareductas
inhibitor
shown
exhibit
pronounc
immunomodulatori
eff
ect
independ
lipid
lower
benefi
cial
eff
ect
statin
appear
involv
restor
improv
endotheli
function
hypothes
statin
improv
endotheli
dysfunct
septic
patient
method
doubleblind
placebocontrol
random
trial
undertaken
enrol
adult
patient
within
hour
sever
sepsi
septic
shock
diagnosi
random
placebo
atorvastatin
mgday
short
term
endotheli
dysfunct
assess
measur
plasmat
level
elisa
measur
fl
owmedi
vasodilat
brachial
arteri
basal
hour
random
result
studi
patient
placebo
group
mean
age
year
male
apach
ii
risk
score
statin
group
mean
age
year
male
apach
ii
risk
score
baselin
characterist
placebo
group
similar
statin
patient
well
mean
length
stay
icu
day
respect
time
vasopressor
hour
respect
signifi
cant
diff
erenc
observ
tempor
variat
biomark
level
treatment
control
group
intrahospit
mortal
rate
statin
group
placebo
group
p
introduct
novel
sorbent
hemoadsorpt
devic
cytokin
remov
cytosorb
usa
develop
success
test
anim
model
sepsi
experi
clinic
set
still
limit
case
report
fi
rst
clinic
trial
test
hypothesi
treatment
sorbent
hemoadsorpt
could
safe
eff
ectiv
reduc
cytokin
septic
patient
acut
lung
injuri
ali
method
ventil
patient
fulfi
lling
criteria
sever
sepsi
ali
enrol
multicent
random
control
openlabel
studi
compar
standard
care
without
hemoperfus
treatment
primari
endpoint
safeti
reduct
treat
patient
underw
hemoperfus
fl
ow
rate
ml
minut
hour
per
day
consecut
day
overal
mean
reduct
individu
plasma
cytokin
control
treatment
group
treatment
period
calcul
use
gener
linear
model
result
fortythre
patient
treat
control
complet
studi
analyz
incid
organ
dysfunct
enrol
treatment
vs
control
septic
shock
vs
p
acut
respiratori
distress
syndrom
vs
p
renal
failur
vs
p
treatment
seriou
devicerel
advers
event
occur
averag
chang
hematolog
blood
paramet
except
modest
reduct
platelet
count
albumin
treatment
hemoperfus
decreas
blood
concentr
signifi
cantli
p
similar
reduct
p
p
p
mortal
vs
control
p
mortal
vs
control
p
diff
er
signifi
cantli
two
studi
group
conclus
fi
rst
clinic
studi
novel
sorbent
hemoadsorpt
devic
patient
sever
sepsi
ali
devic
appear
safe
decreas
blood
concentr
sever
cytokin
research
need
studi
eff
ect
devic
clinic
outcom
septic
patient
respons
chang
endotoxin
proinfl
ammatori
molecul
method
forti
septicsept
shock
patient
renal
failur
enrol
studi
patient
preoper
endotoxin
levelunit
eaa
spectral
submit
highvolum
hemodiafi
ltration
mlkghour
prismafl
ex
gambro
new
treat
heparinco
membran
oxiri
gambro
pretreat
hour
main
clinic
biochem
data
evalu
data
express
mean
sd
oneway
anova
test
bonferroni
correct
use
evalu
data
chang
p
consid
signifi
cant
result
tabl
present
main
result
studi
conclus
septicsept
shock
patient
renal
failur
crrt
new
treat
heparinco
membran
oxiri
gambro
clinic
feasibl
posit
eff
ect
renal
function
hemodynam
adsorb
eff
ect
proinfl
ammatori
mediat
may
role
result
data
trend
toward
decreas
endotoxin
treatment
warrant
investig
refer
introduct
endotoxin
compon
outer
membran
gramneg
bacteria
consid
import
factor
pathogenesi
septic
shock
aim
studi
determin
whether
endotoxin
elimin
treatment
ad
standard
treatment
would
improv
organ
function
patient
septic
shock
method
adult
patient
septic
shock
requir
renal
replac
therapi
rrt
confi
rmed
endotoxemia
suspect
gramneg
infect
consecut
ad
studi
within
fi
rst
hour
diagnosi
patient
receiv
full
standard
treatment
septic
shock
endotoxin
elimin
perform
use
membran
oxiri
gambro
sweden
medic
devic
continu
rrt
uniqu
featur
endotoxin
adsorbt
endotoxin
activ
assay
use
monitor
endotoxin
elimin
therapi
baselin
hour
hour
hour
hour
hour
key
indic
improv
hemodynam
organ
function
decreas
endotoxin
activ
ea
blood
continu
variabl
present
mean
valu
standard
deviat
result
high
ea
level
baselin
endotoxin
activ
unit
eau
signifi
cantli
decreas
rrt
oxiri
membran
eau
p
map
increas
baselin
mmhg
p
mean
norepinephrin
use
decreas
p
respect
sofa
score
decreas
point
p
procalcitonin
level
declin
ngml
p
conclus
rrt
oxiri
membran
result
eff
ectiv
elimin
endotoxin
blood
therapi
associ
increas
blood
pressur
reduct
vasopressor
requir
improv
organ
function
applic
endotoxin
activ
assay
use
bedsid
monitor
endotoxemia
icu
patient
introduct
sever
sepsi
septic
shock
remain
seriou
problem
critic
care
medicin
mortal
rate
sever
studi
demonstr
posit
eff
ect
select
adsorpt
lp
blood
pressur
pao
fio
ratio
endotoxin
remov
mortal
purpos
studi
evalu
effi
cienci
use
select
adsorpt
lp
toraymyxin
pmxf
toray
japan
lp
adsorb
alteco
medic
ab
sweden
complex
treatment
patient
sever
sepsi
method
fortysix
patient
gramneg
sepsi
postop
period
enrol
studi
toraymyxin
pmxf
use
pmxf
group
n
alteco
lp
adsorpt
use
alteco
lp
group
n
clinic
characterist
list
tabl
sofa
score
pao
fio
procalcitonin
pct
creactiv
protein
crp
endotoxin
activ
assay
eaa
note
hour
select
adsorpt
lp
result
hour
pmxf
signifi
cantli
decreas
pct
ngml
p
decreas
crp
mgl
p
sofa
score
p
hour
alteco
lp
signifi
cantli
decreas
pct
ngml
mortal
rate
n
pmxf
group
n
alteco
lp
group
introduct
corticosteroid
cs
therapi
sepsi
remain
controversi
fi
rst
introduc
sepsi
manag
antiinfl
ammatori
properti
cs
found
role
septic
shock
amelior
inconsist
outcom
surviv
sepsi
campaign
ssc
includ
cs
level
recommend
septic
shock
adapt
practic
ssc
guidelin
vari
critic
care
unit
accordingli
survey
conduct
elucid
usag
cs
septic
shock
uk
critic
care
physician
ccp
method
follow
approv
uk
intens
care
societi
ic
survey
publicis
ic
websit
newslett
result
total
intensivist
respond
onlin
survey
seventyfour
ccp
prescrib
cs
septic
shock
poorli
respons
fl
uid
resuscit
vasopressor
therapi
six
initi
cs
time
vasopressor
therapi
none
initi
cs
patient
sever
sepsi
cs
hydrocortison
use
commonli
use
intraven
regimen
mg
hourli
follow
mg
hourli
ccp
would
prescrib
infus
less
commonli
use
regimen
mg
hourli
mg
hourli
would
consid
ad
fl
udrocortison
prior
initi
cs
ccp
would
perform
short
synacthen
test
would
major
ccp
would
stop
cs
resolut
shock
state
vasopressor
infus
termin
whilst
fi
xed
durat
withdraw
cs
also
diff
ere
taperedwean
steroid
stop
abruptli
ccp
would
base
cs
cessat
pattern
clinic
context
ccp
believ
cs
benefi
cial
wherea
unsur
benefi
ts
septic
shock
respond
indic
critic
care
unit
written
protocol
cs
septic
shock
conclus
percept
usag
cessat
cs
septic
shock
vari
appear
shift
last
decad
uk
survey
identifi
ed
icu
use
cs
septic
shock
perform
short
synacthen
test
appear
mani
intensivist
use
cs
septic
shock
despit
confl
ict
outcom
data
strive
practic
evidencebas
medicin
robust
reliabl
method
randomis
control
trial
attempt
resolv
cs
debat
practic
remain
divers
subject
refl
ect
survey
refer
introduct
decemb
decemb
patient
scotland
present
confi
rmed
anthrax
infect
manifest
soft
tissu
diseas
relat
heroin
inject
case
repres
fi
rst
known
outbreak
recent
recogn
form
anthrax
term
inject
anthrax
appear
associ
high
mortal
rate
confi
rmed
case
uk
outbreak
epidemiolog
data
outbreak
publish
report
systemat
describ
fi
nding
patient
present
compar
fi
nding
nonsurvivor
survivor
method
better
describ
inject
anthrax
develop
questionnair
sent
clinician
care
confi
rmed
case
outbreak
complet
questionnair
describ
patient
nonsurvivor
survivor
return
result
preliminari
analysi
categor
data
signifi
cantli
fisher
exact
test
greater
proport
patient
compar
without
follow
fi
nding
surviv
histori
alcohol
use
p
presenc
lethargi
p
confus
p
nausea
p
abdomin
pain
p
need
vasopressor
p
oxygen
mechan
ventil
steroid
p
present
excess
bleed
surgeri
p
initi
analysi
continu
data
demonstr
compar
survivor
present
nonsurvivor
signifi
cantli
oneway
anova
increas
respiratori
rate
percent
neutrophil
complet
blood
count
hemoglobin
inr
creactiv
protein
bilirubin
signifi
cantli
decreas
temperatur
systol
blood
pressur
platelet
sodium
albumin
calcium
correct
albumin
base
excess
bicarbon
p
conclus
implic
appar
diff
erenc
note
nonsurvivor
survivor
survey
case
fi
rst
known
outbreak
inject
anthrax
requir
studi
howev
diff
erenc
might
inform
design
research
futur
outbreak
method
identifi
patient
need
anthraxspecifi
c
therapi
toxindirect
antibodi
introduct
base
result
previou
studi
identifi
ed
clinic
risk
factor
emerg
gr
infect
icu
develop
new
algorithm
combat
choic
particular
antibiot
drug
guid
addit
risk
factor
sever
ill
data
infecti
focu
respons
therapi
durat
also
state
aim
current
studi
evalu
effi
caci
safeti
preemptiv
approach
method
random
prospect
control
trial
carri
septemb
septemb
patient
submit
block
random
stratifi
ed
basi
initi
sap
ii
exp
score
antibiot
therapi
start
day
inclus
treatment
group
proven
gr
pathogen
control
group
initi
data
gather
demograph
diagnosi
proven
risk
factor
sepsisrel
mortal
sever
infl
ammatori
respons
ventilatorassoci
pneumonia
organ
dysfunct
dynam
sir
cpi
sofa
score
subsequ
infecti
isol
ventilatorfre
day
length
icu
stay
outcom
follow
patient
result
total
patient
enrol
statist
signifi
cant
diff
erenc
basal
characterist
found
subsequ
score
valu
length
icu
stay
number
ventilatorfre
day
also
compar
group
major
gr
pathogen
isol
day
inclus
diff
erenc
found
regard
concomit
gr
fl
ora
relat
antibiot
therapi
new
organ
dysfunct
sever
similar
group
p
inhospit
mortal
treatment
group
versu
control
group
p
signifi
cant
diff
erenc
kaplanmei
estim
surviv
also
found
logrank
test
p
major
advers
reaction
observ
conclus
implement
new
polici
fail
reduc
degre
organ
dysfunct
sever
associ
signifi
cant
surviv
benefi
moreov
even
though
reach
statist
signifi
canc
second
peak
gr
isol
observ
possibl
complic
preemptiv
therapi
whether
approach
could
lead
vancomycin
mic
creep
could
still
nich
later
cours
treatment
andor
nontrauma
patient
remain
explor
refer
introduct
acinetobact
baumannii
baum
lead
caus
septicemia
patient
hospit
icu
high
mortal
rate
aim
studi
investig
risk
factor
associ
baum
bacteremia
mortal
rate
introduct
french
militari
hospit
kaboul
intern
airport
kaia
base
provid
surgic
care
intern
forc
afghan
nation
armi
soldier
also
local
patient
develop
multiresist
bacteria
mrb
nosocomi
infect
rais
major
problem
complic
care
combat
casualti
aim
studi
assess
preval
mrb
carriag
admiss
icu
combat
support
hospit
method
use
prospect
observ
studi
patient
admit
french
militari
icu
kaia
month
juli
septemb
hospit
patient
assess
presenc
colon
mrb
nasal
rectal
swab
perform
identifi
respect
methicillinresist
staphylococcu
aureu
mrsa
extendedspectrum
bacteria
esblb
follow
data
record
patient
admiss
demograph
characterist
bacteriolog
result
length
stay
type
previou
hospit
result
sixtythre
patient
admit
mean
length
stay
ml
day
mean
age
patient
year
patient
hospit
combatrel
trauma
noncombatrel
trauma
medic
patholog
postop
care
afghan
western
swab
realiz
eight
patient
fortythre
percent
reveal
esblb
colon
escherichia
coli
patient
klebsiella
pneumonia
one
patient
acinetobact
baumanii
one
patient
patient
colon
mrsa
ten
patient
directli
admit
icu
hospit
admiss
transfer
resuscit
stabil
care
level
unit
two
last
categori
ml
previou
hospit
respect
day
hour
among
patient
transfer
care
level
unit
ml
diff
erent
colon
noncolon
patient
versu
hour
p
mannwhitney
test
conclus
studi
preval
colon
esblb
admiss
high
suggest
high
preval
mdr
colon
local
popul
afghanistan
remain
import
intensifi
prevent
polici
mrb
crosstransmiss
deploy
icu
critic
care
volum
suppl
http
introduct
aim
studi
describ
clinic
epidemiolog
profi
le
icu
patient
receiv
tigecyclin
tgc
evalu
potenti
benefi
ts
tgc
higher
dose
method
patient
admit
icu
june
may
receiv
tgc
evalu
case
exclud
infect
microbiolog
confi
rmed
result
studi
period
patient
fulfi
lled
inclus
criteria
sd
group
mg
everi
hour
hd
group
mg
everi
hour
sd
group
hd
group
signifi
cantli
diff
erent
term
age
sever
diseas
durat
tgc
therapi
rate
concomit
activ
antibiot
use
inadequ
empir
antimicrobi
therapi
iiat
p
ns
mdr
baumannii
k
pneumonia
main
pathogen
isol
percentag
germ
baumannii
k
pneumonia
higher
sd
tgc
group
p
otherwis
infect
due
less
suscept
germ
tgc
mic
valu
mainli
treat
tgc
higher
dose
p
signifi
cant
diff
erenc
found
term
icu
mortal
p
rate
abnorm
laboratori
measur
tgc
treatment
similar
two
group
p
ns
patient
requir
tgc
discontinu
dose
reduct
suspect
advers
event
vap
subpopul
patient
receiv
sd
hd
clinic
cure
rate
microbiolog
erad
percentag
higher
tgc
use
higher
dose
vs
p
vs
p
tabl
show
multivari
analysi
clinic
cure
predictor
vap
subgroup
conclus
critic
ill
patient
hd
tgc
use
seem
safe
combin
activ
antibiot
may
increas
rate
mdr
germ
vap
clinic
success
iiat
sever
degre
patient
clinic
condit
still
remain
major
determin
vap
treatment
failur
refer
introduct
amikacin
inhal
drugdevic
combin
clinic
develop
adjunct
treatment
intub
mechan
ventil
patient
gramneg
pneumonia
product
use
proprietari
vibrat
mesh
nebul
system
pdd
clinic
amikacin
sulfat
formul
inhal
ml
mgml
amikacin
solut
twicedaili
cours
therapi
design
use
two
deliveri
system
one
system
intub
patient
onvent
figur
second
handheld
hh
system
patient
extub
complet
cours
therapi
figur
investig
vitro
amikacin
lung
dose
deliv
pdd
clinic
method
estim
lung
dose
eld
onvent
set
measur
vitro
collect
aerosol
amikacin
fi
lter
end
endotrach
tube
ventil
eld
hh
devic
calcul
fi
ne
particl
fraction
fpf
postmouthpiec
multipli
vitro
deliv
dose
postmouthpiec
fpf
refl
ect
lung
deposit
observ
phase
clinic
trial
eightyon
nebul
volum
median
diamet
vmd
introduct
recent
studi
demonstr
load
dose
mgkg
total
bodi
weight
amikacin
septic
patient
requir
reach
suffi
cient
peak
concentr
studi
examin
paramet
infl
uenc
relat
amikacin
dose
peak
concentr
method
retrospect
studi
look
patient
peak
level
multivari
linear
regress
analysi
done
sever
paramet
administ
dose
calcul
total
bodi
weight
ideal
bodi
weight
adjust
bodi
weight
type
intens
care
patient
bmi
daili
fl
uid
balanc
sofa
score
apach
score
patient
characterist
analyz
result
linear
correl
dose
amikacin
peak
level
confi
rmed
figur
total
amikacin
administr
result
therapeut
peak
level
multivari
linear
regress
analysi
show
best
linear
correl
adjust
bodi
weight
sofa
score
comparison
variabl
four
patient
group
base
deviat
measur
peak
level
predict
peak
level
accord
linear
correl
show
new
variabl
may
infl
uenc
peak
level
conclus
confi
rm
low
dose
mgkg
amikacin
intens
care
patient
seldom
result
therapeut
peak
level
propos
load
dose
mgkg
good
reach
therapeut
level
although
remain
subtherapeut
due
linear
correl
therapeut
level
may
reach
higher
dose
mgkg
new
variabl
need
investig
explain
high
variabl
achiev
peak
level
introduct
antibioticassoci
diarrhoea
aad
occur
mani
patient
receiv
antibiot
often
lead
increas
morbid
prolong
inhospit
stay
addit
healthcar
resourc
utilis
age
antibiot
prolong
postop
ward
icu
stay
suggest
independ
risk
factor
patient
popul
probiot
may
use
prevent
antibioticassoci
diarrhoea
yet
routin
recommend
compon
periop
care
aim
studi
model
longterm
cost
associ
aad
assess
eff
ectiv
probiot
prevent
strategi
develop
simul
model
determin
clinic
cost
outcom
attribut
aad
assess
costeff
ectiv
probiot
part
periop
regim
construct
decis
critic
care
volum
suppl
http
tree
model
observ
longterm
cost
outcom
probiot
compar
convent
therapi
societ
perspect
input
paramet
extract
metaanalysi
clinic
trial
nation
databas
includ
incid
number
cost
qualityadjust
health
state
remain
life
qali
outcom
assess
overal
cost
attribut
add
costeff
ectiv
probiot
describ
costsqali
result
indic
estim
increment
lifetim
cost
per
add
patient
larg
driven
increas
icu
length
stay
readmiss
rate
addit
probiot
standard
periop
regim
associ
small
surviv
benefi
month
yet
cost
reduct
patient
main
cost
increas
durat
icu
stay
readmiss
contribut
total
expens
conclus
aad
associ
signifi
cant
increas
cost
societ
perspect
provis
probiot
achiev
substanti
cost
save
recommend
costeff
ectiv
regim
periop
set
prevent
add
er
potenti
signifi
cant
reduct
inhospit
cost
resourc
expenditur
introduct
novel
treatment
strategi
invas
candidiasi
ic
constantli
emerg
nevertheless
diffi
culti
diagnosi
pose
challeng
reliabl
effi
caci
safeti
previous
develop
approb
icu
algorithm
empir
antimycot
therapi
combin
signifi
cant
risk
factor
ic
three
major
clinic
criteria
persist
nonbacteri
sepsi
hand
preemptiv
therapi
base
identifi
cation
mycot
antigen
andor
antimycot
antibodi
serum
regard
reliabl
even
though
known
low
sensit
aim
current
studi
compar
evalu
possibl
outcom
benefi
protocol
implement
versu
detect
galactomanan
patient
serum
trigger
antimycot
treatment
initi
method
random
prospect
control
trial
carri
septemb
septemb
implic
inclus
exclus
criteria
patient
submit
block
random
stratifi
ed
basi
initi
sap
ii
exp
score
antimycot
therapi
start
day
inclus
control
group
posit
galactomanan
serum
test
preemptiv
therapi
group
initi
data
gather
demograph
proven
risk
factor
icrel
mortal
sever
infl
ammatori
respons
organ
dysfunct
dynam
sir
sofa
valu
candida
colon
index
ventilatorfre
day
length
icu
stay
outcom
follow
patient
result
total
patient
enrol
statist
signifi
cant
diff
erenc
basal
characterist
found
subsequ
sir
sofa
score
show
fi
rm
dynam
control
group
although
new
organ
dysfunct
sever
insignifi
cantli
lower
length
icu
stay
number
ventilatorfre
day
compar
inhospit
mortal
preemptiv
therapi
group
versu
control
group
p
total
seven
advers
reaction
observ
among
treat
patient
yet
associ
higher
mortal
risk
conclus
choic
empir
versu
preemptiv
therapi
led
earlier
stabl
reduct
degre
organ
dysfunct
sever
show
least
inferior
equal
term
surviv
benefi
expedi
treatment
moreov
galactomanan
detect
fail
guid
choic
individu
antimycot
base
expect
candida
spp
refer
introduct
invas
candidemia
major
caus
increas
mortal
among
icu
patient
antifung
agent
like
liposomal
amphotericin
b
azol
could
accomplish
claim
fi
rst
choic
treatment
invas
fungal
infect
ifi
side
eff
ect
eff
ectiv
especi
cardiothorac
surgeri
patient
group
highrisk
patient
focu
new
strategi
agent
new
class
antimycot
agent
echinocandin
low
profi
le
side
eff
ect
low
interact
potenti
high
eff
ectiv
treatment
candidemia
power
option
treatment
ifi
report
singlecent
experi
modifi
ed
clinic
treatment
approach
base
clinic
score
leon
use
echinocandin
fi
rstline
therapi
proven
suspect
fungal
infect
method
may
octob
patient
treat
cardiothorac
icu
evalu
cardiothorac
postop
patient
proven
suspect
ifi
prophylaxi
figur
record
evalu
cardiothorac
procedur
microbiolog
yeast
date
cardiothorac
surgeri
score
casu
icu
clinic
data
mean
age
year
male
patient
patient
combin
cabg
valv
procedur
n
group
htx
ltx
n
assist
therapi
n
tavi
n
procedur
mean
predict
mortal
use
logarithm
casu
score
onset
ifi
c
albican
isol
c
glabrata
length
antifung
treatment
use
micafungin
case
day
erad
yeast
success
mortal
patient
remain
high
lower
predict
casu
score
mortal
yeast
relat
conclus
describ
treatment
approach
show
encourag
result
treatment
ifi
especi
highrisk
cardiothorac
patient
fungi
relationship
colon
invas
fungal
infect
ifi
sever
ill
icu
patient
vad
support
describ
studi
analyz
incid
outcom
fungal
infect
colon
vad
patient
bridg
transplant
destin
therapi
method
conduct
retrospect
review
vad
implant
surgic
icu
incid
fungal
colon
antifung
prophylaxi
bacteri
sepsi
mortal
ifi
versu
ifi
patient
compar
result
studi
period
patient
sever
heart
failur
cardiogen
shock
select
vad
implant
nine
destin
therapi
overal
mortal
rate
mechan
assist
confi
rmed
n
highli
suspect
n
ifi
occur
icu
stay
patient
treat
echinocandin
voriconazol
andor
liposom
amphotericin
b
isol
fungi
six
candida
albican
two
parapsilosi
one
glabrata
one
invas
pulmonari
aspergillosi
antifung
prophylaxi
fl
uconazol
administ
patient
mean
day
mainli
recent
implant
ifi
popul
n
system
vad
bacteri
sepsi
mortal
rate
mortal
without
sepsi
reduc
fungal
colon
signifi
cantli
present
vs
ifi
vad
patient
mortal
rate
dramat
higher
ifi
vs
accord
literatur
see
tabl
conclus
center
observ
high
incid
ifi
icu
patient
vad
associ
mortal
rate
screen
fungal
colon
appear
import
icu
stay
vad
patient
trial
need
investig
use
drug
choic
time
antifung
prophylaxi
highrisk
patient
refer
introduct
echinocandin
recommend
fi
rstline
treatment
candidaemia
costeff
ectiv
model
develop
uk
perspect
examin
cost
outcom
antifung
treatment
candidaemia
form
invas
candidiasi
base
european
clinic
guidelin
method
cost
treatment
outcom
echinocandin
anidula
fungin
compar
caspofungin
micafungin
fl
uconazol
voriconazol
amphotericin
b
model
includ
nonneutropen
patient
age
year
confi
rmed
candidaemia
anoth
form
invas
candidiasi
receiv
intraven
fi
rstline
treatment
patient
categoris
clinic
success
failur
patient
persistentbreakthrough
infect
frequenc
data
outcom
taken
mixedtreat
comparison
success
treat
patient
switch
oral
therapi
clinic
failur
switch
diff
erent
antifung
class
assum
secondlin
treatment
durat
equival
fi
rstline
treatment
two
line
therapi
requir
treat
infect
input
allcaus
mortal
cost
treatmentrel
advers
event
ae
medic
resourc
use
cost
lifeyear
calcul
use
publish
model
antifung
agentrel
ae
taken
product
labelliteratur
resourc
use
deriv
literatur
discuss
clinic
expert
drug
acquisit
administr
cost
taken
standard
uk
cost
sourc
result
firstlin
anidulafungin
treatment
candidaemia
costeff
ectiv
per
lifeyear
gain
versu
fl
uconazol
increment
costeff
ectiv
ratio
anidulafungin
cost
save
versu
caspofungin
micafungin
term
lifeyear
gain
due
lower
icu
cost
higher
rate
surviv
combin
higher
probabl
clinic
success
conclus
anidulafungin
costeff
ectiv
compar
fl
uconazol
treatment
candidaemia
cost
save
versu
echinocandin
uk
european
guidelin
recommend
echinocandin
fi
rstline
treatment
candidaemia
model
indic
anidulafungin
marri
clinic
eff
ectiv
costeff
ectiv
introduct
invas
fungal
infect
ifi
aff
ect
icu
patient
increas
incid
ifi
associ
poor
prognosi
complic
diffi
culti
identifi
cation
fungal
organ
tradit
cultur
method
emerg
candida
speci
resist
triazol
therapi
studi
aim
assess
preval
ifi
organ
respons
outcom
patient
aff
ect
major
patient
treat
echinocandin
whilst
nine
patient
initi
treat
fl
ucanazol
six
requir
therapi
escal
echinocandin
result
studi
consist
publish
data
whilst
ifi
preval
low
associ
increas
morbid
critic
ill
patient
studi
led
chang
hospit
polici
regard
antifung
use
icu
echinocandin
fi
rstline
preemptiv
treatment
ifi
keenli
await
result
fire
studi
provid
import
insight
identifi
cation
patient
risk
ifi
optim
drug
therapi
introduct
aim
studi
compar
selfreport
belief
actual
clinic
practic
oxygen
therapi
icu
hyperoxia
frequent
encount
ventil
patient
prolong
exposur
repeatedli
shown
induc
lung
injuri
system
toxic
method
onlin
questionnair
icu
clinician
conduct
investig
belief
motiv
regard
oxygen
therapi
critic
ill
patient
furthermor
arteri
blood
ga
abg
sampl
correspond
ventil
set
retriev
retrospect
assess
object
oxygen
april
march
icu
three
teach
hospit
netherland
result
analyz
questionnair
respons
receiv
icu
physician
nurs
major
respond
believ
oxygeninduc
lung
injuri
concern
although
barotrauma
volutrauma
gener
consid
impos
greater
risk
mechan
ventil
frequent
allow
minim
satur
rang
questionnair
kpa
figur
selfreport
fio
adjust
hypothet
patient
case
variabl
satur
level
moder
impact
underli
clinic
condit
studi
actual
clinic
practic
total
abg
sampl
correspond
ventil
set
cover
patient
admiss
retriev
analysi
show
median
iqr
pao
kpa
median
fio
median
peep
total
pao
registri
higher
previous
suggest
oxygen
goal
kpa
case
pao
higher
target
rang
neither
fio
peep
level
lower
next
abg
sampl
taken
conclus
clinician
acknowledg
detriment
eff
ect
prolong
exposur
hyperoxia
icu
report
low
toler
high
satur
level
howev
selfreport
intent
conserv
oxygen
therapi
consist
express
object
data
actual
clinic
practic
larg
proport
patient
expos
high
potenti
toxic
oxygen
level
introduct
mechan
ventil
oxygen
infl
uenc
adjust
fio
posit
endexpiratori
pressur
peep
recommend
fio
peep
set
howev
recent
audit
found
complianc
doctor
recommend
low
conclus
implement
fpi
algorithm
signifi
cantli
reduc
fio
increas
peep
appli
mechan
ventil
within
fi
rst
hour
whether
impact
earlier
wean
due
reach
wean
criteria
fio
sooner
result
shorten
durat
mechan
ventil
investig
futur
refer
system
appli
humidifi
er
optim
humid
typeb
use
three
patient
typev
four
patient
fl
ow
start
lminut
fl
ow
rate
titrat
upward
maximum
lminut
lminut
agfr
measur
intratrach
pressur
trace
done
minut
airway
pressur
measur
repeat
maxim
expiratori
pressur
measur
mmhg
agfr
respiratori
circuit
almost
typeb
obviou
decreas
agfr
typev
lminut
assum
fl
ow
lminut
respect
hfnc
signifi
cantli
increas
maxim
expiratori
pressur
group
mmhg
typev
mmhg
maximum
mmhg
typeb
agfr
set
lminut
higher
agfr
found
result
larger
increas
maximum
expiratori
pressur
data
indic
hfnc
associ
increas
intratrach
expiratori
pressur
diffi
cult
determin
endexpiratori
pressur
chose
maxim
expiratori
pressur
substitut
reason
agfr
typev
lower
assum
fl
ow
may
resist
gener
nc
larger
increas
expiratori
pressur
studi
previous
report
may
due
eff
ect
high
respiratori
resist
japanes
rel
small
airway
structur
compar
western
peopl
conclus
hfnc
eff
ectiv
provid
higher
expiratori
pressur
import
know
fl
ow
rate
lower
expect
venturi
type
use
result
weaninginduc
pulmonari
edema
diagnos
instanc
paop
signifi
cantli
increas
case
evlwi
bnp
plasma
protein
hemoglobin
concentr
signifi
cantli
increas
instanc
respect
signifi
cantli
chang
case
without
weaninginduc
pulmonari
edema
increas
evlwi
mlkg
increas
bnp
pgml
increas
plasma
protein
concentr
hemoglobin
concentr
exhibit
good
area
roc
curv
predict
weaninginduc
pulmonari
edema
respect
area
roc
curv
statist
diff
erent
baselin
valu
evlwi
bnp
plasma
protein
hemoglobin
concentr
predict
weaninginduc
pulmonari
edema
conclus
increas
evlwi
plasma
protein
hemoglobin
concentr
bnp
valuabl
altern
pulmonari
arteri
cathet
diagnos
weaninginduc
pulmonari
edema
primari
aim
studi
assess
impact
pressur
support
ventil
psv
rate
pneumothorax
mortal
critic
ill
patient
lung
injuri
secondari
aim
evalu
pressurevolum
pv
relationship
spontan
mode
ventil
associ
lower
rate
atelectasi
less
muscl
atrophi
better
airfl
ow
distribut
importantli
lower
sedat
requir
relat
lower
mortal
accordingli
hypothes
use
psv
patient
moderatesever
lung
injuri
would
rate
pneumothorax
mortal
within
standard
care
hypothes
given
spontan
natur
set
pressur
peep
ps
tidal
volum
vt
would
relat
airway
pressur
method
adult
patient
admit
two
surgicalmed
icu
subject
invas
mechan
ventil
mv
enrol
patient
stratifi
ed
lung
injuri
score
li
two
group
lisl
lish
exclus
criteria
includ
pneumothorax
admiss
use
ventilatori
strategi
inabl
trigger
ventil
patient
ventil
psv
treat
pro
nata
haldol
morphin
clozapin
airway
pressur
conclus
demonstr
psv
minim
sedat
patient
sever
lung
injuri
safe
associ
low
incid
barotrauma
atelectasi
mortal
ppl
durat
mv
within
standard
care
also
demonstr
psv
pv
relationship
may
diff
er
set
higher
vt
may
deleteri
introduct
aim
studi
compar
two
ventil
strategi
ardsnet
protocol
open
lung
manag
use
comput
control
hour
standard
therapi
patient
ard
typic
appli
mechan
ventil
support
breath
cost
therapi
high
requir
much
attent
physician
adjust
proper
ventil
set
time
manner
closedloop
ventil
concept
therefor
develop
test
two
induc
ard
pig
method
hardwar
system
compos
ventil
servo
spectrophotometri
cevox
capnographi
devic
electr
imped
tomographi
devic
goe
mf
ii
patient
monitor
sirecust
softwar
develop
labview
approv
ethic
committe
two
kg
pig
expos
surfact
deplet
warm
salin
washout
induc
ard
pao
fio
mmhg
one
pig
model
ventil
automat
ardsnet
protocol
anoth
automat
ventil
open
lung
manag
blood
ga
analysi
bga
carri
everi
half
hour
result
artifi
cial
ventil
use
auto
ardsnet
protocol
success
stabil
oxygen
minim
plateau
pressur
cmh
control
ph
valu
acidosi
alkalosi
manag
hand
auto
open
lung
manag
er
distinct
result
ventil
signifi
cant
improv
oxygen
lung
complianc
observ
within
breath
recruit
maneuv
subject
ventil
tidal
volum
mlkg
compar
result
automat
ventil
set
bga
provid
tabl
everi
hour
conclus
auto
open
lung
manag
concept
gave
much
better
ga
exchang
auto
ardsnet
protocol
preliminari
result
show
necess
evalu
two
diff
erent
ventil
strategi
therefor
experi
pig
model
implement
near
futur
obtain
result
statist
signifi
canc
ensur
safeti
autom
mechan
ventil
system
intelliventasv
develop
provid
fulli
close
loop
mechan
ventil
use
ventil
control
keep
etco
spo
within
expertbas
rang
ventil
ard
patient
focus
deliv
adequ
oxygen
allow
elimin
co
protect
lung
object
compar
intelliventasv
convent
ventil
safeti
effi
caci
compar
number
manual
adjust
two
ventilatori
modal
method
random
control
studi
includ
consecut
patient
receiv
mechan
ventil
least
hour
patient
randomli
ventil
either
intelliventasv
convent
ventil
hamilton
bonaduz
switzerland
paramet
adjust
clinician
charg
patient
ventilatori
oxygen
paramet
record
cycl
cycl
hour
blood
gase
perform
everi
hour
result
twentyfour
patient
ard
includ
femal
male
median
age
year
apach
ii
score
pao
fio
inclus
eleven
ventil
convent
group
intelliventasv
group
studi
stop
one
patient
intelliventasv
group
pneumothorax
caus
ventil
deliv
vt
slightli
higher
intelliventasv
vs
mlkg
p
time
spent
variou
paramet
suboptim
zone
safeti
two
ventil
mode
time
spent
optim
zone
effi
caci
two
ventil
mode
introduct
ventilatorinduc
lung
injuri
vili
wellknown
side
eff
ect
mechan
ventil
pressur
volum
need
induc
vili
healthi
anim
far
greater
pressur
volum
appli
clinic
practic
possibl
explan
may
presenc
local
pressur
multipli
stress
raiser
method
retrospect
analyz
ct
scan
patient
ard
ct
scan
healthi
subject
homogen
lung
would
gastissu
ratio
region
lung
region
expand
less
neighbour
region
strain
vicari
nonless
expand
region
measur
stress
raiser
comput
ratio
ga
fraction
region
interest
neighbour
region
infl
ation
would
homogen
ratio
equal
one
infl
ation
surround
region
would
greater
region
interest
strain
ratio
two
greater
one
taken
measur
stress
raiser
consid
patholog
stress
raiser
region
show
infl
ation
ratio
greater
percentil
control
group
defi
ned
extent
stress
raiser
fraction
lung
volum
threshold
extent
stress
raiser
increas
sever
ard
lung
parenchyma
mild
moder
sever
ard
p
extent
stress
raiser
correl
dead
space
fraction
r
p
fraction
poorli
aerat
tissu
r
p
also
neg
correl
fraction
well
infl
ate
tissu
r
p
respons
peep
pass
cmh
minim
averag
decreas
stress
raiser
extent
interindividu
variabl
great
patient
stress
raiser
increas
pass
peep
peep
stress
raiser
turn
greater
nonsurvivor
patient
survivor
patient
vs
lung
volum
p
art
strategi
increas
risk
barotrauma
rel
risk
rr
ci
fi
rst
day
random
need
initi
increas
vasopressor
mean
arteri
pressur
mmhg
rr
ci
p
hour
random
howev
art
strategi
increas
risk
sever
acidosi
ph
hour
random
rr
ci
p
conclus
art
feasibl
incid
advers
event
similar
group
except
sever
acidosi
hour
random
henc
adjust
studi
protocol
increas
respiratori
rate
msarm
introduct
cardiac
surgic
procedur
associ
high
incid
postop
complic
increas
cost
mortal
purpos
studi
evalu
prospect
impact
two
protect
mechan
ventil
strategi
use
lowtid
volum
ventil
mlkgibw
cardiac
surgeri
conclus
reliabl
pressur
measur
also
complianc
estim
via
test
cathet
high
two
cathet
fi
lling
volum
critic
point
precis
measur
pressur
estim
complianc
immedi
unpack
adhes
balloon
materi
might
prevent
reliabl
pressur
measur
therefor
fi
rst
measur
overfi
lling
balloon
retent
excess
ga
seem
strongli
recommend
introduct
low
tidal
volum
vt
ventil
intens
care
patient
without
lung
injuri
attenu
system
infl
ammatori
respons
contribut
specifi
c
organ
infl
ammatori
respons
system
pictur
remain
elucid
investig
eff
ect
low
vt
ventil
compar
medium
high
vt
hepat
splanchnic
cerebr
cytokin
respons
experiment
larg
anim
postop
sepsi
model
method
twenti
pig
group
protect
ventil
pv
ventil
low
vt
mlkg
peep
cmh
pig
group
control
c
ventil
vt
mlkg
peep
cmh
cathet
introduc
arteri
jugular
bulb
hepat
vein
portal
vein
laparotomi
hour
simul
surgic
procedur
baselin
ensu
continu
endotoxin
infus
start
hour
diff
erenc
analyz
anova
repeat
measur
result
level
higher
hepat
vein
arteri
jugular
bulb
portal
vein
level
higher
arteri
jugular
bulb
compar
portal
hepat
vein
level
higher
portal
vein
compar
jugular
bulb
hepat
vein
organspecifi
c
concentr
higher
arteri
concentr
comparison
ventil
group
show
hepat
vein
higher
group
c
compar
group
pv
end
experi
peak
concentr
portal
vein
higher
group
c
compar
group
pv
experi
mainli
gener
liver
result
point
signifi
cant
nonhepat
product
ventil
low
vt
mediumhigh
peep
attenu
hepat
splanchnic
cytokin
product
compar
mediumhigh
vt
lower
peep
refer
introduct
airway
pressur
releas
ventil
aprv
allow
spontan
breath
throughout
ventil
cycl
increas
venou
return
cardiac
index
signifi
cantli
improv
organ
perfus
import
septic
shock
patient
prevent
extrathorac
organ
system
failur
secondari
poor
perfus
benefi
ts
aprv
cardiovascular
chang
notic
patient
acut
lung
injuri
acut
respiratori
distress
syndrom
well
establish
whether
appli
aprv
improv
surviv
outcom
septic
shock
patient
primari
outcom
whether
use
aprv
septic
shock
patient
restor
hemodynam
stabil
earlier
cmv
mode
secondari
hypothesi
whether
use
aprv
septic
shock
patient
improv
surviv
icu
method
institut
review
board
approv
retrospect
analyz
clinic
data
septic
shock
patient
receiv
ventil
support
januari
decemb
tertiari
care
hospit
cox
proport
hazard
model
use
adjust
potenti
confound
factor
nonparametr
wilcoxon
rank
sum
test
use
assess
signifi
cant
outcom
diff
erenc
group
time
eventsurviv
data
analyz
use
kaplanmei
method
analys
accomplish
use
sa
version
result
among
patient
exclud
per
exclus
criteria
incomplet
data
n
resuscit
n
icu
readmiss
n
head
injuri
n
final
patient
includ
receiv
cmv
receiv
aprv
begin
studi
diff
erenc
group
relat
hemodynam
paramet
revers
shock
achiev
less
hour
statist
signifi
cant
group
aprv
n
cmv
n
p
proport
patient
recov
septic
shock
initi
ventil
therapi
higher
aprv
cmv
group
vs
respect
p
mortal
rate
signifi
cantli
higher
cmv
n
compar
aprv
n
p
conclus
use
aprv
septic
shock
patient
restor
hemodynam
stabil
earlier
cmv
mode
signifi
cant
improv
icu
surviv
use
aprv
cmv
earli
initi
aprv
ventil
septic
shock
patient
associ
decreas
icu
mortal
obes
patient
risk
develop
atelectasi
acut
respiratori
distress
syndrom
ard
prone
posit
pp
may
reduc
atelectasi
improv
oxygen
outcom
sever
hypoxem
patient
ard
littl
known
eff
ect
obes
ard
patient
introduct
protect
mechan
ventil
mv
ard
base
reduc
stretch
pulmonari
tissu
sometim
result
sever
hypoventil
avoid
use
high
respiratori
rate
highfrequ
positivepressur
ventil
hfppv
fulli
explor
especi
associ
strategi
aim
avoid
hypercapnia
method
induc
ard
eight
pig
lung
lavag
salin
plu
hour
injuri
mv
low
peep
high
drive
pressur
dp
perform
recruit
maneuv
rm
follow
peep
titrat
use
amount
alveolar
collaps
electr
imped
tomographi
eit
stabil
hour
tidal
volum
vt
mlkg
respiratori
rate
rr
breathsminut
peep
select
peepfio
tabl
arma
studi
kept
constant
two
step
hfppv
rr
one
without
inspiratori
paus
one
paus
inspiratori
time
anoth
hfppv
step
use
peep
titrat
eit
rm
wrm
hfppv
step
vt
set
reach
paco
mmhg
distribut
region
ventil
analyz
use
eit
equilibrium
consid
paco
stabl
variat
minut
result
hfppv
allow
reduct
paco
level
versu
mmhg
besid
use
lower
vt
mlkg
stabil
wrm
respect
signifi
cant
diff
erent
result
compar
without
inspiratori
paus
wrm
allow
better
alveolar
homogen
improv
oxygen
shunt
dead
space
dp
compar
step
see
tabl
conclus
hfppv
convent
mechan
ventil
abl
maintain
stabl
paco
clinic
accept
valu
allow
reduct
vt
wrm
peep
titrat
use
eit
allow
physiolog
benefi
ts
sever
ard
model
highfrequ
percuss
ventil
hfpv
rescu
techniqu
sever
acut
lung
injuryacut
respiratori
distress
syndrom
ard
patient
especi
smoke
inhal
respiratori
burn
studi
aim
character
hfpv
deliv
percussionnair
evalu
hypobar
interfer
hfpv
order
assess
usabl
altitud
method
use
mechan
test
lung
mimick
ard
complianc
mlcmh
two
resist
level
cmh
olsecond
ventil
hypobar
chamber
ascentsdesc
ft
perform
adjust
paramet
modifi
ed
one
time
altitud
besid
paramet
crossmeasur
standalon
hardwar
oxygen
consumpt
respir
three
calcul
paramet
studi
lowfrequ
tidal
volum
vt
integr
instantan
fl
ow
measur
fleisch
pneumotachograph
endinspiratori
pmei
endexpiratori
pmee
mean
pressur
pmei
pmee
hfpv
refl
ect
plateau
pressur
posit
endexpiratori
pressur
convent
ventil
correct
altitudeinduc
set
modifi
cation
work
pressur
also
test
result
data
display
overestim
pulmonari
pressur
reliabl
paramet
ascent
set
appear
respiratori
paramet
vt
increas
pmei
ft
descent
set
revers
direct
decreas
vt
decreas
pmee
ft
modifi
work
pressur
adequ
correct
pmei
pmee
vt
case
manual
correct
paramet
ft
level
also
correct
set
multivari
analysi
establish
adjust
paramet
vt
pmei
pmee
practic
depend
altitud
oxygen
consumpt
respir
high
lminut
ft
stabl
altitud
reduc
percuss
rate
fio
conclus
hfpv
safe
use
altitud
provid
paramet
use
manual
adjust
set
order
avoid
expos
patient
volutrauma
barotrauma
ascent
major
hypoventil
alveolar
collaps
descent
high
oxygen
consumpt
current
main
limit
use
longrang
aeromed
evacu
applic
peep
commonli
use
acut
respiratori
distress
syndrom
ard
shown
improv
oxygen
identifi
patient
benefi
applic
peep
discrimin
recruit
nonrecruit
postul
gattinoni
colleagu
recent
dellamonica
colleagu
present
method
predict
alveolar
recruit
hypothesis
amount
recruit
volum
allow
discrimin
ard
patient
patient
healthi
lung
hl
method
recalcul
recruit
volum
rv
patient
ard
accord
method
propos
dellamonica
colleagu
increment
peep
manoeuvr
peep
increas
plateau
pressur
reach
cmh
rv
calcul
chang
endexpiratori
lung
volum
minu
total
respiratori
system
complianc
time
peep
chang
rv
comparison
patient
hl
undergo
elect
surgeri
gener
anaesthesia
measur
use
protocol
result
ard
hl
patient
exhibit
typic
pv
curv
stepwis
recruit
figur
rais
peep
cmh
ard
patient
recruit
ml
mean
sd
hl
patient
ml
strong
correl
r
total
rv
endinspiratori
volum
plateau
pressur
cmh
group
recruit
found
extent
group
figur
conclus
rel
contribut
rv
lung
volum
gain
similar
ard
patient
healthi
lung
result
question
relev
recruit
defi
ned
dellamonica
colleagu
typic
phenomenon
ard
support
babi
lung
concept
recruit
volum
close
relat
size
lung
introduct
venoven
extracorpor
membran
oxygen
vvecmo
respiratori
failur
icu
use
varieti
clinic
situat
demonstr
signifi
cantli
improv
surviv
without
disabl
adult
respiratori
distress
syndrom
ecmo
present
risk
factor
bloodstream
infect
although
recent
publish
data
support
view
use
antibiot
prophylaxi
aim
examin
vvecmo
risk
factor
nosocomi
bloodstream
infect
larger
studi
need
confi
rm
fi
nding
assess
need
specifi
c
intervent
name
routin
antibiot
prophylaxi
introduct
aptt
common
tool
anticoagul
monitor
ing
extracorpor
membran
oxygen
ecmo
thromboelasto
graphi
teg
anoth
avail
option
set
method
prospect
observ
studi
consecut
patient
venoven
ecmo
anticoagul
provid
critic
care
volum
suppl
http
unfract
heparin
titrat
aptt
ratio
target
kaolinactiv
teg
kteg
contemporarili
measur
guid
heparin
infus
baselin
kteg
reaction
time
r
minut
accept
anticoagul
exce
minut
anticoagul
may
great
result
mean
ecmo
durat
day
total
kteg
collect
comparison
aptt
kteg
r
report
tabl
four
patient
hemorrhag
complic
neither
aptt
kteg
r
signifi
cantli
diff
erent
patient
hemorrhag
event
compar
patient
without
hemorrhag
event
latter
receiv
signifi
cantli
lower
total
heparin
dose
p
conclus
anticoagul
excess
onehalf
sampl
accord
teg
monitor
neglig
base
aptt
refer
introduct
use
extracorpor
membran
oxygen
ecmo
rediscov
wake
pandem
infl
uenza
howev
report
patient
receiv
ecmo
often
develop
virusassoci
hemophagocyt
syndrom
vah
compar
without
ecmo
support
although
ampl
evid
extens
cytokin
activ
key
factor
vah
ecmo
could
potenti
trigger
exacerb
patholog
amplifi
cytokin
activ
studi
investig
whether
mediat
cytokin
may
produc
ecmo
method
patient
sever
respiratori
failur
place
ecmo
enrol
june
juli
studi
approv
ethic
committe
blood
specimen
drawn
blood
circuit
inlet
centrifug
pump
outlet
hollow
fi
ber
oxygen
frequenc
three
four
time
per
day
blood
gcsf
gmcsf
measur
global
use
multiplex
cytokin
bead
array
system
bioplex
biorad
tokyo
japan
measur
use
elisa
kit
shinotest
tokyo
japan
result
two
patient
interstiti
pneumonia
studi
ecmo
system
consist
rotafl
ow
centrifug
pump
maquet
japan
tokyo
japan
biocub
tnc
coat
nipro
osaka
japan
percutan
cardiopulmonari
support
system
capiox
eb
terumo
tokyo
japan
blood
fl
ow
rate
lminut
total
blood
set
collect
case
blood
level
gmcsf
detect
limit
increas
ecmo
mediat
detect
inlet
signifi
cant
increas
observ
outlet
p
p
p
introduct
sever
exacerb
chronic
obstruct
pulmonari
diseas
copd
tachypnea
consequ
respiratori
acidosi
airfl
ow
limit
due
small
airway
obstruct
lead
lung
hyperinfl
ation
respiratori
distress
ga
exchang
impair
invas
mechan
ventil
could
worsen
lung
hyperinfl
ation
produc
viciou
circl
investig
whether
increas
extracorpor
carbon
dioxid
remov
ecco
cl
could
reduc
respiratori
rate
rr
prolong
time
lung
empti
allow
resolut
hyperinfl
ation
method
six
patient
copd
exacerb
respiratori
acidosi
paco
mmhg
ph
tachypnea
rr
despit
maxim
noninvas
ventil
underw
venoven
extracorpor
membran
oxygen
vvecmo
patient
awak
spontan
breath
adequ
airoxygen
mixtur
correct
hypoxemia
pao
mmhg
keep
blood
fl
ow
stabl
lminut
chang
ga
fl
ow
artifi
cial
lung
modifi
extracorpor
co
clearanc
percentag
total
patient
co
product
ecco
cltotal
vco
observ
variat
rr
record
rr
three
level
ga
fl
ow
patient
figur
patient
rr
decreas
increas
extracorpor
co
remov
neg
correl
found
rr
ecco
cltotal
vco
r
p
patient
abl
obtain
reduct
rr
vs
rr
low
ga
fl
ow
vs
rr
maxim
ga
fl
ow
p
select
maxim
ga
fl
ow
variabl
diff
erent
patient
lminut
correspond
diff
erent
level
ecco
cltotal
vco
rang
rr
respons
rang
conclus
patient
copd
exacerb
fail
noninvas
ventil
vvecmo
allow
one
maintain
spontan
breath
titrat
extracorpor
co
remov
lead
control
rr
approach
could
interrupt
viciou
circl
dynam
hyperinfl
ation
allow
defl
ation
lung
parenchyma
tabl
present
main
result
co
remov
membran
oxygen
rang
mlminut
patient
surviv
treatment
wean
ventil
end
ecco
remov
one
oxygen
use
everi
patient
without
clot
circuit
major
bleed
problem
previous
shown
ex
vivo
porcin
model
lung
elast
calcul
peep
chang
divid
lung
volum
increas
close
correl
convent
measur
lung
elast
use
oesophag
pressur
studi
hypothes
success
chang
lung
volum
peepstep
manoeuvr
could
predict
lung
elast
object
studi
valid
hypothesi
patient
acut
respiratori
failur
arf
method
thirteen
patient
arf
studi
increment
peep
trial
cmh
determin
chang
expiratori
tidal
volum
follow
peep
step
convent
calcul
lung
elast
obtain
tidal
variat
airway
pressur
minu
tidal
variat
oesophag
pressur
divid
tidal
volum
posit
oesophag
cathet
verifi
ed
accord
baydur
measur
chang
endexpiratori
lung
volum
peepstep
manoeuvr
use
spirometri
compar
endexpiratori
lung
volum
chang
calcul
el
stepwis
chang
peep
result
close
correl
measur
buildup
endexpiratori
lung
volum
peepstep
manoeuvr
el
convent
determin
use
oesophag
pressur
measur
see
figur
conclus
esophag
pressur
measur
diffi
cult
perform
rare
use
routin
clinic
practic
fi
nding
indic
chang
peep
togeth
measur
result
chang
endexpiratori
volum
spirometri
ventil
could
use
determin
lung
elast
separ
relat
lung
chest
wall
elast
well
transpulmonari
pressur
refer
introduct
longterm
use
mechan
ventil
may
lead
ventilatorinduc
diaphragmat
dysfunct
vidd
increas
durat
wean
mv
hypothes
stimul
diaphragm
mv
may
prevent
vidd
may
lead
earli
wean
studi
feasibl
gener
coordin
contract
diaphragm
investig
use
novel
transven
diaphragmat
pace
system
method
two
juvenil
pig
anesthet
propofol
ventil
vent
assist
control
mode
mv
nellcor
puritan
bennett
use
fl
uoroscopi
novel
multipolar
neurostimul
cathet
inspirx
rl
respithera
bloomington
mn
usa
thread
left
intern
jugular
vein
advanc
junction
right
atrium
superior
vena
cava
use
modifi
ed
selding
techniqu
success
captur
right
left
phrenic
nerv
confi
rmed
fl
uoroscop
visual
peak
airway
pressur
pawp
blood
gase
determin
minut
mv
mv
mv
stimul
appli
togeth
mvstim
stimul
stim
animalventil
dyssynchroni
stimul
mvstim
note
peak
airway
pressur
reduc
stim
discern
paradox
movement
diaphragm
addit
pco
po
confi
rmed
adequ
ventil
oxygen
provid
system
pawp
could
reduc
tabl
introduct
retrospect
studi
suggest
cardiac
troponin
level
often
elev
patient
acut
exacerb
chronic
obstruct
pulmonari
diseas
aecopd
indic
poor
surviv
novel
highsensit
cardiac
troponin
hsctnt
assay
better
analyt
precis
standard
troponin
ctnt
assay
elabor
prospect
cohort
studi
investig
prognost
valu
novel
biomark
patient
aecopd
method
fiftysix
patient
mean
age
year
male
fi
nal
diagnosi
aecopd
enrol
diagnos
acut
coronari
syndrom
exclud
measur
cardiac
troponin
standard
fourthgener
assay
highsensit
assay
clinic
electrocardiograph
echocardiograph
data
collect
admiss
primari
prognost
endpoint
death
day
followup
introduct
british
thorac
societi
guidelin
communityacquir
pneumonia
cap
advoc
icu
referr
patient
score
recent
develop
score
system
smartcop
design
identifi
patient
need
intens
respiratori
vasopressor
support
irv
valid
varieti
set
predict
need
icu
admiss
defi
ned
need
irv
greater
accuraci
use
routin
uk
institut
method
retrospect
analys
critic
care
admiss
patient
diagnosi
cap
uk
district
gener
hospit
icnarccod
diagnos
pneumonia
bacteri
viral
organ
isol
period
august
januari
ascertain
smartcop
score
referr
icu
match
relat
need
irv
length
inotrop
ventilatori
support
icu
length
stay
result
search
reveal
potenti
match
five
patient
exclud
cap
note
seven
patient
avail
analysi
analys
note
patient
match
criteria
small
sampl
strong
associ
increas
smartcop
score
need
irv
correl
coeffi
cient
r
also
strong
correl
longer
inotrop
support
r
longer
ventilatori
support
r
increas
smartcop
score
weaker
correl
length
icu
stay
r
moreov
none
patient
admit
icu
score
higher
time
icu
referr
conclus
small
sampl
higher
smartcop
score
associ
increas
likelihood
irv
suggest
studi
larger
sampl
size
perform
investig
whether
smartcop
improv
predict
need
irv
uk
intens
care
patient
introduct
streptococc
pneumonia
remain
common
caus
communityacquir
pneumonia
cap
bacteri
mening
bacteremia
sever
pneumonia
caus
streptococc
pneumonia
frequent
exist
emerg
room
icu
perform
studi
evalu
eff
ect
steroid
therapi
sever
streptococc
pneumonia
patient
mechan
ventil
retrospect
method
enrol
adult
streptococc
pneumonia
patient
requir
mechan
ventil
seven
patient
group
administ
steroid
hydrocortison
mgday
remain
six
patient
receiv
steroid
therapi
ns
group
convent
therapi
mechan
ventil
commenc
patient
pao
fio
show
less
clinic
complain
short
breath
patient
receiv
appropri
fl
uid
therapi
vasoact
agent
blood
transfus
accord
protocol
earli
goaldirect
therapi
surviv
sepsi
campaign
guidelin
also
treat
antibiot
immunoglobulin
gday
day
sivelestat
sodium
hydrat
mgkgday
day
apach
score
group
ns
group
sequenti
organ
failur
assess
score
respect
score
show
signifi
cant
diff
erenc
group
procalcitonin
pct
ns
group
ngml
respect
signifi
cant
diff
erenc
group
pct
declin
signifi
cantli
group
pao
fio
ns
group
signifi
cantli
higher
group
icu
admiss
day
admiss
signifi
cant
diff
erenc
day
icu
admiss
ns
group
declin
signifi
cantli
icu
admiss
group
also
tend
declin
conclus
steroid
therapi
sever
streptococc
pneumonia
patient
mechan
ventil
may
potenti
maintain
oxygen
lung
signifi
cant
eff
ect
chang
infl
ammatori
marker
crp
introduct
electr
imped
tomographi
eit
noninvas
nonradi
imag
techniqu
use
visual
ventil
distribut
lung
could
distinguish
depend
dorsal
nondepend
ventral
part
method
aim
studi
observ
ventil
distribut
depend
nondepend
lung
region
individu
patient
three
diff
erent
level
support
pressur
support
ps
neural
adjust
ventilatori
assist
nava
ventil
ten
mechan
ventil
patient
icu
includ
ratio
dependentnondepend
distribut
ventil
signifi
cantli
higher
lower
support
level
compar
higher
support
level
ps
nava
howev
nava
signifi
cantli
less
imped
loss
diff
erent
level
assist
compar
ps
tidal
volum
decreas
decreas
assist
level
ps
wherea
nava
ventil
electr
activ
diaphragm
decreas
ps
nava
higher
level
assist
three
patient
show
increas
depend
tidal
imped
variat
tiv
lower
assist
level
cmh
increas
tiv
occur
nava
ventil
conclus
ventil
depend
part
lung
compar
nondepend
part
lower
level
assist
could
indic
higher
support
level
contribut
diaphragm
reduc
nava
ventil
autoregul
patient
adjust
tidal
ventil
maintain
homogen
ventil
distribut
statu
asthmaticu
purpos
analyz
bipap
use
outcom
children
statu
asthmaticu
obes
ped
method
patient
place
bipap
ped
statu
asthmaticu
januari
august
includ
analysi
subject
divid
moder
sever
exacerb
subdivid
follow
growth
curvebas
weight
subgroup
percentil
percentil
percentil
subject
receiv
standard
asthma
therapi
addit
bipap
data
obtain
bedsid
respiratori
therapist
collect
retrospect
studi
investig
data
store
analyz
use
redcap
databas
result
three
hundr
fi
ftynin
subject
analyz
tabl
show
time
bipap
per
visit
children
whose
weight
percentil
reveal
trend
toward
longer
treatment
time
bipap
compar
two
group
explor
feasibl
reliabl
physiolog
signifi
canc
diaphragm
thicken
ultrasound
method
five
healthi
subject
particip
monitor
inspiratori
fl
ow
volum
esophag
gastric
pressur
diaphragm
electr
activ
esophag
surfac
electromyographi
subject
perform
seri
inspiratori
maneuv
tidal
breath
thresholdload
breath
muller
maneuv
inspir
variou
lung
volum
function
residu
capac
end
inspiratori
eff
ort
subject
instruct
close
glotti
relax
respiratori
muscl
maintain
lung
volum
elimin
diaphragm
activ
sonograph
imag
diaphragm
thicken
maneuv
obtain
use
mmode
mhz
linear
array
probe
place
right
ninth
intercost
space
middl
anterior
axillari
line
result
diaphragm
thicken
zone
apposit
readili
visual
ultrasound
fi
subject
mean
endexpiratori
diaphragm
thick
mm
sd
mm
tidal
breath
diaphragm
thicken
mean
sd
blandaltman
coeffi
cient
reproduc
mm
approxim
measur
variabl
aros
calip
posit
ultrasound
machin
diaphragm
thick
measur
chang
probe
place
diff
erent
intercost
interspac
diaphragm
inspiratori
thicken
increas
signifi
cantli
increas
inspiratori
eff
ort
also
vari
lung
volum
independ
eff
ort
inspiratori
volum
inspiratori
capac
lung
volum
chang
contribut
minim
diaphragm
thicken
conclus
visual
diaphragm
thicken
zone
apposit
ultrasound
provid
feasibl
noninvas
techniqu
monitor
diaphragm
activ
healthi
subject
diaphragm
thicken
primarili
refl
ect
muscular
eff
ort
rather
alter
muscl
conform
induc
chang
lung
volum
especi
lower
inspiratori
volum
theoret
advantag
monitor
electr
activ
diaphragm
eadi
neural
trigger
support
breath
navamaquet
yet
shown
translat
signifi
cant
clinic
benefi
assess
eff
ect
eadi
monitor
patient
risk
prolong
wean
outcom
introduct
emerg
endotrach
intub
result
accident
oesophag
intub
patient
often
disastr
consequ
previous
publish
highli
specifi
c
sensit
novel
method
detect
endotrach
intub
base
diff
erenc
ventil
pressur
waveform
oesophagu
trachea
patient
healthi
lung
detect
algorithm
base
diff
erenc
complianceelast
lung
oesophagu
gener
dvalu
indic
tracheal
intub
oesophag
intub
aim
current
studi
valid
algorithm
patient
lung
diseas
method
obtain
institut
approv
intub
ventil
icu
patient
includ
inclus
criteria
control
mechan
ventil
least
mild
moder
lung
injuri
accord
murray
lung
injuri
score
connect
piec
place
endotrach
tube
ventil
bag
piec
compris
thin
airfi
lled
cathet
insert
tube
lumen
cm
distal
end
second
cathet
locat
proxim
end
tube
perform
three
consecut
manual
bag
ventil
record
pressur
curv
cathet
ventil
dvalu
calcul
result
mean
age
sd
patient
year
male
mean
sd
murray
score
patholog
includ
pulmonari
oedema
pneumonia
atelectasi
traumat
lung
injuri
dvalu
repres
figur
median
iqr
rang
dvalu
algorithm
therefor
confi
rmed
high
sensit
detect
correct
endotrach
intub
also
patient
lung
diseas
hypothesi
oesophag
complianc
increas
signifi
cantli
patient
lung
diseas
specifi
citi
algorithm
aff
ect
aim
compar
two
novel
endotrach
tube
ett
mallinckrodt
taperguard
tg
taper
polyvinyl
chlorid
pvc
cuff
kimvent
microcuff
mc
cylindr
polyurethran
cuff
convent
portex
pt
globular
pvc
cuff
leakag
across
cuff
microaspir
simul
clinic
situat
shown
globular
pvc
cuff
protect
poorli
leakag
due
microchannel
form
infold
redund
cuff
materi
hypothes
tg
mc
better
prevent
microaspir
major
mechan
ventilatorassoci
pneumonia
vap
common
caus
ventilatorassoci
pneumonia
vap
aspir
oral
secret
endotrach
tube
et
subglott
suction
drainag
ssd
recommend
safeti
measur
aspir
due
high
eff
ectiv
current
two
type
cuff
shape
spindl
taper
predomin
highvolum
lowpressur
hvlp
et
ssd
howev
shape
suitabl
prevent
drip
onto
subglotti
determin
purpos
studi
determin
whether
et
taperedtyp
cuff
reduc
incid
vap
method
approv
appropri
ethic
committe
conduct
singleinstitut
prospect
random
clinic
trial
eff
ectiv
use
et
diff
erent
cuff
type
introduct
nation
audit
project
highlight
need
improv
airway
manag
icu
key
recommend
continu
use
endtid
carbon
dioxid
etco
monitor
preintub
checklist
diffi
cult
airway
trolley
complet
cycl
audit
aim
quantifi
current
state
airway
manag
icu
eff
ectiv
implement
recommend
method
data
collect
carri
prospect
phase
includ
document
intub
use
etco
incid
seriou
advers
event
sae
content
intub
box
compar
diffi
cult
airway
societi
da
guidelin
reaudit
carri
month
follow
introduct
preintub
checklist
document
sticker
diffi
cult
airway
trolley
standard
basic
bedsid
airway
box
checklist
content
train
program
airway
manag
icu
staff
also
introduc
microct
scan
skyscan
bruker
belgium
perform
use
resolut
axial
section
cm
cuff
reconstruct
volum
secret
assess
densiti
criterion
microbiolog
cultur
ett
lavag
fl
uid
obtain
patient
demograph
clinic
data
record
diff
erent
set
bench
experi
inject
ml
waterbas
polym
new
ett
diff
erent
size
measur
resist
airfl
ow
use
ett
clean
devic
airway
medix
close
suction
system
biovo
technolog
tel
aviv
israel
also
obtain
resist
valu
intact
ett
control
studi
ett
remain
place
median
day
iqr
rang
amount
secret
assess
ct
scan
ml
rang
ml
secret
volum
relat
patient
sever
admiss
sap
pf
ratio
day
intub
invers
correl
patient
age
present
p
r
bacteri
growth
present
ett
fl
uid
cultur
candida
spp
show
elev
preval
bench
test
clean
devic
reduc
resist
airfl
ow
diff
erenc
clean
ci
cmh
olsecond
p
clean
resist
result
higher
intact
ett
although
clinic
neglig
diff
erenc
diff
erenc
ci
cmh
olsecond
p
conclus
microct
scan
feasibl
promis
techniqu
assess
secret
volum
ett
extub
use
ett
clean
devic
decreas
resist
airfl
ow
bench
test
eff
ectiv
devic
clinic
set
could
properli
assess
postextub
ct
scan
object
develop
valid
simplifi
ed
score
identifi
patient
di
icu
report
relat
complic
method
data
collect
prospect
multicenterstudi
consecut
intub
icu
use
develop
simplifi
ed
score
di
valid
extern
consecut
intub
procedur
icu
intern
bootstrap
iter
multivari
analysi
main
predictor
di
incid
relat
patient
mallampati
score
iii
iv
obstruct
sleep
apnea
syndrom
reduc
mobil
cervic
spine
limit
mouth
open
patholog
sever
hypoxia
coma
oper
nonanesthesiologist
sevenitem
simplifi
ed
score
macocha
score
introduct
mechan
ventil
neonat
fl
owdepend
resist
endotrach
tube
ett
caus
notic
pressur
diff
erenc
airway
tracheal
pressur
may
potenti
lead
retard
passiv
driven
expir
dynam
lung
infl
ation
consecut
importantli
increas
aim
studi
evalu
correl
ntprobnp
cce
potenti
use
variabl
wean
process
mv
method
twentytwo
longterm
hour
mechan
ventil
patient
capabl
perform
wean
trial
spontan
breath
sbt
enrol
studi
inclus
criteria
age
year
equip
standard
arteri
cathet
line
exclus
criteria
neuromuscular
diseas
tracheotomi
renal
failur
traumat
brain
injuri
wean
process
ntprobnp
plasma
level
cce
standard
hemodynam
ventilatori
data
collect
minut
extub
hour
hour
later
remov
tracheal
tube
patient
histori
heart
failur
receiv
continu
posit
airway
pressur
cpap
group
patient
normal
cardiac
function
maintain
spontan
breath
sb
group
result
sixtysix
pair
ntprobnp
cce
valu
obtain
patient
sb
group
cpap
group
respect
group
trend
toward
increas
ntprobnp
valu
extub
opposit
trend
observ
regard
cce
valu
p
ntprobnp
level
show
increas
extub
compar
convers
cce
show
invers
trend
overal
neg
correl
found
ntprobnp
cce
valu
r
p
signifi
cant
invers
correl
found
ntprobnp
cce
r
respect
p
overal
correl
ntprobnp
cce
sb
group
cpap
group
standard
hemodynam
ventilatori
data
show
signifi
cant
chang
studi
conclus
ntprobnp
correl
well
cce
latter
seem
addit
attract
index
cardiovascular
state
associ
ntprobnp
chang
may
provid
inform
cardiac
function
beatbybeat
basi
wean
process
mv
comparison
outcom
earli
late
tracheostomi
critic
ill
patient
k
suzuki
kusunoki
yamanou
k
tanigawa
introduct
tracheostomi
one
commonli
perform
procedur
critic
ill
patient
requir
longterm
mechan
ventil
howev
optim
time
method
perform
tracheostomi
popul
remain
establish
present
studi
compar
outcom
earli
late
tracheostomi
critic
adult
patient
diff
erent
clinic
condit
method
patient
need
tracheostomi
critic
care
medic
center
hiroshima
prefectur
hospit
januari
decemb
survey
patient
tracheostomi
indic
mechan
ventil
exclud
subject
earli
tracheostomi
et
defi
ned
day
tracheal
intub
late
tracheostomi
lt
defi
ned
day
intub
compar
patient
characterist
type
tracheostomi
procedur
length
wean
ventil
outcom
group
data
shown
mean
sd
unpair
test
mannwhitney
u
test
use
statist
analys
statist
signifi
canc
accept
p
result
one
hundr
patient
survey
et
lt
group
includ
patient
respect
tracheostomi
perform
use
percutan
procedur
patient
et
lt
surgic
procedur
patient
et
lt
sixtytwo
patient
et
lt
surviv
discharg
patient
die
icu
et
lt
fiftysix
patient
et
lt
wean
ventil
support
tracheostomi
cannula
remov
patient
et
lt
signifi
cant
diff
erenc
type
tracheostomi
procedur
period
tracheostomi
icu
hospit
discharg
rate
patient
could
wean
ventil
remov
tracheostomi
cannula
icu
hospit
mortal
group
length
mechan
ventil
time
remov
tracheostomi
cannula
signifi
cantli
shorter
et
group
vs
vs
day
respect
conclus
retrospect
studi
earli
tracheostomi
reduc
length
wean
tracheostomi
time
remov
tracheostomi
cannula
diff
erenc
length
icu
stay
patient
outcom
critic
ill
adult
patient
requir
mechan
ventil
tracheostomi
perform
earlier
stage
may
shorten
durat
artifi
cial
ventil
random
clinic
trial
essenti
determin
eff
ectiv
safeti
earli
tracheostomi
refer
variabl
cours
blood
vessel
pretrach
area
risk
clinic
relev
bleed
recent
report
patient
undergo
pdt
conduct
systemat
review
report
evalu
clinic
outcom
follow
use
ultrasound
scan
us
pdt
method
two
investig
perform
search
literatur
use
follow
databas
central
embas
medlin
scopu
follow
elig
criteria
use
popul
includ
adult
year
manag
icu
use
ultrasound
guid
decisionmak
prepdt
guid
pdt
perform
report
clinic
relev
outcom
measur
nonrandomis
control
trial
classifi
ed
accord
cochran
nonrandomis
studi
method
group
criteria
evalu
risk
bia
result
initi
search
identifi
ed
report
studi
met
elig
criteria
eight
case
seri
one
randomis
control
trial
rct
one
prospect
cohort
studi
incorpor
patient
two
studi
specifi
calli
report
data
patient
obes
n
patient
one
studi
report
data
group
patient
spinal
cord
fi
xation
n
us
use
guid
decis
perform
pdt
surgic
tracheostomi
fi
studi
decis
perform
surgic
tracheostomi
rang
case
us
use
guid
insert
point
seven
studi
use
realtim
four
studi
time
perform
usguid
pdt
report
four
studi
rang
minut
studi
compar
time
taken
without
us
data
complic
procedur
report
nine
studi
minor
bleed
report
eight
case
overal
prolong
bleed
report
two
case
episod
catastroph
bleed
among
case
high
risk
bia
identifi
ed
fi
studi
term
patient
select
intervent
protocol
defi
ned
three
report
attempt
made
blind
aspect
studi
conclus
use
us
guidanc
could
theoret
help
minimis
risk
haemorrhag
complic
pdt
perhap
reduc
time
taken
perform
pdt
howev
current
inadequ
evid
control
cohort
studi
rct
suggest
routin
use
pdt
select
unselect
group
improv
clinic
relev
outcom
measur
introduct
fail
airway
situat
potenti
catastroph
event
requir
correct
approach
appropri
tool
recent
ventrain
present
manual
devic
emerg
ventil
smallbor
cannula
provid
expiratori
assist
appli
venturi
eff
ect
method
use
simularti
human
patient
simul
evalu
ventrain
initi
studi
eff
ectiv
secur
ventil
oxygen
patient
second
phase
ventrain
perform
compar
consid
present
gold
standard
quicktrach
ii
portex
minitrach
ii
selding
kit
melker
emerg
cricothyrotomi
cathet
set
seven
anesthesiologist
perform
emerg
transcricoid
ventil
devic
set
result
ventrain
provid
averag
tidal
volum
ml
averag
minut
volum
l
consid
situat
modifi
cation
pao
mmhg
paco
mmhg
second
phase
time
need
obtain
eff
ectiv
oxygen
ventrain
found
shorter
devic
median
diff
erenc
vs
minitrach
second
vs
melker
second
vs
quicktrach
second
figur
abil
remov
co
result
bigger
averag
diff
erenc
vs
minitrach
vs
melker
vs
quicktrach
figur
moreov
user
judg
favor
conclus
manikin
studi
ventrain
seem
abl
appropri
oxygen
ventil
patient
cicv
situat
compar
best
avail
choic
shown
inferior
introduct
eff
ectiv
deliveri
aerosol
bronchodil
patient
asthma
crucial
adequ
therapi
critic
care
emerg
set
often
administ
pressuremet
dose
inhal
pmdi
bronchodil
deliveri
depend
correct
patient
techniqu
administr
abil
measur
treatment
respons
diffi
cult
monitor
point
care
particularli
resourcepoor
set
standard
inhospit
monitor
unavail
method
pointofcar
devic
airfl
ow
measur
bronchodil
deliveri
design
test
use
resourcelimit
set
handheld
devic
construct
clinic
aerosol
deliveri
tube
bidirect
sensor
pressur
diff
erenti
detect
aerosol
element
figur
custom
lowcost
introduct
protocolbas
care
tracheostomis
patient
import
advers
event
confer
high
rate
mortal
littl
known
regard
exist
formal
evidencebas
guidelin
tracheostomi
care
aim
studi
perform
systemat
review
evidencebas
guidelin
adult
tracheostomi
care
method
systemat
search
pubm
medlin
guidelin
clearinghous
centr
evidencebas
practic
profession
societi
guidelin
relat
care
adult
patient
tracheostomi
perform
two
review
addit
googl
search
publicli
avail
tracheostomi
care
guidelin
perform
search
term
tracheostom
tracheotom
protocol
guidelin
standard
manag
consensu
algorithm
filter
english
languag
human
januari
date
adult
patient
guidelin
apprais
criteria
qualiti
guidelin
retriev
assess
use
apprais
guidelin
research
evalu
ii
agre
ii
instrument
search
result
summaris
tabl
total
guidelin
identifi
ed
five
found
satisfi
agre
ii
criteria
three
relat
entir
spectrum
tracheostomi
manag
major
inform
publish
evid
base
conclus
five
evidencebas
guidelin
adult
tracheostomi
manag
identifi
ed
may
repres
pauciti
evid
subject
suggest
clinic
trial
topic
need
contribut
evid
base
also
highlight
need
intern
consensu
topic
reduc
duplic
eff
ort
standardis
practic
improv
outcom
conclud
major
airwayrel
signifi
cant
complic
icu
result
displac
block
tracheostomi
recommend
togeth
intens
care
societi
nation
tracheostomi
safeti
project
icu
uk
emerg
airway
manag
plan
guidelin
aim
survey
establish
whether
guidelin
exist
familiar
work
within
icu
east
england
eoe
eas
avail
emerg
degre
emerg
tracheostomi
train
within
region
method
data
collect
via
telephon
survey
icu
eoe
train
region
juli
one
senior
icu
nurs
one
icu
traine
question
per
hospit
question
relat
exist
access
guidelin
tracheostomi
emerg
respond
degre
emerg
tracheostomi
train
perceiv
avail
formal
train
result
icu
question
perform
manag
tracheostomi
respond
knew
guidelin
cover
emerg
describ
locat
four
respond
thought
guidelin
access
emerg
set
onehalf
comput
system
requir
login
search
function
regard
emerg
manag
respond
felt
compet
tracheostomi
emerg
almost
exclus
experi
inhous
teach
respond
awar
formal
emerg
tracheostomi
manag
cours
conclus
despit
nation
guidanc
within
uk
survey
highlight
implement
awar
emerg
tracheostomi
guidelin
icu
eoe
region
poor
present
readili
access
emerg
emerg
train
larg
inform
avail
formal
train
cours
recognis
order
improv
patient
safeti
need
ensur
emerg
tracheostomi
manag
includ
guidelin
equip
formalis
tracheostomi
emerg
train
adopt
embrac
univers
refer
introduct
fatal
incid
relat
block
tracheostomi
tube
prompt
review
trust
provid
safe
tracheostomi
care
chang
staffi
ng
educ
oper
polici
recommend
train
potenti
fi
rst
respond
tracheostomi
laryngectomi
emerg
remain
outstand
aim
quantifi
train
defi
cit
tracheostomi
common
critic
care
patient
requir
ongo
manag
artifi
cial
airway
discharg
ward
even
commun
critic
care
unit
care
tracheostomi
patient
transfer
ward
nation
audit
project
highlight
complic
includ
hypox
brain
injuri
death
nation
patient
safeti
agenc
recognis
number
avoid
aspect
exist
guidelin
manag
patient
includ
emerg
wide
known
method
anonym
onlin
survey
sent
traine
may
respond
tracheostomi
emerg
organis
traine
anaesthesiacrit
care
gener
medicin
gener
surgeri
ent
thorac
e
approach
complet
form
includ
achiev
respons
rate
respond
compris
anaesthesiacrit
care
medicin
surgeri
onehalf
manag
tracheostomylaryngectomi
emerg
incid
occur
ward
one
outpati
clinic
receiv
formal
train
manag
blockedmisplac
tracheostomi
tube
awar
guidelin
onethird
respond
lack
confi
denc
manag
emerg
felt
would
benefi
formal
train
includ
simul
conclus
popul
patient
exterioris
trachea
increas
repres
highrisk
group
manag
airway
emerg
patient
part
standard
lifesupport
cours
accord
traine
scenario
rel
common
signifi
cant
proport
fi
rst
respond
poorli
equip
deal
trust
includ
specifi
c
train
emerg
manag
neck
breather
part
inhous
resuscit
train
would
contend
nation
resuscit
cours
consid
introduct
usual
percutan
tracheostomi
accomplish
via
tracheal
tube
sever
complic
percutan
dilat
tracheostomi
pdt
may
relat
poor
visual
tracheal
structur
altern
impli
extub
reinsert
laryng
mask
lma
accident
extub
well
injur
vocal
cord
infl
ate
cuff
disloc
appear
imposs
method
subject
bronchoscop
view
obtain
via
lma
seem
better
obtain
endotrach
tube
et
method
prospect
observ
studi
bedsid
pdt
perform
use
ciaglia
blue
dolphin
method
critic
ill
patient
patient
tracheal
tube
exchang
lma
undertak
pdt
insert
lma
qualiti
ventil
blood
ga
valu
view
tracheal
punctur
site
view
balloon
dilat
rate
follow
good
good
bare
accept
poor
poor
result
pdt
lma
success
patient
n
rate
case
regard
ventil
blood
ga
analysi
identifi
cation
relev
structur
tracheal
punctur
site
view
insid
trachea
pdt
rate
assign
one
patient
requir
tracheal
reintub
inadequ
ventil
damag
bronchoscop
report
gastric
aspir
conclus
blue
dolphin
pdt
use
lma
show
defi
nite
advantag
regard
inspect
dilat
process
method
improv
visual
trachea
larynx
videoassist
procedur
prevent
diffi
culti
associ
use
et
cuff
punctur
tube
transect
needl
accident
extub
bronchoscop
lesion
lma
result
eff
ectiv
success
ventilatori
devic
pdt
may
especi
relev
case
diffi
cult
patient
anatomi
improv
structur
visual
optim
oper
condit
intensivist
perform
pdt
scrupul
decid
method
use
icu
blue
dolphin
pdt
lma
becom
procedur
choic
introduct
acut
cor
pulmonal
acp
associ
increas
mortal
patient
ventil
acut
respiratori
distress
syndrom
ard
intervent
lung
assist
ila
allow
lungprotect
ventilatori
strategi
whilst
allow
co
remov
requir
adequ
right
ventricular
rv
function
rv
restrict
includ
presystol
pulmonari
wave
routin
assess
ard
method
prospect
analysi
retrospect
collect
data
patient
echo
ila
perform
data
includ
epidemiolog
ventilatori
factor
lvrv
function
evid
rv
restrict
pulmonari
hemodynam
data
shown
mean
sdmedian
interquartil
rang
result
thirtytwo
patient
year
male
sofa
score
includ
pulmonari
hypertens
pht
hospit
mortal
mortal
associ
age
day
ila
length
icu
stay
inotrop
support
nitric
oxid
level
ventilatori
support
associ
pressor
requir
p
wors
pao
fio
ratio
vs
p
higher
pulmonari
arteri
pressur
mmhg
vs
p
echo
featur
acp
found
signifi
cant
diff
erenc
rv
systol
function
pulmonari
acceler
time
pulmonari
veloc
time
integr
survivor
nonsurvivor
incid
rv
restrict
high
independ
pht
rv
systol
function
level
respiratori
support
correl
co
level
restrict
kpa
vs
p
see
figur
conclus
typic
echo
featur
acp
seen
studi
possibl
protect
ventilatori
strategi
allow
use
ila
incid
rv
restrict
may
refl
ect
subtl
abnorm
rv
function
studi
requir
elucid
rv
pathophysiolog
critic
ill
adult
patient
ard
refer
introduct
global
left
ventricular
electromechan
dyssynchroni
glvd
uncoordin
lv
contract
reduc
extent
intrins
energi
transfer
myocardium
circul
lead
reduct
peak
lv
pressur
rise
prolong
total
isovolum
time
tivt
fall
stroke
volum
potenti
import
paramet
routin
assess
critic
ill
cardiothorac
patient
method
prospect
analysi
retrospect
collect
data
cardiothorac
icu
patient
underw
echocardiographi
perform
addit
epidemiolog
factor
echo
data
includ
comprehens
assess
lvrv
systol
diastol
function
includ
doppler
analysi
isovolum
contract
relax
eject
time
et
fi
lling
time
ft
tivt
calcul
total
et
total
ft
tei
index
ict
irt
et
tivt
secondminut
tei
index
use
defi
ne
glvd
data
shown
mean
sdmedian
interquartil
rang
result
total
patient
year
male
apach
ii
score
includ
preval
glvd
high
associ
signifi
cantli
increas
mortal
vs
p
diff
erenc
requir
cardiorespiratori
support
two
popul
signifi
cant
diff
erenc
glvd
vs
glvd
requir
p
mitral
regurgit
vs
p
measur
lv
systol
diastol
function
two
group
good
correl
two
method
use
assess
dyssynchroni
lv
tivt
lv
tei
index
correl
coeffi
cient
p
conclus
glvd
limit
cardiac
output
common
cardiothorac
icu
signifi
cantli
relat
mortal
diagnos
underli
caus
sought
treatment
instig
minim
tivt
pace
optimizationrevascular
inotrop
titrationvolaemia
optim
refer
introduct
correct
coagulopathi
central
venou
cathet
cvc
insert
common
practic
howev
ultrasound
guidanc
use
controversi
mechan
complic
rare
studi
oncolog
patient
suggest
cvc
placement
without
prior
correct
coagulopathi
safe
studi
avail
critic
ill
patient
guidelin
give
recommend
routin
correct
coagulopathi
even
sever
ultrasound
guidanc
use
purpos
retrospect
studi
evalu
safeti
practic
method
data
ultrasoundguid
intervent
includ
complic
prospect
collect
depart
audit
purpos
studi
involv
cvc
insert
icu
februari
novemb
electron
medic
laboratori
record
paperbas
nurs
chart
retrospect
studi
intervent
specifi
calli
look
blood
result
coagul
abnorm
interventionrel
complic
studi
period
ultrasound
guidanc
employ
total
central
line
insert
icu
patient
coagulopathi
detect
case
time
cvc
placement
day
cvc
insert
coagul
abnorm
correct
case
patient
sever
coagulopathi
patient
coagulopathi
moder
sever
correct
correct
start
cvc
insert
reason
unrel
cvc
placement
eight
two
patient
sever
less
sever
coagulopathi
respect
bleed
complic
observ
conclus
patient
undergo
cvc
insert
icu
coagulopathi
common
observ
uncompl
cvc
placement
patient
sever
uncorrect
coagulopathi
patient
coagulopathi
moder
sever
combin
studi
data
suggest
ultrasoundguid
cvc
placement
without
routin
correct
coagul
abnorm
may
safe
icu
introduct
earli
bleed
exit
site
cvc
picc
placement
common
event
caus
diffi
culti
patient
care
logist
problem
experi
rate
signifi
cant
local
bleed
placement
picc
without
revers
taper
may
high
hour
hour
rate
bleed
placement
largebor
dialysi
cathet
hour
method
aim
pilot
studi
verifi
effi
caci
cyanoacryl
glue
reduc
risk
earli
bleed
exit
site
cvc
picc
placement
studi
group
adult
patient
consecut
undergo
placement
polyurethan
cvc
picc
without
revers
taper
nonintens
ward
hospit
line
insert
accord
protocol
includ
chlorhexidin
antisepsi
maxim
steril
barrier
ultrasound
guidanc
ekg
guidanc
secur
sutureless
devic
two
minut
placement
glue
exit
site
cover
temporari
gauz
dress
replac
transpar
membran
hour
patient
assess
hour
hour
result
consecut
patient
picc
dialysi
cathet
nine
cvc
signifi
cant
local
bleed
hour
hour
cathet
placement
local
advers
reaction
occur
damag
polyurethan
cathet
detect
conclus
glue
inexpens
highli
eff
ectiv
tool
avoid
risk
earli
bleed
exit
site
cathet
placement
also
suggest
next
futur
glue
might
prove
benefi
cial
collater
eff
ect
risk
extralumin
contamin
reduc
entranc
bacteria
space
cathet
skin
well
risk
disloc
increas
stabil
cathet
insid
skin
breach
introduct
year
ago
use
chest
radiograph
golden
standard
ensur
correct
posit
central
venou
cathet
cvc
question
frequent
use
cvc
also
challeng
decid
retrospect
evalu
routin
larg
surgic
unit
swedish
univers
hospit
method
xray
central
regist
chest
xray
perform
unit
almost
entir
use
confi
rm
cvc
posit
certofi
x
cvc
set
selding
techniqu
combin
certodyn
universaladapt
b
braun
germani
use
routin
equip
right
jugular
vein
standard
approach
total
number
xray
perform
patient
unit
correspond
approxim
number
insert
cvc
time
sinc
confi
rmatori
xray
routin
xray
rare
perform
indic
unit
xray
cost
time
approxim
year
chest
xray
perform
refl
ect
use
intracardiac
confi
rmation
correct
cvc
posit
also
reduc
use
cvc
trend
continu
time
approxim
cvc
insert
unit
xray
perform
case
cost
chest
xray
today
mean
xray
cost
approxim
experienc
medic
problem
intracardiac
ecg
use
posit
confi
rmation
contrari
aspir
venou
blood
without
appar
pwave
patient
sinu
rhythm
may
suggest
improp
placement
cvc
exampl
right
brachial
vein
conclus
continu
use
cvc
frequenc
year
ago
use
xray
confi
rmation
practic
case
would
paid
approxim
annual
reduc
use
cvc
combin
intracardiac
confi
rmation
cvc
posit
allow
us
reduc
cost
associ
cvc
insert
correspond
reduct
rate
also
decreas
patient
exposur
xray
irradi
introduct
case
arrhythmia
beattobeat
variat
arteri
pressur
ap
may
impair
accuraci
autom
cuff
measur
inde
oscillometr
devic
reli
detect
arteri
wall
oscil
aim
determin
icu
patient
whether
brachial
cuff
measur
realli
less
reliabl
arrhythmia
regular
rhythm
method
patient
arrhythmia
carri
intraarteri
cathet
prospect
consecut
includ
multicent
studi
arrhythm
inclus
regular
rhythm
patient
includ
second
inclus
possibl
case
chang
cardiac
rhythm
three
pair
invas
brachial
cuff
monitor
measur
mean
arteri
pressur
map
respect
averag
patient
underw
second
set
measur
cardiovascular
intervent
passiv
leg
rais
volum
expans
initi
ofincreas
catecholamin
infus
allow
assess
map
chang
introduct
signifi
cant
chang
haemodynam
occur
brain
stem
death
bsd
evid
yield
transplant
organ
may
decreas
donor
remain
preload
respons
prior
donat
suggest
optimis
cardiac
output
co
may
benefi
cial
potenti
organ
donor
describ
current
uk
practic
regard
co
monitor
group
method
review
databas
brainstemdead
potenti
organ
donor
collect
specialist
nurs
organ
donat
snod
period
april
octob
across
multipl
uk
centr
databas
contain
data
donor
manag
period
initi
snod
review
immedi
prior
transfer
oper
theatr
analys
data
co
monitor
vasopressorinotrop
use
inform
missingnot
record
dataset
treatment
refer
interpret
givennot
done
fiftythre
patient
evid
co
monitor
lidco
popular
method
figur
total
patient
receiv
treatment
vasopressor
andor
inotrop
co
data
utilis
varieti
way
figur
conclus
major
potenti
donor
requir
vasopressor
andor
inotrop
post
bsd
seem
minor
current
co
monitor
variat
co
data
utilis
direct
haemodynam
manag
welcom
develop
standardis
bundledriven
donor
manag
refer
indocyanin
green
plasma
disappear
rate
icgpdr
dynam
liver
function
test
noninvas
measur
puls
densitometri
icgpdr
associ
mortal
marker
outcom
due
predomin
use
icgpdr
icu
set
normal
rang
base
scarc
data
avail
outsid
icu
given
minut
method
prospect
reevalu
normal
rang
analyz
potenti
impact
biometr
data
icgpdr
measur
icgpdr
iv
inject
mgkg
icg
limon
pulsion
munich
introduct
mix
venou
oxygen
satur
svo
repres
wellrecogn
paramet
oxygen
deliveri
consumpt
vo
mismatch
use
advoc
critic
ill
patient
order
guid
hemodynam
resuscit
oxygen
deliveri
optim
nevertheless
pulmonari
arteri
cathet
pac
readili
avail
use
devoid
risk
furthermor
use
decreas
recent
year
surgic
cardiac
surgic
patient
benefi
guid
therapi
devic
unclear
central
venou
oxygen
satur
scvo
suggest
altern
svo
monitor
due
feasibl
sever
set
unfortun
concern
aris
capabl
correl
svo
relationship
infl
uenc
sever
factor
hemodynam
impair
patholog
process
hemodynam
instabl
shock
often
complic
cardiac
surgeri
svo
scvo
relationship
specifi
calli
investig
set
aim
studi
compar
svo
scvo
valu
patient
cardiogen
shock
cardiac
surgeri
method
prospect
observ
studi
design
conduct
inclus
criteria
patient
underw
elect
urgentemerg
cardiac
surgeri
cardiac
index
ci
lminutem
estim
mean
pac
left
ventricl
eject
fraction
lvef
lactat
mmoll
age
year
central
venou
cathet
cvc
pac
insert
patient
surgeri
right
intern
jugular
vein
accord
standard
procedur
proper
posit
pac
confi
rmed
pressur
trace
chest
xray
mix
central
venou
blood
sampl
collect
distal
port
pac
cvc
respect
minut
icu
admiss
everi
hour
total
three
sampl
period
patient
blood
sampl
analyz
cooximet
radiomet
fl
ex
radiomet
copenhagen
denmark
statist
analysi
perform
stat
direct
cheshir
uk
graphpad
ver
prism
san
diego
ca
usa
data
test
normal
distribut
kolmogorovsmirnov
test
statist
analysi
perform
linear
regress
analysi
agreement
absolut
valu
scvo
svo
assess
mean
bia
limit
agreement
loa
mean
bia
deviat
accord
method
describ
bland
altman
result
total
patient
enrol
case
three
blood
sampl
collect
two
patient
two
blood
sampl
drawn
exit
inclus
criteria
linear
regress
analysi
two
variabl
result
r
blandaltman
analysi
figur
pool
measur
svo
scvo
show
mean
bia
loa
sd
bia
respect
conclus
scvo
advoc
attract
simpl
indic
vo
mismatch
role
surrog
wellestablish
svo
investig
sever
set
purpos
hemodynam
resuscit
critic
ill
septic
patient
nevertheless
svo
scvo
relationship
infl
uenc
sever
factor
due
scvo
depend
global
blood
fl
ow
redistribut
occur
hemodynam
impair
shown
previous
healthi
peopl
scvo
valu
tend
underestim
svo
valu
due
higher
oxygen
content
inferior
vena
cava
circulatori
shock
homogen
oxygen
extract
region
blood
fl
ow
method
assess
benefi
tee
data
provid
assess
fi
domain
hypovolemia
right
ventricular
dysfunct
left
ventricular
dysfunct
sepsi
valvular
abnorm
bedsid
practition
list
diagnos
see
primari
tee
imag
perform
train
physician
use
likert
scale
assess
diff
erenti
diagnosi
tee
compar
chang
use
pair
test
result
request
tee
access
hemodynam
instabl
total
patient
screen
nine
elig
total
tee
studi
perform
complic
tee
patient
toler
longterm
placement
probe
well
fi
diagnost
domain
studi
right
ventricular
failur
commonli
underdiagnos
contributor
hemodynam
instabl
among
patient
prior
tee
p
figur
introduct
echocardiographi
increasingli
util
inten
sive
care
physician
everyday
practic
standard
echocardiograph
studi
report
qualiti
assur
medicoleg
requir
necessit
establish
dedic
system
within
critic
care
set
describ
process
set
critic
care
echocardiographi
cce
laboratori
base
experi
three
separ
icu
method
retrospect
review
analysi
process
involv
establish
echocardiographi
laboratori
within
icu
result
creat
cce
servic
involv
number
stage
take
sever
year
achiev
major
compon
includ
staffi
ng
equip
qualiti
control
studi
archiv
network
capabl
staffi
ng
object
identifi
recruit
staff
adequ
train
expertis
cce
provid
specialist
cover
addit
support
train
junior
medic
nurs
staff
need
acquir
fund
highqual
ultrasound
machin
relat
hardwar
well
longterm
dicombas
archiv
report
system
base
project
annual
volum
echo
studi
correspond
digit
storag
network
connect
highli
desir
includ
obligatori
backup
solut
site
alloc
busi
case
incorpor
preced
develop
identifi
abl
fund
sourc
administr
approv
essenti
implement
stage
requir
presenc
project
leader
organ
trial
scanner
archiv
report
research
system
ensur
compat
exist
hospit
cardiolog
network
assist
individu
archiv
report
softwar
refl
ect
institut
icu
specifi
cs
coordin
depart
import
clear
contractu
vendor
oblig
servic
mainten
futur
upgrad
hardwar
softwar
need
specifi
ed
train
credenti
staff
best
achiev
within
systemat
framework
includ
ongo
compet
review
educ
qa
program
partnership
cardiolog
may
benefi
group
major
pitfal
associ
poor
initi
train
lack
expertis
leadership
bad
vendor
contract
conclus
establish
cce
laboratori
requir
care
plan
alloc
adequ
human
fi
nancial
resourc
mani
potenti
problem
identifi
ed
prevent
advanc
strong
expert
leadership
play
import
role
introduct
contrastenhanc
ultrasonographi
ceu
dynam
digit
ultrasoundbas
imag
techniqu
allow
quantifi
cation
microvascularis
capillari
vessel
novel
method
assess
tissu
perfus
ideal
design
use
icu
ceu
costeff
ectiv
safe
repeatedli
perform
bedsid
without
radiat
nephrotox
critic
care
volum
suppl
http
method
frequenc
ceu
use
multidisciplinari
surgic
icu
retrospect
evalu
period
septemb
septemb
furthermor
contribut
novel
method
manag
critic
ill
icu
patient
well
accuraci
assess
result
total
ceu
studi
perform
critic
ill
icu
patient
frequent
indic
includ
assess
liver
perfus
assess
pancrea
kidney
perfus
pancrea
kidney
transplant
assess
renal
perfus
acut
kidney
injuri
aki
assess
activ
bleed
assess
bowel
perfus
studi
correct
diagnosi
achiev
transport
critic
ill
patient
radiolog
depart
diagnost
procedur
well
applic
iodin
contrast
agent
avoid
case
signifi
cant
new
fi
nding
detect
twelv
miss
convent
standard
doppler
ultrasound
prior
ceu
assess
seven
case
aki
impair
delay
perfus
microcircul
kidney
observ
six
patient
three
patient
urgent
surgic
intervent
perform
ceu
result
three
case
activ
bleed
exclud
bedsid
due
absenc
contrast
agent
extravas
hematoma
thigh
perihepat
abdomin
caviti
without
need
complementari
ct
imag
angiographi
one
case
regular
perfus
intestin
anastomosi
confi
rmed
need
surgic
explor
none
patient
undergo
ceu
manifest
advers
reaction
develop
complic
associ
imag
techniqu
conclus
contrastenhanc
ultrasonographi
clearli
improv
visual
perfus
variou
tissu
like
superior
standard
doppler
ultrasound
safe
well
toler
critic
ill
patient
promis
indic
use
ceu
icu
may
assess
kidney
microcircul
assess
liver
perfus
liver
transplant
liver
trauma
patient
introduct
even
though
invas
hemodynam
devic
usual
use
assess
septic
shock
victim
evalu
heart
function
lv
dysfunct
well
right
heart
syndrom
uncommon
sepsi
critic
patient
intens
care
ultrasound
disclos
data
lead
appropri
treatment
method
studi
prospect
crosssect
studi
measur
perform
within
hour
icu
admiss
exclud
patient
histori
copd
pulmonari
hypertens
diseas
goodqual
imag
acquir
subject
includ
analysi
primari
object
disclos
hemodynam
chang
septic
patient
icuu
introduct
thermodilut
td
consid
gold
standard
measur
cardiac
index
ci
critic
ill
patient
aim
studi
compar
intermitt
bolu
td
ci
intermitt
automat
calibr
ci
autoci
two
continu
ci
obtain
puls
contour
analysi
picco
picci
pulsiofl
ex
pucci
method
interim
result
ongo
prospect
multicentr
studi
patient
age
sap
ii
score
sofa
score
patient
underw
picco
monitor
via
femor
line
whilst
radial
line
kept
place
four
time
period
fi
rst
two
period
pulsiofl
ex
connect
radial
line
last
two
connect
femor
line
fi
rst
third
period
pulsiofl
ex
calibr
tdci
second
fourth
period
pulsiofl
ex
calibr
autoci
simultan
picci
pucci
measur
obtain
everi
hour
simultan
tdci
autoci
obtain
everi
hour
also
look
eff
ect
intervent
total
cci
tdci
valu
obtain
pair
picci
pucci
pair
autocitdci
measur
tdci
valu
rang
lminutem
mean
autoci
picci
pucci
pearson
correl
coeffi
cient
compar
mean
pucci
picci
valu
per
patient
r
comparison
autoci
tdci
r
chang
autoci
correl
well
chang
tdci
r
concord
coeffi
cient
chang
pucci
versu
chang
picci
r
cc
chang
picci
pucci
induc
intervent
correl
well
r
cc
percentag
error
pe
obtain
bland
altman
analysi
r
diff
erent
comparison
present
tabl
preliminari
result
indic
unstabl
critic
ill
patient
ci
reliabl
monitor
pulsiofl
ex
technolog
via
femor
line
pulsiofl
ex
also
abl
keep
track
chang
ci
interim
result
ongo
studi
use
noninvas
hemodynam
monitor
nexfi
n
critic
ill
patient
introduct
periop
goaldirect
therapi
pgdt
substanti
improv
outcom
highrisk
surgic
patient
approach
need
initi
invest
increas
staff
workload
econom
factor
might
particip
weak
adher
pgdt
concept
model
studi
support
pgdt
costeff
ectiv
real
econom
data
base
recent
clinic
trial
lack
perform
econom
analysi
hemodynam
optim
use
stroke
volum
variat
trial
order
elucid
issu
method
hospit
care
invoic
patient
includ
trial
retrospect
extract
due
natur
data
adopt
healthcar
payer
perspect
perform
comparison
induc
cost
vigileo
n
control
n
group
construct
cost
tree
use
studi
group
complic
occurr
distribut
paramet
increment
costeff
ectiv
ratio
per
complic
avoid
calcul
fi
nalli
diff
erent
reimburs
categori
assess
potenti
cost
driver
result
decreas
rate
vs
patient
number
complic
vs
observ
origin
trial
vigileo
group
mean
cost
interven
patient
lower
vs
p
accord
costtre
analysi
patient
complic
n
consum
signifi
cantli
resourc
gain
per
avoid
complic
confi
rm
lower
complic
rate
import
cost
driver
clinic
care
patient
cost
vs
p
ward
stay
cost
vs
p
decreas
intervent
contrari
intervent
increas
anaesthesia
cost
vs
p
conclus
intraop
fl
uid
optim
use
stroke
volum
variat
vigileoflotrac
system
show
substanti
improv
morbid
also
associ
econom
benefi
observ
benefi
highli
exceed
increas
monitor
cost
trial
introduct
hemodynam
monitor
import
highrisk
surgic
patient
order
detect
correct
circulatori
instabl
therebi
improv
outcom
extravascular
lung
water
index
evlwi
refl
ect
pulmonari
edema
new
edward
lifesci
accur
measur
evlwi
correct
actual
volum
lung
parenchyma
evlwic
aim
studi
prove
stronger
correl
evlwic
pao
fio
compar
evlwi
patient
undergo
pulmonari
resect
method
prospect
observ
studi
seven
patient
lung
cancer
undergo
pulmonari
resect
monitor
use
plathform
evlwi
assess
thermodilut
follow
time
point
intub
singlelung
ventil
lung
resect
icu
admiss
hour
hour
icu
admiss
evlwic
valu
also
collect
pao
fio
measur
time
point
result
signifi
cant
correl
found
evlwi
pao
fio
r
p
signifi
cant
correl
seen
evlwic
pao
fio
r
p
figur
conclus
despit
small
sampl
size
studi
show
patient
undergo
pulmonari
resect
evlwic
strongli
correl
pao
fio
evlwi
therefor
may
valuabl
tool
reliabl
hemodynam
monitor
subgroup
patient
refer
extracardiac
arteriopathi
alloc
gdt
convent
hemodynam
therapi
exclud
patient
endocard
previou
use
dobutamin
need
iabp
high
dose
vasopressor
emerg
surgeri
gdt
protocol
involv
hemodynam
resuscit
aim
target
cardiac
index
lminutem
threestep
approach
fl
uid
therapi
ml
lactat
ringer
solut
dobutamin
infus
dose
red
blood
cell
transfus
reach
hematocrit
level
result
twenti
patient
gdt
group
compar
control
patient
group
compar
concern
baselin
characterist
sever
score
except
higher
preval
hypertens
heart
failur
gdt
group
intraop
data
show
diff
erenc
regard
length
extracorpor
circul
fl
uid
balanc
transfus
inotrop
requir
patient
gdt
group
given
fl
uid
within
fi
rst
hour
compar
convent
group
ml
vs
ml
p
gdt
patient
show
median
icu
stay
day
ci
compar
day
control
patient
ci
moreov
hospit
stay
less
prolong
gdt
patient
day
vs
day
p
method
sixteen
patient
divid
two
group
one
group
treat
restrict
approach
mlkghour
liber
approach
mlkghour
patient
randomli
alloc
use
seal
envelop
thorac
part
surgic
procedur
patient
receiv
onelung
ventil
olv
group
treat
restrict
volum
approach
patient
receiv
fl
uid
rate
mlkghour
pao
fio
intub
extub
group
treat
liber
volum
approach
fl
uid
replac
mlkghour
pao
fio
intub
extub
surgeri
combin
olv
found
signifi
cantli
aff
ect
pao
fio
valu
anova
f
p
partial
averag
pao
fio
level
signifi
cantli
higher
restrictivereplac
group
liberalreplac
group
anova
f
p
partial
interact
group
anova
f
p
partial
mean
length
stay
icu
similar
restrictivereplac
group
day
liberalreplac
group
day
anova
f
p
partial
conclus
result
small
sampl
indic
esophag
carcinoma
surgeri
detriment
eff
ect
pao
fio
valu
restrict
periop
volum
signifi
cantli
aff
ect
volum
restrict
also
aff
ect
length
stay
icu
hypothes
goaldirect
therapi
gdt
associ
increas
risk
cardiac
complic
highrisk
noncardiac
surgic
patient
patient
limit
cardiopulmonari
reserv
risk
mortal
morbid
major
surgeri
augment
oxygen
deliveri
index
combin
intraven
fl
uid
inotrop
gdt
shown
reduc
postop
mortal
morbid
highrisk
patient
howev
concern
regard
cardiac
complic
associ
fl
uid
challeng
inotrop
use
augment
cardiac
output
may
deter
clinician
institut
earli
gdt
patient
like
benefi
method
systemat
search
medlin
embas
central
databas
random
control
trial
gdt
highrisk
surgic
patient
studi
includ
cardiac
surgeri
trauma
pediatr
surgeri
exclud
minim
heterogen
review
rate
cardiac
complic
arrhythmia
acut
myocardi
ischemia
acut
pulmonari
edema
metaanalys
perform
forest
plot
drawn
use
revman
softwar
data
present
odd
ratio
or
ci
p
valu
compar
calcul
echocardiograph
standard
formul
stroke
volum
crosssect
time
integr
coecho
rate
everi
patient
co
measur
twice
baselin
volum
load
ml
lactat
ringer
solut
agreement
covig
comc
coecho
evalu
mean
simpl
linear
regress
r
blandaltman
analysi
result
twenti
patient
enrol
studi
valu
r
bia
limit
agreement
summar
tabl
co
valu
rang
lminut
echo
vigileo
mostcar
pearson
blandaltman
method
show
poor
agreement
coecho
covig
demonstr
tendenc
overestim
see
figur
percentag
error
pe
contrari
mostcar
measur
show
good
agreement
echocardiographi
see
tabl
pe
conclus
vigileo
prove
substitut
refer
system
preload
data
necessari
vascular
imped
estim
may
one
main
limit
made
vigileo
measur
less
accur
mostcar
one
contrari
mostcar
uncalibr
total
independ
system
shown
properli
estim
vascular
imped
hemodynam
stabl
patient
comparison
unstabl
condit
need
confi
rm
observ
refer
previou
studi
found
associ
sever
acut
infl
ammatori
state
increas
arteri
stiff
ness
known
whether
noninvas
puls
waveform
analysi
could
predict
develop
multipl
organ
failur
septic
patient
purpos
studi
evalu
photoplethysmograph
brachial
arteri
puls
wave
transit
time
augment
index
chang
respons
induc
forearm
ischemia
septic
icu
patient
correl
indic
develop
subsequ
end
organ
damag
method
prospect
observ
studi
patient
sepsi
within
hour
admiss
sever
sepsi
assess
apach
ii
score
median
sofa
score
median
threeminut
signal
record
done
concurr
brachial
arteri
elbow
radial
arteri
wrist
origin
design
photoplethysmograph
rest
minut
induc
forearm
ischemia
record
analyz
obtain
puls
wave
transit
time
augment
index
rest
second
induc
ischemia
sofa
score
recalcul
hour
post
record
result
studi
consecut
gener
icu
patient
neg
linear
relationship
puls
wave
transit
time
median
ms
rest
increas
sofa
score
hour
p
r
postischem
puls
wave
transit
time
increas
patient
median
ms
associ
found
proport
increas
subsequ
chang
sofa
correl
rest
median
postischem
median
augment
index
sofa
score
statist
signifi
cant
r
p
conclus
studi
indic
earli
sepsi
puls
waveform
characterist
could
predict
risk
develop
end
organ
failur
puls
wave
transit
time
robust
augment
index
could
easier
use
patient
poor
perfus
vascular
reactiv
indic
seem
predict
valu
context
refer
clinic
practic
blood
volum
bv
typic
measur
thermodilut
recent
contrastenhanc
ultrasound
ceu
propos
altern
minim
invas
approach
bv
assess
method
measur
bv
use
singl
peripher
inject
small
bolu
ultrasound
contrast
agent
uca
detect
ultrasound
scanner
measur
acoust
backscatt
two
indic
dilut
curv
idc
deriv
two
diff
erent
site
circulatori
system
idc
analysi
permit
deriv
mean
transit
time
mtt
bolu
take
travel
inject
site
two
measur
site
assess
bv
site
obtain
multipli
diff
erenc
mtt
blood
fl
ow
studi
compar
diff
erent
volum
vitro
setup
ceu
true
setup
volum
thermodilut
acquir
volum
method
vitro
setup
consist
centrifug
pump
network
tube
variabl
volum
electromagnet
fl
owmet
measur
adjust
gener
fl
ow
heat
devic
maintain
constant
temperatur
two
thermistor
thermodilut
measur
ultrasound
transduc
pressur
stabil
small
bolu
uca
dilut
cold
salin
mg
ml
salin
inject
system
cold
uca
passag
fi
rst
second
region
interest
roi
measur
simultan
ultrasound
transduc
thermistor
measur
perform
diff
erent
fl
ow
volum
bv
estim
use
two
diff
erent
approach
name
ceu
thermodilut
idc
process
fi
tted
separ
dedic
model
estim
cold
uca
bolu
two
roi
two
thermistor
measur
repeat
three
time
result
linear
relat
bv
estim
two
techniqu
observ
correl
coeffi
cient
bia
ceu
respect
true
volum
ml
bia
thermodilut
ml
promin
diff
erenc
two
techniqu
observ
case
high
volum
low
fl
ow
possibl
due
diff
erent
transport
kinet
uca
heat
use
cardiac
output
monitor
shown
benefi
cial
set
periop
medicin
critic
ill
recent
applic
set
major
trauma
describ
describ
preliminari
experi
embed
bioreact
fl
ow
monitor
within
major
trauma
primari
survey
sever
injur
patient
subsequ
eff
ect
patient
manag
method
institut
ethic
approv
obtain
intub
major
trauma
patient
sequenti
enrol
exclus
includ
major
thorac
burn
children
bioreact
fl
ow
monitor
nicom
cheetah
appli
time
ecg
lead
calibr
step
perform
handov
prehospit
team
time
avail
oxygen
deliveri
data
record
trauma
team
member
survey
regard
perceiv
benefi
ts
concern
monitor
infl
uenc
fl
ow
monitor
fl
uid
resuscit
time
ct
defi
nitiv
dispos
oricu
measur
compar
control
popul
match
injuri
sever
score
age
sex
result
cardiac
index
avail
mean
minut
median
minut
sd
fl
uid
respons
mean
minut
median
sd
oxygen
deliveri
calcul
mean
minut
median
sd
passiv
leg
rais
perform
patient
due
concern
pelvic
brain
injuri
volum
fl
uid
infus
mean
vs
ml
p
time
ct
mean
vs
minut
p
time
defi
nitiv
dispos
mean
vs
minut
p
reduc
fl
ow
monitor
group
although
signifi
cantli
diff
erent
compar
match
control
group
mannwhitney
u
rank
sum
eightyfour
percent
trauma
team
member
survey
felt
fl
ow
monitor
data
use
felt
may
impair
clinic
manag
conclus
cardiac
index
fl
uid
respons
oxygen
deliveri
data
obtain
inform
primari
survey
rather
introduc
delay
use
fl
ow
monitor
associ
trend
toward
decreas
time
imag
less
fl
uid
use
predamag
control
point
reduc
time
defi
nitiv
dispos
research
requir
confi
rm
benefi
ts
mechan
refer
introduct
puls
pressur
variat
ppv
dynam
indic
fl
uid
respons
known
low
sensibl
specifi
citi
patient
ventil
pressur
support
ps
aim
investig
patientventil
asynchroni
potenti
sourc
hemodynam
interfer
ps
method
perform
prospect
studi
includ
ps
ventil
patient
met
inclus
criteria
fl
uid
deplet
patient
show
asynchroni
index
ai
exceed
includ
asynchroni
group
ag
remain
patient
includ
synchroni
group
sg
beattobeat
hemodynam
variabl
record
pram
mostcar
vytech
health
srl
padova
itali
ppv
cutoff
use
identifi
fl
uid
respondersnonrespond
fl
uid
challeng
ml
normal
salin
given
minut
increas
cardiac
index
minut
indic
fl
uid
respons
result
far
eight
patient
show
ai
overal
sensit
versu
sg
overal
specifi
citi
versu
ag
overal
cohen
k
versu
ag
see
figur
howev
none
respond
ag
group
detect
ppv
statist
analysi
feasibl
within
subgroup
minifl
uid
challeng
wide
use
strategi
manag
fl
uid
load
icu
although
might
ration
strategi
data
minifl
uid
challeng
reliabl
limit
investig
valu
chang
puls
contour
cardiac
output
result
minifl
uid
challeng
ml
predict
fl
uid
load
respons
method
measur
eff
ect
administr
ml
bolu
colloid
infus
co
modelfl
ow
com
lidco
coli
cvp
map
patient
mechan
ventil
elect
cardiothorac
surgeri
data
analys
smallest
volum
predict
eff
ect
ml
cardiac
output
result
coli
com
increas
ml
fl
uid
load
best
result
observ
chang
com
ml
fl
uid
load
area
roc
ci
chang
modelfl
ow
co
least
sensit
specifi
citi
ml
fl
uid
load
sensit
specifi
citi
similar
cutoff
co
measur
lidco
devic
ml
fl
uid
load
patient
popul
map
coli
predict
respons
accuraci
mathemat
chanc
see
figur
conclus
chang
puls
contour
co
use
minifl
uid
challeng
assess
fl
uid
respons
postcardiac
surgeri
patient
introduct
fluid
respons
defi
ned
base
arbitrari
increas
cardiac
output
co
stroke
volum
sv
hypothesis
variat
heart
effi
cienci
eh
slope
defi
ned
rel
increas
co
rel
increas
mean
fi
lling
pressur
pmsa
use
altern
defi
nition
fl
uid
respons
introduct
fluid
overload
associ
poor
outcom
critic
ill
thu
accur
predictor
posit
haemodynam
respons
increas
stroke
volum
fl
uid
challeng
vital
method
studi
predict
valu
posit
respons
defi
ned
chang
stroke
volum
mlkg
fl
uid
bolu
rang
haemodynam
variabl
static
cvp
activ
circul
volum
central
blood
volum
total
end
diastol
volum
dynam
systol
pressur
variat
stroke
volum
variat
contactil
dpdt
group
ventil
children
median
weight
kg
variabl
measur
use
transpulmonari
ultrasound
dilut
pram
arteri
puls
contour
method
perform
pair
measur
prefl
uid
postfl
uid
challeng
sv
respons
rate
overal
predict
valu
poor
slightli
better
static
versu
dynam
variabl
tabl
sv
respons
analys
continu
variabl
two
predict
multivari
variabl
chang
tedvi
baselin
dpdt
r
p
conclus
predict
abil
typic
static
dynam
haemodynam
variabl
taken
isol
poor
howev
improv
predict
seen
baselin
contractil
taken
account
pressur
map
guid
fl
uid
therapi
microcirculatori
perfus
patient
undergo
abdomin
surgeri
method
patient
undergo
elect
abdomin
surgeri
random
ppvciguid
group
n
mapguid
n
group
ppv
ci
map
measur
use
noninvas
fi
nger
arteri
blood
pressur
measur
devic
ccnexfi
n
edward
lifesci
bmey
amsterdam
netherland
tidal
volum
mlkg
peep
mmhg
group
map
mmhg
maintain
ppvci
group
intraop
algorithm
use
keep
ppv
ci
lminut
use
fl
uid
therapi
dobutamin
noradrenalin
infus
respect
sublingu
microvascular
perfus
measur
anesthesia
induct
everi
subsequ
hour
use
sidestream
darkfi
eld
imag
microscan
microvis
medic
amsterdam
netherland
perfus
small
vessel
densiti
pvd
valu
offl
ine
quantifi
ed
fi
rst
hour
surgeri
ppvciguid
group
tend
receiv
fl
uid
mapguid
group
vs
ml
p
time
point
pvd
slightli
lower
ppvciguid
group
mmmm
compar
mapguid
group
mmmm
p
group
pvd
remain
stabl
fi
rst
hour
surgeri
howev
hour
start
surgeri
pvd
ppvci
group
restor
tend
higher
mapguid
group
vs
mmmm
p
hour
surgeri
administ
fl
uid
volum
correl
invers
pvd
r
p
conclus
goaldirect
fl
uid
manag
result
higher
administ
fl
uid
volum
begin
surgeri
associ
slightli
reduc
microcirculatori
perfus
compar
mapguid
fl
uid
manag
microcirculatori
perfus
tend
improv
surgeri
progress
goaldirect
fl
uid
therapi
group
fi
nding
suggest
goaldirect
mapguid
fl
uid
manag
associ
distinct
pattern
fl
uid
resuscit
may
consequ
microvascular
perfus
introduct
previou
studi
demonstr
loss
glycocalyx
integr
associ
impair
microvascular
function
investig
whether
glycocalyx
dimens
reduc
patient
undergo
cardiac
surgeri
without
cardiopulmonari
bypass
cpb
parallel
loss
microcirculatori
perfus
use
vivo
microcircul
measur
method
patient
undergo
onpump
surgeri
nonpulsatil
n
pulsatil
n
cpb
pump
surgeri
n
underw
sublingu
sidestream
darkfi
eld
imag
baselin
coronari
graft
upon
icu
admiss
assess
perfus
microvascular
vessel
densiti
glycocalyx
integr
evalu
use
glycocheck
measur
softwar
express
perfus
boundari
region
pbr
increas
pbr
repres
deeper
penetr
erythrocyt
glycocalyx
indic
compromis
glycocalyx
thick
introduct
cold
exposur
adapt
exercis
therapeut
purpos
impact
microcircul
healthi
human
well
defi
ned
hypothes
whole
bodi
cold
stress
may
impair
microcircul
method
seven
volunt
recruit
water
immers
procedur
cool
protocol
volunt
everi
minut
immers
ask
step
bath
rest
minut
room
environ
return
water
bath
next
minut
immers
headout
immers
procedur
bath
water
continu
rectal
temperatur
drop
time
minut
termin
maximum
cold
water
immers
time
minut
end
whole
bodi
cool
hour
cool
end
system
hemodynam
direct
vivo
observ
sublingu
microcircul
obtain
sidestream
darkfi
eld
imag
assess
microcirculatori
paramet
convect
oxygen
transport
microvascular
fl
ow
index
mfi
proport
perfus
vessel
ppv
diff
usion
distanc
perfus
vessel
densiti
pvd
total
vessel
densiti
tvd
done
use
semiquantit
method
result
cool
hour
cool
end
signifi
cant
increas
cardiac
output
p
p
observ
chang
heart
rate
mean
arteri
pressur
comparison
baselin
variabl
signifi
cant
chang
ppv
mfi
pvd
tvd
small
vessel
comparison
baselin
variabl
observ
time
conclus
defin
cold
exposur
effect
microcircul
introduct
vasodil
increas
skin
blood
fl
ow
also
sweat
infl
uential
heat
dissip
heat
exposur
exercis
unclear
heat
stress
infl
uenc
microcircul
side
darkfi
eld
imag
visual
blood
fl
ow
capillari
level
help
assess
perfus
heterogen
clinic
experiment
data
show
sublingu
region
clinic
relev
detect
microcirculatori
alter
repres
central
microcircul
cutan
perfus
hypothes
whole
bodi
heat
stress
may
increas
capillari
densiti
method
eight
healthi
men
histori
cold
andor
heat
injuri
recruit
studi
passiv
bodi
heat
perform
continu
immers
waist
water
bath
continu
rectal
temperatur
reach
end
whole
bodi
heat
hour
heat
end
system
hemodynam
direct
vivo
observ
sublingu
microcircul
obtain
sidestream
darkfi
eld
imag
assess
microcirculatori
paramet
convect
oxygen
transport
microvascular
fl
ow
index
mfi
proport
perfus
vessel
ppv
diff
usion
distanc
perfus
vessel
densiti
pvd
total
vessel
densiti
tvd
done
use
semiquantit
method
vessel
separ
larg
mostli
venul
small
mostli
capillari
use
diamet
cutoff
valu
result
whole
bodi
heat
result
signifi
cantli
increas
heart
rate
p
cardiac
output
p
comparison
baselin
variabl
one
hour
heat
end
heart
rate
introduct
serial
measur
lactat
time
may
better
prognost
singl
lactat
concentr
earli
lactateguid
therapi
also
reduc
icu
length
stay
icu
hospit
mortal
studi
aim
assess
prognost
valu
lactat
clearanc
lc
fi
rst
hour
surgic
patient
method
prospect
cohort
year
follow
consecut
enrol
patient
admit
immedi
postop
surgic
icu
hospit
santa
luzia
brazil
patient
assign
two
group
lc
lc
primari
outcom
measur
mortal
day
secondari
outcom
includ
hospit
icu
length
stay
lo
result
total
patient
follow
total
male
underw
elect
surgeri
mean
age
apach
ii
score
sap
mortal
day
n
mortal
day
n
respect
hospit
mortal
n
sixtyon
percent
n
patient
lc
versu
n
lc
lc
older
vs
p
greater
apach
ii
score
vs
p
sap
vs
p
diff
erenc
icu
lo
vs
day
p
hospit
lo
vs
day
p
initi
lactat
level
lower
group
lc
vs
p
howev
mean
lactat
higher
hour
vs
p
patient
die
fi
rst
day
lc
n
p
group
also
higher
mortal
day
n
vs
n
p
rel
risk
mortal
lc
day
ci
ci
respect
signifi
cant
diff
erenc
observ
kaplanmei
surviv
curv
day
p
respect
sensibl
lc
ci
mortal
ci
mortal
specifi
citi
ci
mortal
ci
mortal
conclus
despit
initi
lactat
level
lactat
clearanc
prove
good
predictor
mortal
day
surgic
patient
admit
postop
period
icu
refer
introduct
use
peripher
perfus
object
paramet
anticip
success
resuscit
septic
shock
recent
investig
mottl
score
perfus
paramet
use
decad
propos
correl
septic
shock
surviv
test
studi
clinic
tool
predict
mortal
method
prospect
observ
studi
conduct
patient
consecut
admit
tertiari
hospit
icu
brazil
juli
may
patient
diagnos
septic
shock
enrol
demograph
data
diagnos
shock
origin
sever
score
record
initi
resuscit
score
regist
fi
rst
day
observ
consid
score
lower
limb
without
arteri
cathet
worst
lower
limb
worst
day
exclus
criteria
termin
ill
intervent
decis
incomplet
method
pig
kg
random
one
group
sham
n
hs
n
lr
volum
bled
n
terli
mg
bolu
n
hs
induc
target
map
mmhg
maintain
minut
brain
tissu
oxygen
pressur
pbto
intracrani
pressur
icp
cerebr
perfus
pressur
cpp
haemodynam
blood
ga
analys
assess
prior
hs
baselin
minut
treatment
tissu
marker
brain
oedema
nakcl
apoptosi
preapoptot
protein
bax
oxid
stress
thiobarbitur
acid
reactiv
substanc
tbar
also
measur
result
sham
anim
signifi
cant
chang
variabl
assess
hs
result
signifi
cant
decreas
cpp
mean
vari
mmhg
pbto
mmhg
icp
mmhg
haemodynam
map
mmhg
ci
lminutem
signifi
cant
increas
blood
lactat
mmoll
cerebr
mean
se
sham
sham
bax
sham
tbar
fluid
resuscit
follow
increas
icp
mmhg
decreas
cpp
mmhg
increas
express
cerebr
sham
sham
bax
sham
introduct
shock
induc
mitochondri
damag
lead
tissu
injuri
infl
ammat
resuscit
adjunct
limit
mitochondri
injuri
may
eff
ectiv
reduc
tissu
injuri
protect
sequela
hemorrhag
shock
hs
other
demonstr
protect
eff
ect
inhal
carbon
monoxid
co
nebul
sodium
nitrit
nano
model
hs
aim
test
hypothesi
co
nano
protect
hemorrhag
shockinduc
tissu
injuryinfl
ammat
limit
mitochondri
damag
prevent
bioenerget
failur
method
twenti
anesthet
femal
yorkshir
pig
subject
sever
hemorrhag
unabl
compens
minut
resuscit
volumepressor
muscl
platelet
sampl
obtain
baselin
bl
hour
resuscit
endob
anim
random
standard
care
hsr
n
hsrco
co
minut
n
hsrnano
nano
mg
minut
n
sham
n
co
nano
initi
minut
resuscit
primari
endpoint
chang
muscl
platelet
mitochondri
respir
bl
endob
quantifi
ed
muscl
respiratori
control
ratio
rcr
tradit
respirometri
chang
protonleak
respir
plr
mitochondri
reserv
capac
platelet
secondari
endpoint
mortal
endob
result
skelet
muscl
rcr
decreas
hsr
group
p
sham
decreas
rcr
primarili
due
decreas
adpdepend
respir
without
chang
state
respir
hsr
also
result
platelet
mitochondri
dysfunct
demonstr
increas
plr
decreas
reserv
capac
correl
increas
platelet
activ
fl
ow
cytometri
hsr
co
nano
treatment
prevent
deleteri
chang
muscl
platelet
mitochondri
respir
well
limit
hsrinduc
platelet
activ
co
treatment
also
improv
reserv
capac
compar
baselin
mortal
higher
hsr
co
nano
vs
respect
conclus
sever
hs
mitochondri
injuri
platelet
muscl
limit
co
nano
although
power
secondari
endpoint
mortal
doubl
hsr
versu
adjunct
therapi
suggest
co
nano
may
protect
mitochondri
function
maintain
atpcoupl
respir
reserv
capac
may
confer
surviv
advantag
howev
investig
requir
introduct
norepinephrin
wide
use
septic
shock
howev
eff
ect
remain
controversi
conduct
systemat
review
metaanalysi
compar
eff
ect
norepinephrin
vasopressor
method
pubm
embas
cochran
librari
databas
databas
incept
octob
search
select
random
control
trial
adult
septic
shock
compar
norepinephrin
vasopressor
qualiti
studi
includ
assess
jadad
score
assess
heterogen
treatment
eff
ect
across
trial
use
statist
use
fi
xed
eff
ect
model
p
randomeff
ect
model
p
express
result
risk
ratio
rr
dichotom
outcom
standard
mean
diff
erenc
smd
continu
data
ci
result
eighteen
trial
n
met
inclus
criteria
compar
norepinephrin
fi
diff
erent
vasopressor
dopamin
vasopressin
epinephrin
terlipressin
phenylephrin
mean
jadad
score
overal
diff
erenc
mortal
comparison
norepinephrin
vasopressin
epinephrin
terlipressin
phenylephrin
p
respect
howev
norepinephrin
trend
decreas
mortal
compar
dopamin
rr
ci
p
decreas
heart
rate
hr
smd
ci
p
cardiac
index
smd
ci
p
increas
system
vascular
resist
index
svri
smd
ci
p
treatment
norepinephrin
compar
dopamin
conclus
suffi
cient
evid
prove
norepinephrin
superior
vasopressin
epinephrin
terlipressin
phenylephrin
term
mortal
howev
norepinephrin
associ
decreas
hr
cardiac
index
increas
svri
appear
greater
eff
ect
decreas
mortal
compar
dopamin
introduct
vasopleg
syndrom
common
complic
cardiac
surgeri
neg
impact
patient
outcom
hospit
cost
pathogenesi
vasodilatori
phenomenon
cardiac
surgeri
remain
matter
controversi
loss
vascular
tone
partli
explain
deplet
neurohypophys
arginin
vasopressin
store
vasopressin
commonli
use
adjunct
catecholamin
support
blood
pressur
refractori
septic
shock
eff
ect
vasopleg
shock
unknown
hypothes
use
vasopressin
would
eff
ectiv
treatment
shock
cardiac
surgeri
norepinephrin
decreas
composit
endpoint
mortal
sever
morbid
method
prospect
random
doubleblind
trial
assign
patient
vasopleg
shock
receiv
either
vasopressin
uminut
norepinephrin
kgminut
addit
openlabel
vasopressor
vasopressor
infus
titrat
taper
accord
protocol
maintain
target
blood
pressur
primari
endpoint
major
morbid
accord
st
mortal
mechan
ventil
hour
mediastin
surgic
reexplor
stroke
acut
renal
failur
secondari
outcom
time
mechan
ventil
icu
hospit
stay
new
infect
time
attain
hemodynam
stabil
occurr
advers
event
safeti
result
total
patient
underw
random
infus
studi
drug
patient
receiv
vasopressin
norepinephrin
includ
analysi
patient
receiv
vasopressin
lower
rate
morbid
vs
p
compar
norepinephrin
group
mortal
rate
norepinephrin
group
vasopressin
group
p
signifi
cant
diff
erenc
overal
rate
seriou
advers
event
respect
p
result
patient
two
group
statist
compar
respect
sex
p
age
p
caus
syndrom
takotsubo
subarachnoid
hemorrhag
six
patient
coronari
arteri
bypass
graft
four
patient
polytrauma
two
patient
patient
low
cardiac
output
levosimendan
group
eject
fraction
entranc
hour
hour
control
group
eject
fraction
entranc
hour
hour
compar
two
group
reach
statist
signifi
canc
p
conclus
compar
two
group
notic
start
low
cardiac
output
howev
group
use
drug
therapi
base
levosimendan
saw
return
systol
function
left
ventricl
nearnorm
level
within
hour
control
group
remain
dysfunct
systol
function
shown
drug
therapi
base
levosimendan
contribut
improv
systol
function
left
ventricl
compar
treatment
dobutamin
despit
initi
cardiac
stun
refer
introduct
critic
ill
incid
rais
cardiac
troponin
ctnt
level
high
although
mechan
myocardi
injuri
well
understood
rais
ctnt
level
associ
increas
mortal
aim
studi
determin
incid
preval
outcom
silent
myocardi
injuri
determin
rais
ctnt
level
concomit
ecg
chang
critic
ill
patient
admit
noncardiac
reason
method
ecg
taken
ctnt
measur
daili
fi
rst
week
altern
day
second
week
discharg
icu
death
complet
studi
ctnt
level
ecg
analys
independ
patient
classifi
ed
four
group
defi
nite
mi
ctnt
ngl
defi
nite
ecg
chang
mi
possibl
mi
ctnt
ngl
ischaem
chang
ecg
troponin
rise
alon
ctnt
ngl
ischaem
ecg
chang
normal
medic
note
review
independ
two
icu
clinician
result
total
patient
includ
analysi
femal
mean
age
sd
mean
apach
ii
score
total
patient
least
one
ctnt
level
ngl
stay
icu
twenti
patient
fulfi
lled
criteria
defi
nite
mi
septic
noradrenalin
time
icu
hospit
mortal
respect
thirtynin
patient
possibl
mi
septic
noradrenalin
icu
hospit
mortal
respect
sixtytwo
patient
rais
troponin
without
ecg
septic
noradrenalin
icu
hospit
mortal
respect
twentythre
patient
normal
ctnt
result
serial
ecg
sepsi
icu
hospit
mortal
defi
nite
mi
possibl
mi
recognis
clinic
team
time
conclus
eightyfour
per
cent
critic
ill
patient
rais
ctnt
level
stage
stay
icu
patient
fulfi
lled
criteria
possibl
defi
nite
mi
recognis
clinic
icu
hospit
outcom
signifi
cantli
wors
patient
ctnt
rise
proport
patient
sepsi
similar
patient
defi
nite
possibl
mi
grace
risk
score
predict
death
within
month
hospit
discharg
valid
use
patient
ac
would
perfect
futur
includ
grace
risk
score
medic
record
type
patient
also
would
interest
valid
multicentr
studi
figur
patient
group
prolong
length
stay
icu
hospit
patient
group
recoveri
septic
shock
notic
huge
accumul
fl
uid
balanc
posit
fl
uid
balanc
associ
prolong
length
stay
icu
hospit
ugib
patient
need
intervent
howev
intervent
gb
mention
includ
endoscopi
also
blood
transfus
therefor
determin
whether
ugib
patient
need
urgent
endoscopi
blood
transfus
gb
alon
hypothes
high
lactat
clearanc
clac
would
decreas
likelihood
sustain
ugib
method
retrospect
studi
ugib
patient
visit
emerg
depart
ed
nation
center
global
health
medicin
april
march
receiv
urgent
endoscopi
ed
enrol
collect
patient
gb
blood
lactat
valu
arriv
ed
blood
lactat
valu
bolu
administr
mlkg
ringer
acet
initi
fl
uid
therapi
report
urgent
endoscopi
classifi
ed
sever
ugib
accord
gb
score
classifi
ed
moder
score
classifi
ed
sever
clac
defi
ned
percentag
decreas
blood
lactat
time
arriv
ed
time
initi
fl
uid
therapi
fi
nish
clac
defi
ned
low
clac
defi
ned
high
whether
patient
sustain
bleed
determin
base
report
urgent
endoscopi
relationship
clac
sustain
bleed
examin
fisher
exact
test
p
consid
statist
signifi
cant
result
seventynin
patient
enrol
fiftyon
patient
moder
ugib
patient
sever
ugib
indic
tabl
signifi
cant
relationship
clac
sustain
bleed
moder
ugib
p
hand
signifi
cant
relationship
clac
sustain
bleed
sever
ugib
p
introduct
aim
studi
assess
muscular
glucos
microdialysi
associ
mortal
septic
shock
patient
conduct
preliminari
prospect
studi
includ
septic
shock
patient
hemodynam
optim
accord
intern
recommend
microdialysi
cathet
insert
femor
quadricep
interstiti
fl
uid
sampl
collect
everi
hour
day
determin
muscular
glucos
perform
cma
analyz
cmamicrodialysi
ab
sweden
also
perform
dosag
concomit
blood
glucos
studi
popul
divid
two
group
accord
hospit
mortal
statist
analysi
mannwhitney
test
chisquar
test
comparison
group
quantit
variabl
express
mean
standard
deviat
median
interquartil
rang
appropri
result
includ
patient
septic
shock
mortal
rate
demograph
compar
group
except
age
vs
dead
patient
vs
survivor
respect
p
pneumonia
major
caus
septic
shock
patient
analys
blood
sampl
muscular
glucos
sampl
found
posit
associ
muscular
glucos
blood
glucos
mortal
tissu
glucos
signifi
cantli
higher
among
dead
patient
compar
survivor
hour
compar
data
muscular
glucos
p
blood
glucos
p
signifi
cantli
higher
dead
patient
tabl
conclus
data
suggest
muscular
glucos
assess
microdialysi
blood
glucos
associ
mortal
septic
shock
patient
therefor
muscular
glucos
may
refl
ect
metabol
alter
microcirculatori
dysfunct
induc
septic
shock
method
audit
trust
audit
committe
approv
exist
protocol
use
benchmark
patient
studi
prospect
assess
complianc
local
bowel
protocol
incid
constip
relationship
wean
respiratori
support
feed
hdu
mechan
ventil
icu
patient
stay
ward
day
includ
except
patient
bowel
surgeri
patient
encephalopathi
result
among
hdu
icu
patient
audit
royal
liverpool
univers
hospit
respect
constip
lax
prescrib
patient
open
bowel
day
hdu
icu
case
take
consider
median
age
apach
ii
score
length
stay
constip
nonconstip
patient
similar
relationship
feed
respiratori
support
assess
introduct
note
unit
dislodg
nasogastr
tube
occur
commonli
lead
increas
risk
aspir
interrupt
nutrit
support
skin
breakdown
radiograph
exposur
recommend
posit
nasogastr
tube
confi
rmed
aspir
ph
test
radiograph
confi
rmation
use
possibl
method
perform
retrospect
review
chest
xray
cxr
request
period
june
august
use
trust
radiolog
inform
system
proport
cxr
request
confi
rmation
posit
patient
demograph
measur
estim
fi
nancial
cost
perform
result
patient
admit
critic
care
area
studi
period
total
cxr
perform
confi
rmation
posit
repeat
xray
requir
patient
see
tabl
patient
older
tend
longer
length
stay
mobil
cxr
cost
trust
one
cxr
accept
per
patient
nasogastr
tube
excess
imag
cost
period
conclus
excess
cxr
perform
confi
rmation
nasogastr
tube
patient
popul
recommend
method
posit
confi
rmation
reinforc
amongst
medic
staff
high
number
repeat
imag
patient
indic
dislodg
tube
also
problem
propos
nasogastr
tube
bridl
fi
rst
dislodg
tracheostomi
insert
minimis
dislodg
futur
method
mechan
ventil
enter
fed
icu
patient
n
recruit
interdisciplinari
icu
healthi
overnightfast
volunt
n
serv
refer
prime
constant
iv
infus
hlabel
phenylalanin
phe
tyrosin
use
quantifi
wholebodi
protein
metabol
patient
remain
parenter
nutrit
pn
clinic
indic
control
receiv
pn
start
hour
start
enter
feed
intrins
cphelabel
casein
infus
hour
nasogastr
tube
g
protein
hour
togeth
maltodextrin
ghour
protein
breakdown
synthesi
net
balanc
phe
splanchnic
extract
calcul
end
enter
feed
period
use
equat
steadyst
wholebodi
protein
kinet
comparison
made
wilcoxon
match
pair
mannwhitney
u
test
valu
report
mean
sd
result
protein
net
balanc
lower
patient
refer
group
baselin
vs
mgkg
bwhour
p
enter
feed
vs
mgkg
bwhour
p
recoveri
label
phe
enter
feed
system
circul
higher
refer
group
compar
patient
vs
p
enter
feed
aff
ect
protein
metabol
refer
group
patient
protein
breakdown
becam
slightli
lower
enter
feed
vs
mgkg
bwhour
p
protein
net
balanc
becam
slightli
higher
vs
mgkg
bw
hour
p
conclus
intrins
isotopelabel
casein
use
quantifi
dietari
contribut
protein
metabol
critic
ill
patient
hypocalor
enter
feed
margin
improv
protein
balanc
patient
low
recoveri
enter
administ
label
amino
acid
underlin
need
quantifi
uptak
gastrointestin
tract
protein
turnov
measur
perform
critic
ill
patient
enter
nutrit
method
smallscal
studi
ngt
placement
period
collat
data
suppli
questionnair
healthcar
worker
respons
ngt
placement
result
analysi
advers
incid
report
identifi
ed
never
event
misplac
ngt
within
previou
year
audit
reveal
commonest
type
ngt
radioopaqu
tube
stylet
corfl
placement
occasion
use
electromagnet
placement
system
cortrak
placement
size
common
tube
placement
confi
rmed
xray
ph
aspir
electromagnet
tube
placement
one
patient
time
taken
decis
place
ngt
use
vari
rang
minut
littl
distinct
seen
time
taken
use
ngt
confi
rmed
aspir
alon
minut
xray
minut
although
shortest
interv
seen
electromagnet
ngt
placement
minut
cost
ngt
confi
rmed
aspir
alon
low
approxim
higher
xray
confi
rmationelectromagnet
placement
approxim
conclus
despit
small
dataset
result
demonstr
concern
delay
applic
enter
feed
andor
drug
administr
whilst
reassur
step
taken
avoid
never
event
studi
demonstr
may
delay
timecrit
administr
enter
medicin
optim
nutrit
practic
studi
reveal
signifi
cant
problem
aspir
gastric
content
ph
test
necessit
larg
number
xray
posit
confi
rmation
even
frequenc
volum
gastric
aspir
greater
belief
ph
test
may
suffi
cientli
accur
sinc
mani
factor
alter
patient
gastric
ph
possibl
new
technolog
electromagnet
ngt
placement
may
allow
fasterequ
safe
practic
studi
includ
costbenefi
analysi
need
confi
rm
refer
eighteen
read
newli
place
ng
tube
read
old
ng
tube
fiftythre
per
cent
routin
ph
read
fals
high
ph
despit
ng
tube
stomach
figur
twentyeight
per
cent
newli
place
ng
tube
fals
high
ph
read
figur
conclus
popul
icu
patient
routinedaili
check
ng
ph
aspir
appear
limit
almost
certainli
due
use
continu
ng
feed
togeth
ppi
use
ph
test
newli
place
ng
tube
howev
appear
reliabl
introduct
sepsi
common
caus
death
icu
destruct
intestin
barrier
function
increas
transloc
bacteria
system
blood
fl
ow
lead
sepsi
probiot
may
benefi
cial
eff
ect
improv
critic
ill
patient
modul
intestin
barrier
reduct
infl
ammat
aim
trial
determin
eff
ect
probiot
infl
ammatori
biomark
mortal
rate
sepsi
critic
ill
patient
icu
method
doubleblind
random
control
trial
conduct
critic
ill
patient
admit
icu
randomli
assign
receiv
placebo
probiot
day
apach
score
sequenti
organ
failur
assess
sofa
system
concentr
procalcitonin
pct
protein
c
measur
initi
studi
day
also
mortal
evalu
patient
result
pct
level
decreas
protein
c
level
increas
signifi
cantli
probiot
group
treatment
period
p
signifi
cant
diff
erenc
pct
protein
c
level
day
two
group
p
respect
compar
control
probiot
eff
ectiv
improv
apach
sofa
score
day
p
signifi
cant
diff
erenc
probiot
control
group
mortal
rate
vs
respect
p
conclus
probiot
reduc
infl
ammat
mortal
rate
critic
ill
patient
might
consid
adjunct
therapi
sepsi
introduct
aim
studi
establish
whether
diff
erent
type
sepsi
impact
selenium
level
selenium
essenti
trace
element
involv
antioxid
immunolog
reaction
selenium
level
shown
low
patient
system
infl
ammatori
respons
syndrom
sepsi
selenium
replac
recommend
patient
sepsi
greater
day
supplement
may
also
help
prevent
develop
new
infect
icu
method
prospect
survey
selenium
level
collect
patient
admit
septic
shock
tertiari
icu
month
octob
march
result
selenium
level
measur
patient
septic
shock
abdomin
chest
sepsi
main
sourc
infect
abdomin
sourc
sepsi
lowest
level
shown
tabl
septic
shock
patient
selenium
level
taken
within
fi
rst
day
admiss
subnorm
level
mgdt
day
level
within
normal
rang
shown
figur
introduct
glutamin
regul
mani
biolog
function
preserv
cell
act
key
respiratori
fuel
nitrogen
donor
rapidli
divid
cell
modul
express
mani
gene
associ
metabol
cell
defenc
repair
cytokin
product
sever
thorac
trauma
glutamin
supplement
essenti
bodi
consum
produc
glutamin
eff
ect
becom
depend
rout
deliveri
method
fiftytwo
patient
year
old
surgeri
sever
thorac
trauma
assess
two
group
group
receiv
gkgday
iv
glutamin
g
enter
glutamin
day
supplement
enter
nutrit
group
b
receiv
iv
glutamin
supplement
enter
nutrit
gkgday
day
wean
time
durat
po
ileu
incid
time
resolut
vap
glycem
level
percentag
decreas
crp
hour
assess
group
result
wean
time
durat
po
ileu
signifi
cantli
lower
group
although
incid
vap
similar
group
time
vap
resolut
lower
glycem
control
better
group
percentag
crp
decreas
higher
group
see
figur
conclus
glutamin
becom
essenti
amino
acid
sever
thorac
trauma
patient
fed
tpn
enter
oral
although
hard
evid
lack
administr
rout
may
effi
cient
soon
possibl
result
total
cholesterol
tc
lowdens
lipoproteincholesterol
ldlc
level
less
chang
signifi
cantli
low
ratio
group
vs
mgdl
p
tc
vs
mgdl
p
ldlc
compar
high
ratio
group
postop
patient
laboratori
paramet
advers
event
show
statist
signifi
cant
diff
erenc
group
see
tabl
introduct
optim
feed
critic
ill
patient
treat
icu
controversi
present
guidelin
protein
feed
base
weak
evid
obtain
suboptim
method
whole
bodi
protein
kinet
attract
techniqu
assess
optim
protein
intak
measur
eff
ect
protein
feed
strategi
protein
synthesi
rate
protein
degrad
rate
protein
balanc
protein
kinet
measur
critic
ill
neurosurg
patient
hypocalor
normocalor
parenter
nutrit
method
neurosurg
patient
mechan
ventil
n
studi
energi
expenditur
measur
indirect
calorimetri
patient
random
receiv
hour
measur
energi
expenditur
follow
hour
whole
bodi
protein
kinet
measur
last
half
hour
feed
period
use
stabl
isotopelabel
phenylalanin
tracer
continu
infus
label
phenylalanin
tyrosin
plasma
sampl
obtain
later
analyz
content
label
amino
acid
use
mass
spectrometri
protein
kinet
calcul
use
standard
steadyst
kinet
addit
amino
acid
concentr
analyz
hplc
student
test
use
statist
analys
patient
receiv
g
amino
acid
kgday
p
day
measur
energi
expenditur
respect
energi
expenditur
kcalkgday
p
day
respect
plasma
amino
acid
concentr
mm
p
day
respect
whole
bodi
protein
synthesi
lower
energi
expenditur
given
versu
mgkghour
p
whilst
protein
degrad
unalt
versu
mgkghour
p
also
protein
oxid
unalt
versu
mgkghour
p
result
higher
whole
bodi
protein
balanc
normocalor
nutrit
versu
mgkg
hour
p
conclus
protein
kinet
measur
protocol
use
use
assess
effi
caci
nutrit
support
critic
ill
patient
critic
ill
neurosurg
patient
treat
icu
hypocalor
feed
associ
neg
protein
balanc
amino
acid
oxid
diff
erent
control
trial
epan
clinicaltrialsgov
show
withhold
parenter
nutrit
fi
rst
week
icu
stay
wherebi
toler
substanti
calor
defi
cit
late
pn
acceler
recoveri
shorten
wean
time
compar
earli
parenter
substitut
defi
cient
enter
feed
earli
pn
examin
impact
late
pn
compar
earli
pn
incid
recoveri
icuaw
method
preplan
subanalysi
adult
patient
includ
epan
trial
studi
perform
octob
novemb
includ
patient
requir
intens
care
day
well
computergener
admiss
categorymatch
random
sampl
shortstay
icu
patient
latter
correct
possibl
bia
evok
earlier
icu
discharg
one
two
studi
group
assessor
blind
treatment
alloc
evalu
muscl
strength
clinic
three
time
weekli
awaken
onward
perform
nerv
conduct
studi
electromyographi
nc
emg
weekli
primari
outcom
incid
icuaw
diagnos
clinic
medic
research
council
mrc
sum
score
fi
rst
evalu
secondari
outcom
includ
icuaw
worst
last
mrc
evalu
recoveri
icuaw
incid
abnorm
fi
nding
nc
emg
analys
perform
total
dataset
forbaselin
characterist
propens
scorematch
sampl
correct
possibl
imbal
group
plasma
total
bilirubin
quantifi
ed
patient
daili
icu
liver
enzym
alt
ast
ggt
alp
quantifi
ed
twice
weekli
patient
icu
random
predefi
ned
subset
patient
circul
bile
salt
also
quantifi
ed
mshplc
baselin
day
day
last
day
icu
n
gallbladd
sludg
evalu
ultrasound
icu
day
blind
assessor
n
result
day
random
end
intervent
window
plasma
bilirubin
higher
late
pn
earli
pn
group
p
late
pn
group
soon
pn
start
day
plasma
bilirubin
also
fell
two
group
becam
compar
maximum
level
ggt
alp
alt
icu
stay
higher
earli
pn
group
p
compar
baselin
circul
glycin
taurin
conjug
primari
bile
salt
elev
day
day
last
day
icu
stay
p
howev
diff
erenc
two
group
patient
earli
pn
late
pn
group
gallbladd
sludg
day
vs
p
conclus
toler
substanti
calor
defi
cit
withhold
pn
day
critic
ill
increas
circul
level
bilirubin
reduc
occurr
gallbladd
sludg
lower
ggt
alp
alt
level
result
suggest
hyperbilirubinemia
critic
ill
die
necessarili
refl
ect
cholestasi
instead
may
adapt
respons
addit
analys
propens
scorematch
patient
popul
ongo
refer
durat
renal
replac
therapi
rrt
impact
intervent
earli
marker
catabol
investig
method
studi
impact
earli
versu
late
pn
daili
marker
catabol
icu
total
studi
popul
propens
scorematch
subgroup
longstay
patient
addit
calcul
net
incorpor
rate
extra
amino
acid
suppli
earli
pn
result
plasma
urea
ureacreatinin
ratio
nitrogen
excret
increas
time
icu
earli
pn
increas
marker
catabol
fi
rst
day
amino
acid
infus
onward
margin
improv
nitrogen
balanc
also
group
receiv
pn
fi
rst
week
icu
ureagenesi
increas
infus
amino
acid
fi
rst
week
approxim
twothird
extra
amino
acid
suppli
earli
pn
net
wast
urea
fi
nding
confi
rmed
propens
scorematch
subgroup
longstay
patient
higher
urea
level
earli
pn
rather
kidney
function
may
driven
observ
longer
durat
rrt
support
multipl
regress
analysi
conclus
extra
amino
acid
suppli
earli
pn
appear
ineffi
cient
revers
neg
nitrogen
balanc
insuffi
cient
amino
acid
deliveri
rather
insuffi
cient
incorpor
instead
increas
degrad
urea
substanti
catabol
extra
amino
acid
lead
pronounc
urea
gener
may
prolong
durat
rrt
earli
pn
group
introduct
muscl
weak
critic
ill
associ
prolong
depend
ventilatori
support
delay
rehabilit
muscl
wast
relat
poor
nutrit
long
consid
major
determin
wherea
import
myofi
ber
integr
recent
emerg
hypothes
nutrient
restrict
earli
ill
aggrav
atrophi
preserv
myofi
ber
integr
activ
crucial
cellular
qualiti
control
pathway
autophagi
latter
could
import
preserv
muscl
function
method
critic
ill
patient
n
random
earli
earlypn
late
latepn
initi
parenter
nutrit
complet
fail
enter
nutrit
maintain
normoglycemia
mg
dl
insulin
epan
studi
vastu
laterali
biopsi
harvest
week
compar
match
control
n
result
compar
control
muscl
critic
ill
patient
show
reduc
myofi
ber
densiti
shift
smaller
especi
type
myofi
ber
lower
myosin
actin
mrna
upregul
mrna
ubiquitin
ligas
muscleringfi
small
increas
autophagosom
format
marker
increas
autophag
substrat
ubiquitin
p
latepn
result
larger
calor
defi
cit
earlypn
substanti
impact
atrophi
marker
contrast
latepn
increas
p
coincid
less
accumul
ubiquitin
proteinsaggreg
p
fewer
patient
latepn
develop
muscl
weak
compar
earlypn
vs
p
multivari
analysi
lower
ratio
p
higher
myofi
ber
densiti
p
independ
associ
muscl
weak
conclus
earlypn
counteract
muscl
atrophi
wherea
suppress
autophagi
aggrav
weak
statist
muscl
weak
explain
atrophi
wast
rather
impair
autophagi
preserv
muscl
densiti
thu
toler
nutrient
restrict
earli
critic
ill
may
preserv
myofi
ber
integr
activ
autophagi
introduct
closur
acut
hospit
emerg
depart
ed
import
ramifi
cation
centr
expect
take
result
workload
continu
reconfi
gurat
emerg
care
like
produc
increas
number
scenario
littl
evid
avail
support
plan
initi
thu
implic
diffi
cult
anticip
studi
aim
demonstr
one
hospit
experi
rationalis
emerg
care
eff
ect
workload
method
retrospect
studi
conduct
larg
teach
hospit
activ
data
analys
period
follow
closur
neighbour
ed
result
subsequ
compar
year
prior
closur
attend
triag
data
admiss
rate
wait
time
compar
across
two
period
workload
data
grade
physician
chisquar
test
use
examin
diff
erenc
group
result
period
studi
gross
attend
fi
gure
increas
whilst
admiss
rate
rose
follow
closur
neighbour
ed
proport
highacu
patient
attend
institut
increas
dramat
proport
categori
one
two
patient
manchest
triag
scale
increas
p
p
respect
likewis
ambul
arriv
increas
proport
total
increas
attend
p
admiss
ed
icu
increas
consult
workload
includ
categori
patient
p
conclus
reconfi
gurat
emerg
care
dramat
implic
exist
servic
may
alway
anticip
rationalis
ed
may
result
concentr
highacu
patient
accompani
downturn
number
patient
whose
present
amen
care
deliv
set
abrupt
chang
case
mix
requir
reexamin
exist
workforc
senior
overcrowd
estim
emerg
depart
simplest
score
best
introduct
emerg
depart
ed
overcrowd
major
intern
problem
neg
impact
patient
care
provid
among
valid
method
measur
emerg
physician
choos
simpl
complex
score
aim
present
studi
compar
complex
nation
emerg
depart
overcrowd
scale
nedoc
simpl
occup
rate
determin
evalu
correl
score
qualit
assess
crowd
method
studi
conduct
two
academ
hospit
one
counti
hospit
vervier
ed
censu
patient
visit
per
year
sampl
occur
period
januari
fi
sampl
time
day
result
ed
staff
consid
overcrowd
major
concern
three
ed
median
rang
nedoc
rang
found
signifi
cant
correl
introduct
evid
accid
emerg
depart
overload
patient
result
delay
healthcar
provis
larg
proport
patient
consist
patient
minor
ill
seen
healthcar
provid
primari
care
set
aim
studi
determin
characterist
patient
use
gp
walkin
servic
patient
satisfact
eff
ect
emerg
depart
ed
servic
method
survey
conduct
sheffi
eld
rotherham
walkin
centr
week
septemb
octob
selfreport
valid
questionnair
use
conduct
survey
patient
present
centr
estim
sampl
size
around
patient
centr
requir
achiev
statist
robust
result
postvisit
short
questionnair
also
sent
agre
second
questionnair
provid
contact
detail
ed
data
also
obtain
april
march
year
year
open
gp
walkin
centr
data
enter
analys
pasw
statist
ethic
approv
studi
obtain
nh
ethic
review
committe
result
total
patient
particip
survey
rotherham
sheffi
eld
mean
age
particip
year
sheffi
eld
year
rotherham
higher
proport
user
femal
around
centr
patient
rate
high
conveni
centr
open
hour
locat
apart
locat
sheffi
eld
centr
rate
high
around
research
particip
overal
patient
satisfi
ed
servic
rotherham
centr
around
sheffi
eld
centr
base
estim
monthli
count
patient
attend
ed
gp
walkin
centr
around
monthli
reduct
minor
attend
ed
expect
howev
ed
routin
data
show
signifi
cant
reduct
minor
attend
result
open
gp
walkin
centr
conclus
walkin
centr
shown
increas
access
healthcar
servic
longer
open
hour
walkin
facil
although
eff
ect
reduct
patient
load
ed
visibl
centr
cover
fraction
popul
centr
potenti
divert
patient
ed
refer
overcrowd
emerg
depart
ed
wide
known
problem
caus
problem
delay
ed
neg
impact
patient
safeti
aim
studi
analys
whether
reform
emerg
care
reduc
patient
fl
ow
ed
method
substanti
reform
emerg
care
took
place
provinc
southern
finland
three
separ
outofhour
servic
primari
healthcar
phc
one
ed
hospit
combin
one
larg
ed
april
basic
principl
new
ed
ed
patient
serious
ill
injur
need
immedi
care
phc
healthcar
centr
take
care
acut
ordinari
ill
nonseri
injuri
offi
ce
hour
achiev
principl
region
fi
vescal
triag
system
plan
implement
inform
plan
establish
citizen
systemat
inform
principl
new
ed
mail
articl
newspap
interview
radio
televis
ed
internet
page
plan
establish
number
patient
visit
region
analyz
year
establish
new
ed
result
period
establish
new
ed
mean
number
gp
patient
visit
period
reform
number
diminish
chang
associ
increas
patient
visit
taken
care
specialist
hospit
resid
see
figur
conclus
extens
reform
emerg
servic
notabl
reduc
patient
fl
ow
ed
refer
abdomin
pain
adolesc
femal
undergon
recent
chang
regard
manag
variou
special
author
report
singlecentr
audit
look
correct
investig
manag
girl
abdomin
pain
emerg
depart
set
method
singlecentr
audit
retrospect
analysi
patient
took
place
use
case
note
computeris
record
document
analys
use
statist
analysi
minimum
standard
set
review
result
exclus
criteria
femal
age
present
paediatr
emerg
depart
leicest
abdomin
pain
predomin
admiss
symptom
period
document
gynaecolog
histori
poor
menstrual
histori
sexual
histori
contracept
perform
basic
investig
urin
dipstick
pregnanc
test
document
analys
regard
discharg
diagnosi
ultrasound
investig
perform
seven
patient
admit
variou
special
ultrasound
undertaken
upon
admiss
conclus
improv
document
minimum
standard
patient
need
multidisciplinari
care
pathway
could
improv
outcom
consider
given
whether
earli
ultrasound
investig
appropri
need
investig
whether
would
improv
longer
term
outcom
introduct
bipap
util
treatment
sever
refractori
statu
asthmaticu
patient
becom
accept
therapi
well
describ
moder
exacerb
sought
analyz
outcom
bipap
qualiti
databas
children
present
statu
asthmaticu
vari
level
sever
method
ped
statu
asthmaticu
patient
requir
bipap
januari
august
bedsid
interview
document
inform
time
therapi
given
incomplet
data
collect
retrospect
data
store
analyz
use
redcap
databas
subject
stratifi
ed
sever
group
base
asthma
score
time
bipap
placement
result
subject
moder
sever
group
sever
group
tabl
show
group
well
match
compar
pertin
data
children
sever
present
place
bipap
sooner
p
remain
bipap
longer
p
moder
group
longer
wait
bipap
placement
tabl
demonstr
higher
initi
bipap
ipapepap
set
increas
age
sever
figur
trend
initi
termin
asthma
score
stratifi
ed
sever
bipap
present
case
seri
toxic
due
novel
substanc
uk
novel
drug
abus
becom
common
throughout
world
repres
particular
diffi
culti
acut
manag
recent
report
european
monitor
centr
drug
drug
addict
europol
report
new
psychoact
substanc
report
via
earli
warn
system
method
retrospect
casenot
review
period
patient
includ
present
due
recent
ingest
physiolog
data
symptom
outcom
destin
patient
emerg
depart
collect
postmortem
toxicolog
analysi
obtain
one
two
patient
die
result
fortyon
attend
identifi
ed
patient
two
patient
die
fi
admit
icu
heart
rate
temperatur
arriv
tend
normal
mean
heart
rate
bpm
sd
mean
temperatur
sd
total
attend
includ
agit
choreiform
movement
uoroephedrin
found
blood
one
patient
die
conclus
outbreak
uk
gave
symptom
similar
stimul
known
legal
high
includ
death
may
novel
substanc
uoroephedrin
underlin
need
prospect
data
collect
earli
nation
intern
inform
share
introduct
thallium
odorless
tasteless
heavi
metal
often
use
intent
poison
sever
patient
thallium
poison
produc
neuromuscular
symptom
extrem
pain
muscl
weak
method
five
case
report
result
patient
work
pharmaceut
factori
join
tea
parti
held
workplac
end
april
fi
patient
drank
tea
teapot
someon
put
thallium
day
later
complain
femor
numb
pain
caus
pressur
week
later
three
fi
patient
profound
hair
loss
three
week
parti
came
er
thought
symptom
might
caus
chemic
search
keyword
lower
extrem
pain
hair
loss
poison
internet
result
thallium
mercuri
lead
forth
suspici
metal
metal
thallium
like
use
factori
immedi
examin
blood
concentr
sever
metal
order
iron
iii
hexacyanoferr
ii
known
antidot
thallium
poison
thallium
posit
blood
metal
concentr
test
three
patient
consent
oral
administr
antidot
two
patient
reject
administr
symptom
mild
get
better
symptom
patient
gradual
disappear
august
also
follow
cours
blood
concentr
thallium
concentr
three
patient
took
antidot
reduc
rapidli
two
patient
take
conclus
patient
recov
without
sequela
three
patient
hair
start
grow
month
ingest
thallium
half
year
hair
restor
former
state
diffi
culti
order
iron
iii
hexacyanoferr
ii
also
known
antidot
cesium
march
megathrust
earthquak
tsunami
hit
japan
giant
tsunami
gave
rise
accid
nuclear
power
gener
plant
rumor
radioact
substanc
includ
cesium
might
spread
talk
citi
near
nuclear
power
plant
author
put
antidot
heavi
supervis
could
also
collect
data
cours
thallium
concentr
thallium
concentr
patient
antidot
reduc
rapidli
patient
loos
stool
thought
side
eff
ect
antidot
refer
sd
sd
drug
aff
ect
central
nervou
cardiovascular
system
result
sever
arrhythmia
death
heart
rate
variabl
hrv
analysi
noninvas
assess
method
allow
evalu
cardiac
autonom
sympathet
parasympathet
activ
aim
studi
evalu
hrv
children
requir
icu
stay
due
tca
poison
method
twenti
children
isol
tca
poison
age
year
hospit
pediatr
icu
march
juli
healthi
children
control
group
enrol
clinic
electrocardiograph
ecg
fi
nding
note
tca
poison
group
group
time
domain
hrv
analysi
sdnn
sdann
sdnni
rmsdd
perform
also
record
frequenc
domain
analysi
result
fi
rst
minut
last
minut
record
vlf
nlf
nhf
lfhf
ratio
averag
level
tca
studi
group
tca
level
posit
correl
durat
qr
interv
p
timedomain
nonspectr
evalu
sdnn
p
sdnn
p
rmsdd
p
p
found
signifi
cantli
lower
tca
intox
group
compar
control
group
p
signifi
cantli
higher
valu
spectral
analysi
frequenc
domain
data
record
fi
rst
minut
intens
care
admiss
show
valu
nlf
p
lfhf
ratio
p
signifi
cantli
higher
tca
intox
group
control
nhf
p
valu
signifi
cantli
lower
frequenc
domain
spectral
analysi
data
record
last
minut
show
lower
nhf
p
tca
intox
group
control
lfhf
ratio
signifi
cantli
higher
p
intox
group
sdnn
p
rmsdd
p
sdnni
p
p
level
higher
patient
posit
ecg
fi
nding
without
posit
ecg
fi
nding
lfhf
ratio
higher
seven
children
seizur
p
conclus
exist
fi
nding
give
us
idea
hrv
valu
determin
arrhythmia
predict
convuls
risk
tca
poison
hrv
use
noninvas
method
determin
treatment
prognosi
tca
poison
result
hmmd
receiv
averag
case
stroke
monthli
thrombolysi
occur
implement
tm
project
lack
neurologist
avail
conduc
case
implement
tm
program
six
case
ischem
stroke
thrombolyz
alteplas
one
case
progress
death
septic
shock
one
case
present
symptomat
intracrani
hemorrhag
conclus
thrombolysi
ischem
stroke
reduc
risk
disabl
mortal
rate
procedur
feasibl
done
commun
set
implement
tm
project
permit
presenc
real
time
consult
special
neurolog
team
tertiari
center
analys
return
home
total
patient
hospit
medic
surgic
depart
shortterm
hospitalis
unit
emerg
depart
stay
durat
hour
patient
worsen
orient
icu
total
patient
cardiac
icu
total
patient
stay
durat
less
hour
ed
hour
forti
percent
patient
support
fi
remen
support
privat
ambul
left
hospit
singl
medic
consult
conclus
nearli
patient
call
french
emerg
medic
dispatch
centr
sent
hospit
transport
support
twothird
case
privat
ambul
fi
remen
ambul
one
two
patient
receiv
simpl
medic
consult
ed
go
back
home
may
concur
defi
cienci
use
gener
medicin
town
prefer
use
emerg
servic
free
one
patient
four
hospit
hour
introduct
earli
onset
eff
ectiv
care
emerg
depart
ed
report
great
infl
uenc
intens
care
patient
morbid
mortal
littl
known
infl
uenc
reorganis
ed
patient
intak
icu
aim
studi
analys
monthli
intak
patient
ed
cardiac
care
unit
ccu
icu
reform
emerg
servic
method
central
hospit
new
ed
start
april
four
older
emerg
room
combin
one
bigger
emerg
depart
observ
ward
introduc
continu
followup
vital
sign
studi
retrospect
analysi
patient
intak
ccu
icu
year
reorganis
use
data
finnish
intens
care
qualiti
consortium
intensium
finland
databas
cardiac
databas
hospit
patient
transfer
ed
icu
ccu
collect
analys
monthli
prepost
comparison
carri
statist
nonparametr
wilcoxon
signedrank
test
total
decreas
monthli
patient
infl
ow
ed
icu
ccu
p
mean
patient
figur
result
longer
overal
hospit
patient
wi
p
higher
number
surgeri
p
er
patient
wi
hospit
icu
surgeri
patient
involv
ca
surgeri
mani
patient
wi
involv
ca
admit
ward
patient
wi
surgeri
patient
injuri
due
ca
thirtythre
per
cent
patient
involv
ca
return
home
one
transfer
wherea
three
patient
wi
return
home
er
three
patient
transfer
one
die
oper
room
observ
paediatr
mortal
medic
treatment
facil
children
three
children
die
wi
three
due
ca
one
septic
shock
due
medic
caus
conclus
war
injuri
prone
caus
polytrauma
ca
accord
pt
iss
niss
triss
ascot
children
experienc
wi
higher
sever
score
predict
mortal
rate
other
stay
longer
hospit
surgeri
research
indic
disast
medicin
establish
systemat
necessari
compil
compendium
disast
medicin
broad
perspect
birdsey
longterm
view
japanes
version
tent
complet
volum
fi
nancial
year
nearli
threequart
written
japanes
although
work
partli
aboveshown
catastroph
japan
sever
problem
left
solv
insuffi
cient
oper
system
japan
dmat
disast
medic
assist
team
seem
caus
larg
number
prevent
death
conclus
larg
number
casualti
major
disast
global
problem
even
develop
countri
role
intensivist
review
mani
role
verifi
ed
import
leader
medic
team
triag
offi
cer
well
profession
fi
eld
specifi
c
intens
care
howev
mani
problem
solv
fi
eld
disast
medicin
order
solv
diversifi
cation
variou
medic
problem
necessari
compil
systemat
disast
medicin
world
version
concept
compendium
process
trial
shown
relat
intens
care
distinct
diff
erenc
pathophysiolog
medic
cardiac
arrest
tca
traumat
patholog
associ
improv
chanc
success
resuscit
includ
hypoxia
tension
pneumothorax
cardiac
tamponad
author
believ
separ
algorithm
requir
manag
outofhospit
tca
attend
highli
train
physician
paramed
team
method
suggest
algorithm
tca
develop
base
greater
sydney
area
helicopt
emerg
medic
servic
standard
oper
procedur
current
avail
evid
result
algorithm
gener
manag
tca
seen
figur
tca
prioriti
given
catastroph
haemorrhag
control
tourniquet
direct
pressur
haemostat
agent
pelvic
long
bone
splintag
volum
resuscit
simultan
oxygena
tion
optimis
occur
proactiv
exclus
tension
pneumothorac
bilater
open
thoracostomi
cardiac
ultrasound
us
use
help
exclud
cardiac
tamponad
assist
prognost
us
presenc
true
cardiac
standstil
versu
low
pressur
statepseudopea
etco
kpa
carri
grave
prognosi
tca
given
high
incid
hypovolaemia
hypoxia
obstruct
shock
prior
tca
role
adrenalin
chest
compress
limit
figur
show
suggest
algorithm
manag
penetr
tca
requir
prehospit
thoracotomi
conclus
suggest
algorithm
design
highli
train
physicianl
prehospit
team
aim
maximis
number
neurolog
intact
survivor
outofhospit
tca
littl
known
benefi
physician
winch
addit
highli
train
paramed
analys
mission
profi
le
intervent
perform
rescu
involv
winch
physician
greater
sydney
area
hem
gsahem
method
winch
mission
involv
physician
august
januari
identifi
ed
prospect
complet
gsahem
electron
databas
structur
casesheet
review
predetermin
list
demograph
data
physicianonli
intervent
poi
conduct
identifi
mission
involv
winch
physician
case
sheet
avail
analysi
major
patient
traumat
injur
male
median
age
year
seven
patient
pronounc
life
extinct
scene
total
poi
perform
patient
administr
advanc
analgesia
common
poi
make
intervent
patient
abnorm
rtsc
score
like
receiv
poi
compar
normal
rtsc
p
perform
poi
effect
median
scene
time
vs
minut
p
see
tabl
conclus
high
poi
rate
coupl
long
rescu
time
occasion
sever
injuri
support
argument
winch
doctor
would
deni
signifi
cant
proport
patient
timecrit
intervent
advanc
analgesia
procedur
sedat
aim
assess
content
state
repair
equip
carri
transfer
critic
care
patient
hospit
chanc
sever
item
dateexpir
stock
identifi
ed
transfer
kit
whilst
move
patient
tertiari
centr
rais
possibl
extens
problem
equip
bag
due
geograph
locat
district
gener
hospit
undertak
around
transfer
critic
care
patient
hospit
per
year
air
clearli
import
equip
well
maintain
journey
method
maintain
two
ident
set
equip
syring
fl
uid
airway
manag
item
forth
drug
bag
take
transfer
one
equip
one
drug
bag
taken
trip
content
four
bag
check
itemis
care
consider
aim
bag
provid
emerg
equip
drug
manag
one
patient
enrout
emerg
new
inventori
devis
excess
item
remov
lighten
bag
improv
access
essenti
item
expir
stock
remov
daili
check
procedur
tamperproof
seal
bag
instig
bag
reassess
month
later
result
total
drug
item
equip
item
expir
would
within
day
initi
assess
combin
weight
one
equip
one
drug
bag
reduc
kg
reduct
introduc
new
inventori
reassess
novemb
item
equip
expir
near
expiri
expir
drug
item
near
expiri
total
kg
small
item
extran
equip
ad
overrestock
remov
conclus
bag
design
clinician
manag
patient
emerg
aris
transfer
critic
care
patient
introduct
simpl
measur
risk
pose
expir
item
clutter
equip
bag
almost
erad
signifi
cant
weight
save
made
er
improv
ergonom
staff
also
import
consider
aeromed
oper
depart
surpris
discov
extent
declin
equip
may
depart
would
fi
nd
similar
posit
anaesthet
registrar
routin
escort
transfer
patient
vest
interest
maintain
equip
secur
buyin
new
check
procedur
clear
result
conclus
prehospit
hyperoxemia
infl
uenc
function
neurolog
outcom
one
reason
fi
nding
could
short
arriv
time
trauma
center
repeat
analys
arteri
blood
gase
perform
therefor
correct
fraction
inspir
oxygen
accord
arteri
blood
ga
analysi
shorten
time
hyperoxemia
thu
reduc
neuron
brain
damag
introduct
sever
burn
patient
often
note
subsequ
neurocognit
problem
experiment
found
strike
prolong
elev
infl
ammatori
marker
brain
exampl
even
injuri
occur
remot
anatom
locat
neuroinfl
ammatori
respons
also
signifi
cantli
blunt
singl
postburn
dose
estrogen
sonic
hedgehog
shh
import
signal
protein
found
brain
control
direct
diff
erenti
neural
stem
cell
infl
uenc
brain
regener
repair
gener
new
neuron
throughout
life
estrogen
blunt
infl
ammat
also
exert
infl
uenc
varieti
stem
cell
hypothes
might
aff
ect
level
shh
postburn
rat
brain
method
male
rat
n
assign
randomli
three
group
controlsno
burn
n
burnplacebo
n
n
burn
rat
receiv
tbsa
dorsal
burn
fl
uid
resuscit
one
dose
placebo
mgkg
intraperiton
minut
post
burn
eight
anim
two
burn
group
burnplacebo
sacrifi
ced
hour
day
respect
sham
group
day
four
two
burn
group
sacrifi
ced
day
brain
tissu
sampl
analyz
elisa
shh
result
mean
level
shh
level
signifi
cantli
elev
within
hour
much
day
post
injuri
burn
anim
receiv
pcgmg
compar
placebotr
burn
anim
pgmg
control
pcgmg
see
figur
conclus
earli
singledos
estrogen
administr
follow
sever
burn
injuri
signifi
cantli
elev
level
shh
brain
tissu
fi
nding
may
repres
extrem
novel
import
pathway
neuroprotect
neuroregener
burn
patient
introduct
mani
propos
resuscit
therapi
cardiac
arrest
trauma
requir
earliest
possibl
intervent
would
occur
volatil
circumst
make
true
inform
consent
clinic
trial
unfeas
purpos
report
experi
use
except
inform
consent
inaugur
pilot
studi
infus
estrogen
acut
injuri
socal
rescu
shock
studi
method
fifti
patient
enrol
rescu
shock
estrogen
placebo
infus
soon
possibl
emerg
depart
trauma
patient
low
systol
blood
pressur
mmhg
two
level
trauma
center
treat
singledos
estrogen
placebo
infus
within
hour
use
except
inform
consent
follow
us
feder
guidelin
result
investigatoriniti
except
inform
consent
studi
feasibl
fda
ind
approv
obtain
day
irb
approv
day
irb
approv
day
commun
consultationnotifi
cation
success
accomplish
one
opt
enrol
patient
legal
repres
notifi
ed
particip
one
die
unidentifi
ed
two
die
known
contact
averag
number
day
verbal
notifi
cation
patient
advoc
day
rang
day
studi
team
began
notifi
cation
patient
famili
abl
reason
understand
inform
studi
one
decid
continu
followup
overal
patient
famili
enthusiast
particip
data
safeti
monitor
board
safeti
concern
review
studi
data
conclus
although
delay
notic
particip
occur
mani
justifi
abl
reason
use
except
inform
consent
novel
timesensit
resuscit
studi
crucial
feasibl
well
accept
patient
advoc
commun
larg
introduct
patient
sever
burn
injuri
experi
rapid
elev
multipl
circul
proinfl
ammatori
cytokin
level
correl
injuri
sever
outcom
anim
critic
care
volum
suppl
http
model
accumul
cytokin
observ
remot
organ
includ
heart
brain
lung
howev
data
lack
regard
longterm
level
cytokin
heart
follow
sever
burn
injuri
also
infus
parenter
estrogen
power
antiinfl
ammatori
agent
would
aff
ect
level
use
rat
model
studi
eff
ect
fullthick
thirddegre
burn
cardiac
level
day
without
infus
method
total
male
rat
assign
randomli
one
three
group
conclus
follow
sever
burn
injuri
anim
model
earli
singl
dose
estrogen
decreas
prolong
let
alon
earli
onset
cardiac
infl
ammat
base
data
clinic
studi
estrogen
infus
serious
entertain
estrogen
may
inexpens
simpl
adjunct
therapi
burn
manag
may
also
obviat
need
mani
subsequ
intervent
altogeth
even
diminish
mortal
conclus
result
studi
highlight
risk
factor
develop
complic
follow
blunt
chest
trauma
risk
stratifi
cation
tool
also
develop
could
assist
predict
poor
outcom
patient
group
next
stage
complet
prospect
valid
studi
refer
introduct
report
risk
chest
drain
insert
inferior
diaphragm
use
current
intern
guidelin
anoth
complic
damag
signifi
cant
peripher
nerv
long
thorac
nerv
caus
wing
scapula
assess
risk
use
european
trauma
cours
method
patient
handbreadth
axilla
anterior
midaxillari
line
british
thorac
societi
safe
triangl
advanc
trauma
life
support
atl
cours
guidanc
method
use
guidelin
place
marker
repres
chest
drain
thorac
wall
cadav
bilater
side
cm
anterior
midaxillari
line
subsequ
dissect
identifi
ed
cours
termin
long
thorac
nerv
site
later
cutan
branch
intercost
nerv
relat
marker
long
thorac
nerv
found
fi
fth
intercost
space
case
alway
posterior
midaxillari
line
contrari
descript
gray
anatomi
edit
termin
inferior
border
serratu
anterior
commonli
found
end
branch
fourth
right
fi
fth
left
intercost
space
rang
third
sixth
later
cutan
branch
intercost
nerv
found
fi
fth
intercost
space
case
contrari
descript
last
anatomi
edit
alway
pass
anterior
midaxillari
line
marker
conclus
placement
cm
anterior
midaxillari
line
minimis
risk
long
thorac
nerv
later
cutan
branch
intercost
nerv
therefor
conclud
area
british
thorac
societi
safe
triangl
inde
safe
anteroposterior
placement
follow
european
trauma
cours
atl
guidelin
anterior
midaxillari
line
exampl
cm
introduct
whole
bodi
comput
tomographi
wbct
appear
use
earli
detect
clinic
occult
injuri
although
indic
controversi
purpos
studi
develop
clinic
predict
score
clarifi
indic
blunt
trauma
patient
multipl
injuri
mi
requir
wbct
method
conduct
retrospect
studi
patient
blunt
trauma
underw
wbct
emerg
center
june
juli
chose
presenc
absenc
mi
injuri
sever
score
need
surgic
intervent
outcom
variabl
use
bivari
analys
identifi
variabl
potenti
predict
present
mi
predictor
variabl
confi
rmed
multivari
logist
regress
analys
assign
score
base
correspond
coeffi
cient
result
among
patient
enrol
mi
group
four
predictor
found
independ
signifi
cant
logist
analysi
bodi
surfac
wound
region
posit
focus
assess
sonographi
trauma
white
blood
cell
count
ddimer
score
assign
predictor
score
assign
predictor
predict
score
calcul
patient
ad
score
area
receiv
oper
characterist
curv
patient
score
less
mi
figur
conclus
patient
score
presenc
mi
less
like
patient
may
requir
wbct
select
ct
scan
bodi
part
base
clinic
present
consid
figur
common
intervent
result
ultrasound
initi
pressor
infus
ionotrop
addit
therapi
includ
blood
transfus
heparin
tpa
cardiac
catheter
surgeri
rosc
achiev
patient
averag
time
rosc
minut
total
patient
underw
al
aliv
hospit
discharg
year
conclus
focus
cardiac
ultrasound
feasibl
adjunct
al
resuscit
may
assist
earli
identifi
cation
revers
caus
cardiac
arrest
care
must
taken
ensur
interrupt
cardiac
compress
made
perform
puls
check
studi
need
examin
outcom
associ
integr
resuscit
introduct
case
report
describ
patient
present
cardiac
arrest
result
obstruct
shock
progress
cardiac
arrest
caus
acut
paraesophag
gastric
herniat
method
patient
medic
histori
laparoscop
repair
symptomat
diaphragmat
hernia
month
prior
present
emerg
depart
pain
upper
abdomen
nausea
physic
examin
laboratori
test
xray
thorax
normal
sent
home
twentyfour
hour
later
paramed
summon
patient
increas
complaint
arriv
paramed
normal
electrocardiogram
ecg
transfer
bed
stretcher
collaps
due
pulseless
electr
activ
pea
cardiopulmonari
resuscit
start
sinu
rhythm
output
regain
sever
minut
patient
transport
hospit
arriv
hospit
xray
thorax
show
intrathorac
stomach
signifi
cant
mediastin
shift
right
result
emerg
laparotomi
concern
correct
gastric
herniat
resect
ischem
part
stomach
patient
remain
hemodynam
stabl
cardiac
ischemia
rule
base
ecg
laboratori
fi
nding
cardiac
ultrasound
cardiac
comput
tomographi
ultrasound
emerg
depart
show
distend
right
ventricl
normal
left
function
disappear
later
reposit
stomach
evid
mediastin
shift
caus
pea
conclus
fi
rst
describ
patient
requir
cardiopulmonari
resuscit
progress
obstruct
shock
due
intrathorac
stomach
especi
laparoscop
repair
diaphragmat
hernia
rare
caus
shock
cardiac
arrest
requir
diff
erent
medic
approach
key
factor
improv
surviv
outofhospit
cardiac
arrest
oohca
alert
algorithm
simpl
eff
ectiv
compressiononli
telephon
cpr
protocol
potenti
help
bystand
initi
cpr
studi
evalu
eff
ectiv
implement
protocol
lieg
dispatch
centr
method
design
beforeandaft
studi
base
retrospect
assess
adult
victim
oohca
implement
alert
protocol
lieg
dispatch
centr
prospect
evalu
period
immedi
implement
protocol
data
extract
ambul
paramed
medic
intervent
team
fi
le
well
audio
record
dispatch
centr
conclus
ohca
patient
unshock
initi
rhythm
prehospit
epinephrin
administr
signifi
cantli
increas
rate
surviv
month
cardiac
arrest
best
singl
predictor
favor
neurolog
outcom
month
follow
prehospit
epinephrin
administr
cardiac
arrest
age
year
follow
total
dose
epinephrin
mg
callrespons
time
minut
method
singlecent
retrospect
cohort
studi
patient
suff
ere
ohca
transport
hospit
april
march
investig
patient
characterist
whether
met
tor
criteria
outcom
time
hospit
discharg
result
total
patient
mean
age
year
male
transport
hospit
suff
ere
ohca
cardiopulmonari
arrest
wit
case
aha
guidelin
cpr
ecc
regard
criteria
tor
appli
case
dead
arriv
success
resuscit
admit
outcom
patient
follow
die
hospit
two
patient
discharg
glasgow
pittsburgh
cerebr
perform
categori
cpc
score
one
patient
transfer
anoth
hospit
cpc
score
conclus
studi
patient
transport
hospit
ohca
met
criteria
tor
outcom
patient
met
tor
criteria
signifi
cantli
wors
meet
criteria
vs
p
japan
eff
ort
made
resuscit
almost
individu
suff
er
ohca
patient
die
within
day
light
fact
even
medic
cost
patient
die
within
day
amount
us
introduct
tor
particularli
strong
impact
japan
introduct
detect
treatment
cardiopulmonari
arrest
anteced
may
less
eff
ectiv
night
weekend
weekday
hospit
staffi
ng
respons
factor
earli
detect
resuscit
cardiopulmonari
arrest
crucial
better
clinic
outcom
conduct
studi
evalu
event
surviv
inhospit
cardiopulmonari
arrest
regular
work
hour
nonmonitor
area
tertiarycar
center
hypoxia
n
cardiac
n
sepsi
n
arrhythmia
n
pe
n
two
ihca
patient
one
like
caus
arrest
report
case
caus
identifi
ed
present
rhythm
ventricular
fi
brillat
vf
n
pulseless
electr
activ
n
asystol
n
total
n
thrombolys
one
patient
refer
emerg
pci
conclus
previous
report
ihca
associ
wors
prognosi
ohca
ohca
surviv
rate
better
report
elsewher
percentag
ihca
attribut
mi
low
one
ohca
patient
refer
emerg
pci
routin
coronari
angiographi
ad
hoc
pci
vf
ohca
associ
increas
surviv
greater
avail
pci
post
ohca
could
improv
mortal
patient
primari
cardiac
patholog
investig
includ
manag
noncardiogen
cardiac
arrest
introduct
mild
therapeut
hypothermia
mth
power
therapi
improv
surviv
neurolog
outcom
outofhospit
cardiac
arrest
benefi
may
also
occur
unconsci
patient
inhospit
cardiac
arrest
aim
compar
evolut
neurolog
outcom
patient
treat
mth
inhospit
versu
outofhospit
cardiac
arrest
method
prospect
studi
patient
treat
mth
cardiac
arrest
commun
hospit
paulo
brazil
return
spontan
circul
unconsci
survivor
receiv
mth
use
topic
ice
cold
salin
infus
order
achiev
goal
temperatur
within
hour
cardiac
arrest
maintain
manag
outofhospit
cardiac
arrest
ohca
clear
cut
histor
use
patient
st
elev
postresuscit
electrocardiogram
ecg
although
poor
predictor
acut
coronari
occlus
cardiac
arrest
studi
investig
benefi
pci
regardless
postresuscit
ecg
benefi
wide
claim
therapeut
hypothermia
cool
paramet
includ
method
analys
consecut
adult
admit
post
ohca
univers
hospit
icu
januari
decemb
patient
receiv
pci
regardless
ecg
chang
cox
proport
hazard
model
use
determin
relationship
pci
cool
surviv
discharg
routin
collect
data
demograph
detail
resuscit
ohca
utstein
data
also
includ
result
surviv
hospit
discharg
survivor
discharg
neurolog
rehabilit
centr
multivari
analysi
use
cox
proport
hazard
model
show
pci
independ
predict
factor
surviv
unrel
ecg
hazard
ratio
ci
cool
signifi
cant
impact
patient
surviv
see
figur
conclus
small
retrospect
studi
primari
pci
appear
independ
predictor
surviv
ohca
consist
studi
suggest
benefi
primari
pci
regardless
postresuscit
ecg
cool
found
improv
surviv
discharg
analysi
requir
determin
impact
neurolog
function
introduct
sedat
therapeut
hypothermia
th
modifi
neurolog
examin
alter
prognost
predict
coma
cardiac
arrest
ca
addit
tool
eeg
evok
potenti
improv
predict
outcom
set
wide
avail
requir
signifi
cant
implement
method
use
new
devic
infrar
pupillometri
examin
valu
quantit
pupillari
light
reactiv
plr
predict
outcom
comatos
postca
patient
treat
th
twentyfour
comatos
ca
patient
treat
th
hour
prospect
studi
percentag
variat
plr
measur
th
hour
ca
use
neurolight
idm
marseil
franc
patient
three
consecut
measur
perform
best
valu
retain
analysi
relationship
plr
surviv
neurolog
outcom
cpc
score
month
analyz
predict
valu
plr
compar
standard
clinic
examin
motor
respons
brainstem
refl
exe
perform
hour
ca
result
quantit
plr
strongli
associ
surviv
median
leftey
plr
variat
survivor
vs
nonsurvivor
p
neurolog
outcom
patient
cpc
vs
cpc
p
compar
fi
nding
obtain
use
rightey
plr
plr
predict
patient
prognosi
falseposit
falseneg
rate
outcom
clinic
examin
signifi
cantli
associ
outcom
howev
motor
respons
mr
brainstem
refl
exe
br
yield
higher
falseposit
falseneg
rate
plr
tabl
conclus
quantit
plr
appear
highli
accur
superior
standard
neurolog
examin
predict
outcom
patient
postca
coma
studi
warrant
confi
rm
promis
fi
nding
acknowledg
support
grant
swiss
nation
scienc
foundat
fn
european
critic
care
research
network
eccrn
figur
mv
associ
signifi
cant
reduct
scto
baselin
p
signifi
cant
chang
scto
found
ih
vs
p
conclus
moder
hv
associ
signifi
cant
reduct
cerebr
satur
whilst
ih
may
detriment
ca
th
whilst
increas
map
supranorm
level
vasopressor
improv
cerebr
oxygen
data
stress
import
strict
control
paco
follow
ca
th
avoid
secondari
cerebr
ischem
insult
introduct
cardiac
arrest
microcirculatori
reperfus
di
order
develop
despit
adequ
cerebr
perfus
pressur
increas
blood
viscos
strongli
hamper
microcircul
result
plug
capillari
bed
arterioven
shunt
diminish
tissu
perfus
aim
present
studi
assess
blood
viscos
relat
cerebr
blood
fl
ow
patient
cardiac
arrest
method
perform
observ
studi
comatos
patient
cardiac
arrest
patient
treat
hypothermia
hour
blood
viscos
measur
ex
vivo
use
contrav
viscomet
mean
fl
ow
veloc
middl
cerebr
arteri
mfvmca
measur
transcrani
doppler
tcd
time
point
signifi
cant
associ
viscos
mfvmca
p
see
figur
conclus
viscos
decreas
fi
rst
day
cardiac
arrest
strongli
associ
increas
cerebr
blood
fl
ow
sinc
viscos
major
determin
cerebr
blood
fl
ow
repeat
measur
may
guid
therapi
help
restor
cerebr
oxygen
cardiac
arrest
preliminari
data
report
sr
might
correl
bad
outcom
combin
nse
sr
might
improv
predict
valu
also
low
nse
good
initi
bi
valu
correl
preserv
cerebr
potenti
encourag
clinician
introduct
accur
predict
neurolog
outcom
cardiac
arrest
desir
prevent
inappropri
withdraw
lifesustain
therapi
patient
could
good
neurolog
outcom
limit
activ
treatment
patient
whose
ultim
neurolog
outcom
poor
establish
guidelin
predict
neurolog
outcom
cardiac
arrest
develop
widespread
use
therapeut
hypothermia
american
associ
neurolog
guidelin
current
recommend
absent
extensor
motor
score
day
post
arrest
reliabl
indic
poor
neurolog
outcom
fals
posit
rate
method
review
exist
literatur
undertaken
examin
whether
util
motor
score
predict
poor
neurolog
outcom
infl
uenc
use
therapeut
hypothermia
result
six
studi
identifi
ed
investig
use
motor
score
day
post
cardiac
arrest
patient
receiv
therapeut
hypothermia
fals
posit
rate
defi
ned
specifi
citi
predict
poor
neurolog
outcom
calcul
fi
six
studi
respect
studi
fpr
motor
score
extens
wors
signifi
cantli
higher
ci
aan
guidelin
conclus
motor
score
day
post
cardiac
arrest
extens
wors
reliabl
predict
poor
neurolog
outcom
therapeut
hypothermia
use
clinic
neurolog
fi
nding
may
valid
predictor
poor
neurolog
outcom
therapeut
hypothermia
introduct
report
young
much
resist
transient
cerebr
ischemia
adult
method
present
studi
compar
chronolog
chang
calcium
bind
protein
cbp
calbindin
cbd
calretinin
cr
parvalbumin
pv
immunoreact
level
hippocamp
region
young
gerbil
adult
follow
minut
transient
cerebr
ischemia
induc
occlus
common
carotid
arteri
present
studi
examin
pyramid
cell
adult
gerbil
hippocampu
die
day
post
ischemia
howev
young
hippocampu
die
day
post
ischemia
compar
immunoreact
level
cbp
cbd
cr
pv
immunoreact
protein
level
cbp
young
sham
higher
adult
sham
adult
immunoreact
protein
level
cbp
markedli
decreas
day
post
ischemia
howev
young
appar
maintain
day
post
ischemia
decreas
young
howev
much
higher
adult
conclus
brief
immunoreact
level
cbp
decreas
ischem
region
young
day
transient
cerebr
ischemia
fi
nding
indic
longer
mainten
cbp
may
contribut
less
delay
neuron
death
damag
young
delay
reach
target
temperatur
hypothes
earli
rapid
induct
hypothermia
mitig
neuron
injuri
improv
surviv
swine
model
tbi
method
twenti
domest
crossbr
pig
kg
subject
atm
ms
later
fl
uid
percuss
tbi
brain
temperatur
icp
measur
use
serum
biomark
neuron
injuri
neuronspecifi
c
enolas
glial
fi
brillari
acid
protein
gfap
neurofi
lament
heavi
chain
measur
daili
use
enzymelink
immunosorb
assay
twelv
injur
anim
rapidli
cool
within
minut
injuri
use
transpulmonari
hypothermia
techniqu
hypothermia
maintain
hour
eight
injur
control
anim
maintain
group
anesthesia
isofl
uran
discontinu
anim
wean
ventil
hour
five
day
post
injuri
surviv
anim
euthan
necropsi
data
analyz
use
logrank
mantelcox
test
anova
result
ten
hypothermia
four
eight
normothermia
anim
surviv
end
studi
df
p
although
probabl
type
error
surviv
curv
studi
clinic
signifi
cant
show
clear
trend
toward
improv
surviv
hypothermia
intracrani
pressur
signifi
cantli
p
lower
hypothermia
group
intervent
gener
anesthesia
hypothermiamitig
rise
serum
biomark
follow
tbi
howev
suppress
biomark
sustain
recoveri
period
hypothermia
group
except
gfap
level
curv
biomark
signifi
cantli
diff
erent
group
conclus
preliminari
fi
nding
show
earli
initi
rapid
induct
prolong
mainten
hour
cerebr
hypothermia
lower
intracrani
pressur
blunt
rise
serum
biomark
improv
surviv
follow
tbi
refer
introduct
traumat
brain
injuri
tbi
contribut
factor
approxim
onethird
injuryrel
death
usa
annual
updat
statist
record
tbi
egypt
lack
current
research
aim
estim
preval
tbi
egypt
order
develop
comprehens
tbi
prevent
program
method
period
one
calendar
month
everi
quarter
descript
epidemiolog
studi
moder
sever
tbi
case
admit
emerg
depart
cairo
main
univers
hospit
data
collect
sheet
includ
person
data
age
sex
resid
incidentrel
data
caus
natur
time
injuri
clinic
radiolog
fi
nding
introduct
one
use
prognost
model
traumat
brain
injuri
impacttbi
model
predict
mortal
unfavor
outcom
aim
studi
whether
ad
marker
coagul
improv
model
predict
power
account
extracrani
injuri
method
patient
tbi
admit
design
trauma
center
screen
retrospect
includ
accord
impact
studi
criteria
predict
outcom
calcul
includ
patient
use
full
impacttbi
model
assess
coagulopathi
extracrani
injuri
use
prothrombin
time
percentag
pt
platelet
count
injuri
sever
score
iss
introduct
evid
suggest
endogen
lactat
produc
aerob
glycolysi
import
substrat
neuron
particularli
condit
increas
energi
demand
studi
aim
examin
brain
lactat
metabol
patient
sever
traumat
brain
injuri
stbi
method
prospect
cohort
stbi
patient
monitor
cerebr
microdialysi
cmd
brain
tissu
oxygen
pbto
studi
brain
lactat
metabol
assess
quantifi
cation
elev
cmd
lactat
sampl
mmoll
match
pyruv
pbto
dichotom
hyperglycolyt
cmd
pyruv
versu
nonhyperglycolyt
hypox
pbto
mmhg
versu
nonhypox
data
express
percentag
per
patient
global
brain
perfus
categor
oligem
normal
hyperem
assess
ct
perfus
ctp
result
twentyfour
patient
total
cmd
sampl
studi
sampl
elev
cmd
lactat
frequent
observ
sem
individu
sampl
brain
lactat
elev
predominantli
hyperglycolyt
whilst
hypox
trend
time
lactat
pattern
shown
figur
ctp
n
averag
hour
tbi
hyperglycolyt
lactat
alway
associ
normal
hyperem
ctp
whilst
hypox
lactat
associ
oligem
ctp
tabl
fi
nding
suggest
predomin
nonischem
lactat
releas
tbi
identifi
fi
rst
time
associ
cerebr
hyperglycolyt
lactat
product
normal
supranorm
brain
perfus
data
support
concept
lactat
may
use
energi
substrat
injur
human
brain
prehospit
set
diffi
cult
use
glasgow
coma
scale
gc
evalu
conscious
state
use
pediatr
patient
sever
trauma
japan
coma
scale
jc
conscious
scale
use
wide
japan
four
grade
simpler
quicker
use
gc
studi
examin
whether
studi
identifi
ed
moder
relat
peep
osnd
weaker
one
ppeak
pm
osnd
thu
select
case
osnd
could
serv
bedsid
marker
eff
ect
airway
pressur
icp
yet
larger
studi
need
come
safer
conclus
refer
introduct
follow
primari
neurolog
insult
initi
manag
ment
traumat
braininjur
tbi
patient
clearli
defi
ned
pathway
howev
arriv
tertiari
center
manag
ment
standard
intracrani
hypertens
ich
system
hypotens
hypoxia
hyperpyrexia
hypocapnia
shown
independ
increas
mortal
despit
numer
studi
current
level
evid
support
specifi
c
manag
object
provid
overview
current
clinic
manag
protocol
uk
method
thirtyon
icu
manag
patient
sever
tbi
identifi
ed
rain
risk
adjust
neurocrit
care
studi
telephon
survey
conduct
result
total
unit
use
cerebr
perfus
pressur
protocol
initi
manag
target
pressur
mmhg
aim
mmhg
ninetyon
percent
unit
monitor
co
routin
target
co
kpa
figur
regard
osmotherapi
mannitol
still
prefer
agent
unit
use
fi
rst
line
use
hyperton
salin
unit
use
either
depend
clinician
prefer
sixteen
percent
question
current
enrol
eurotherm
hypothermia
trial
never
use
hypothermia
one
unit
use
prophylact
hypothermia
routin
remain
unit
use
hypothermia
manag
refractori
ich
conclus
clear
consensu
initi
target
use
surviv
sepsi
campaign
show
protocol
care
reduc
mortal
perhap
time
similar
approach
adopt
specialist
come
togeth
review
evid
formul
guidelin
test
introduct
traumat
brain
injuri
tbi
major
caus
perman
disabl
death
young
patient
controversi
exist
regard
optim
cerebr
perfus
pressur
cpp
requir
tbi
manag
tool
monitor
autoregul
determin
optim
cpp
pressur
reactiv
index
prx
defi
ned
move
correl
coeffi
cient
mean
arteri
blood
pressur
map
intracrani
pressur
icp
frequenc
least
hz
requir
high
frequenc
constrain
use
academ
center
associ
shown
outcom
continu
optim
cpp
base
hour
prx
present
novel
lowfrequ
autoregul
index
lax
base
correl
icp
map
standard
minutebyminut
time
resolut
method
total
patient
brainit
multicentr
european
databas
regist
outcom
icp
map
fi
rst
icu
hour
twentyon
tbi
patient
admit
univers
hospit
leuven
belgium
tubingen
germani
continu
monitor
use
icm
softwar
cambridg
enterpris
allow
continu
prx
calcul
autoregul
indic
versu
cpp
plot
prx
lax
comput
determin
optim
cpp
everi
minut
fi
rst
icu
hour
result
brainit
databas
lax
result
optim
cpp
fi
rst
hour
tabl
show
recommend
respect
outcom
databas
prx
lax
result
recommend
respect
averag
diff
erenc
method
mmhg
conclus
diff
erenc
optim
cpp
deriv
prx
lax
clinic
signifi
cant
lax
allow
recommend
comput
longer
period
signifi
cantli
better
outcom
tabl
observ
patient
optim
cpp
deriv
lax
maintain
introduct
pediatr
patient
alter
mental
statu
am
present
poor
histori
result
delay
test
potenti
poor
outcom
noninvas
detect
alter
cerebr
physiolog
relat
tbi
would
improv
resuscit
outcom
cerebr
rso
r
c
studi
demonstr
util
certain
neurolog
emerg
method
retrospect
analysi
r
c
util
am
rcso
data
collect
everi
second
am
patient
head
ct
patient
neg
head
ct
compar
abnorm
head
ct
roc
analysi
perform
fi
nd
auc
summari
statist
perform
characterist
subgroup
analysi
done
determin
whether
r
c
predict
injuri
locat
result
r
c
read
across
minut
stabl
figur
r
c
read
one
side
wide
diff
erenc
l
r
cerebrum
predict
abnorm
ct
scan
mean
diff
erenc
sensit
detect
ct
lesion
specifi
citi
ppv
npv
mean
diff
erenc
specifi
c
abnorm
head
ct
lower
mean
r
c
read
local
ct
patholog
side
higher
r
c
read
trend
toward
edh
group
conclus
cerebr
rcso
monitor
noninvas
detect
alter
cerebr
physiolog
patholog
relat
tbi
caus
pediatr
alter
mental
statu
util
r
c
monitor
shown
potenti
local
character
intracrani
lesion
among
alter
children
studi
util
r
c
monitor
adjunct
tool
pediatr
alter
mental
statu
evalu
manag
ongo
introduct
fever
danger
secondari
insult
injur
brain
investig
cerebr
hemodynam
eff
ect
intraven
iv
paracetamol
administr
control
fever
neurointens
care
unit
nicu
patient
method
iv
paracetamol
g
minut
administ
nicu
patient
bodi
temperatur
temp
eff
ect
mean
arteri
pressur
map
heart
rate
hr
intracrani
pressur
icp
cerebr
perfus
pressur
cpp
jugular
venou
oxygen
satur
sjvo
temp
record
start
paracetamol
infus
minut
intervent
mainten
cpp
mmhg
icp
mmhg
record
figur
fi
case
norepinephrin
infus
start
cpp
mmhg
anoth
two
case
reason
norepinephrin
dosag
augment
proport
patient
infus
norepinephrin
increas
p
chisquar
trend
conclus
use
iv
paracetamol
eff
ectiv
mainten
normothermia
acut
braininjur
patient
howev
advers
hemodynam
eff
ect
could
repres
secondari
insult
injur
brain
must
rapidli
recogn
treat
refer
introduct
evalu
resourc
util
paramount
critic
ill
patient
traumat
brain
injuri
tbi
littl
known
readmiss
hospit
discharg
evalu
rate
determin
unplan
readmiss
follow
tbi
method
conduct
multicent
retrospect
cohort
studi
april
march
data
obtain
canadian
provinci
trauma
system
base
mandatori
contribut
trauma
centr
hospit
discharg
databas
patient
age
year
tbi
code
respect
includ
patient
die
index
hospit
live
outsid
provinc
could
link
hospit
discharg
databas
exclud
collect
baselin
trauma
characterist
hospit
admiss
month
preced
index
admiss
readmiss
follow
month
primari
outcom
unplan
readmiss
day
month
month
post
discharg
evalu
sociodemograph
clinic
factor
associ
readmiss
use
logist
regress
model
result
among
adult
patient
tbi
identifi
ed
registri
patient
includ
among
sever
moder
mild
traumat
brain
injuri
patient
young
mean
age
year
comorbid
overal
patient
readmit
within
day
within
month
within
month
day
post
discharg
readmit
complic
median
length
stay
day
patient
age
year
comorbid
admiss
prior
index
hospitalis
readmit
sever
tbi
independ
predictor
readmiss
age
highest
ai
number
comorbid
number
admiss
prior
index
hospit
level
index
trauma
center
discharg
destin
associ
readmiss
multivari
analysi
conclus
readmiss
month
follow
tbi
frequent
found
associ
tbi
sever
studi
evalu
reason
readmiss
warrant
order
develop
strategi
prevent
event
introduct
pituitari
disord
follow
traumat
brain
injuri
tbi
frequent
determin
poorli
understood
perform
systemat
review
assess
risk
factor
tbiassoci
pituitari
disord
method
search
medlin
embas
scopu
cochran
librari
biosi
trip
databas
refer
narr
review
cohort
crosssect
casecontrol
studi
enrol
least
fi
adult
tbi
pituitari
axi
test
one
potenti
predictor
report
two
independ
investig
select
citat
extract
data
assess
risk
bia
pool
data
studi
assess
specifi
c
predictor
regardless
pituitari
axi
evalu
one
pituitari
axi
assess
use
data
relat
hypopituitar
data
defect
axi
pituitari
axi
evalu
sever
time
use
assess
farthest
injuri
metaanalysi
perform
use
random
eff
ect
model
use
evalu
heterogen
introduct
prevent
secondari
neurolog
injuri
paramount
improv
neurolog
outcom
traumat
brain
injuri
tbi
evid
suggest
although
therapeut
hypothermia
th
lower
intracrani
pressur
attenu
secondari
cerebr
insult
tbi
also
induc
hypotens
brief
episod
mild
hypotens
braininjur
patient
trigger
secondari
injuri
associ
increas
mortal
patient
tbi
vasopressin
mitig
hypotens
septic
shock
improv
coronari
perfus
hypotherm
cardiac
arrest
model
hypothes
lowdos
vasopressin
infus
may
reduc
cumul
epinephrin
dose
hypotherm
braininjur
swine
method
six
domest
crossbr
pig
subject
epinephrin
infus
gener
anesthesia
standard
tbi
transpulmonari
hypothermia
hour
anim
receiv
care
aim
mean
arteri
pressur
mmhg
hour
anim
receiv
addit
vasopressin
infus
unitsminut
measur
cumul
epinephrin
dose
anim
pre
post
vasopressin
infus
figur
perform
twosampl
wilcoxon
ranksum
test
compar
median
cumul
epinephrin
dose
two
group
median
cumul
epinephrin
dose
anim
receiv
vasopressin
infus
mg
interquartil
rang
iqr
mg
median
cumul
epinephrin
dose
control
group
mg
iqr
mg
statist
signifi
cant
p
base
wilcoxon
ranksum
test
conclus
lowdos
infus
vasopressin
signifi
cantli
reduc
vasopressor
requir
improv
hemodynam
hypotherm
braininjur
swine
hemodynam
stabil
may
improv
neurolog
outcom
introduct
sever
traumat
brain
injuri
tbi
major
caus
death
sever
neurolog
sequela
longterm
function
outcom
tbi
best
time
assess
well
understood
may
evalu
prematur
clinic
studi
resourc
requir
without
much
miss
data
henc
conduct
systemat
review
studi
sever
tbi
patient
evalu
longterm
function
outcom
hypothes
function
impact
measur
glasgow
outcom
scale
go
extend
version
gose
may
plateau
sever
month
patient
sever
tbi
method
perform
systemat
review
random
control
trial
cohort
studi
prospect
retrospect
patient
sever
tbi
search
medlin
embas
cochran
central
biosi
cinahl
trip
databas
incept
decemb
refer
includ
studi
search
addit
studi
two
review
independ
determin
studi
elig
collect
data
primari
outcom
measur
proport
unfavour
function
outcom
go
gose
month
month
month
month
sever
tbi
calcul
freeman
tukeytyp
arcsin
squareroot
transform
pool
data
use
randomeff
ect
model
heterogen
assess
test
sensit
analys
base
priori
hypothes
total
studi
assess
elig
studi
n
includ
studi
use
go
poor
function
outcom
observ
ci
ci
ci
ci
patient
month
month
month
beyond
month
respect
studi
use
gose
poor
function
outcom
observ
patient
month
ci
month
ci
heterogen
present
analys
entir
explain
plan
sensit
analys
conclus
consid
incid
patient
unfavour
outcom
remain
constant
diff
erent
assess
followup
sever
tbi
patient
longer
month
provid
increment
inform
function
outcom
measur
longer
month
injuri
may
warrant
clinic
studi
introduct
prevent
secondari
brain
injuri
cornerston
manag
patient
sever
traumat
brain
injuri
tbi
rais
intracrani
pressur
icp
although
varieti
monitor
method
avail
due
lack
strong
evid
use
vari
consider
object
survey
provid
overview
current
practic
monitor
patient
sever
tbi
neuroicu
across
uk
introduct
pulmonari
complic
frequent
occur
medic
complic
aneurysm
subarachnoid
hemorrhag
asah
earli
respiratori
deterior
erd
may
associ
delay
cerebr
ischemia
dci
outcom
would
potenti
target
therapeut
intervent
investig
whether
respiratori
deterior
within
fi
rst
hour
admiss
predict
dci
poor
outcom
method
conduct
retrospect
studi
consecut
admit
patient
asah
admit
octob
octob
icu
univers
hospit
erd
defi
ned
increas
need
ventilatori
support
second
third
day
admiss
tabl
elect
intub
surgic
procedur
includ
erd
inclus
criteria
avail
detail
inform
respiratori
statu
level
support
admiss
within
hour
hemorrhag
age
year
multivari
surviv
analysi
use
investig
associ
dci
death
glasgow
outcom
scale
go
erd
adjust
condit
admiss
hijdra
score
treatment
ruptur
aneurysm
pulmonari
comorbid
go
assess
month
bleed
dci
defi
ned
describ
recent
result
mean
age
patient
femal
total
patient
develop
dci
mortal
forti
percent
patient
classifi
ed
erd
erd
associ
dci
adjust
hr
ci
p
erd
show
trend
toward
associ
mortal
adjust
hr
ci
p
addit
adjust
age
reble
clear
associ
found
absenc
erd
function
outcom
ordin
logist
regress
analysi
point
increas
go
score
month
ci
p
addit
adjust
age
reble
conclus
erd
within
hour
admiss
associ
increas
risk
poor
function
outcom
asah
dci
investig
requir
assess
whether
prevent
erd
may
improv
outcom
introduct
elev
intracrani
pressur
icp
may
deleteri
eff
ect
cerebr
metabol
mortal
aneurysm
subarachnoid
hemorrhag
sah
relev
yet
well
explor
aim
studi
track
icp
chang
sah
identifi
clinic
factor
associ
explor
relationship
icp
outcom
method
total
consecut
sah
patient
icp
monitor
enrol
episod
icp
mmhg
least
minut
mean
icp
valu
everi
interv
analyz
highest
mean
icp
collect
everi
patient
identifi
ed
icp
valu
analyz
relat
clinic
ct
fi
nding
outcom
icu
mortal
also
introduc
multivari
logist
model
result
eightyon
percent
patient
least
one
episod
elev
icp
highest
mean
icp
mmhg
number
patient
highest
mean
icp
mmhg
episod
hicp
maximum
day
sah
decreas
day
neurolog
statu
aneurysm
rebleed
amount
blood
ct
ct
ischem
lesion
occur
within
hour
sah
signifi
cantli
relat
highest
mean
icp
mmhg
multivari
model
patient
highest
mean
icp
mmhg
show
signifi
cantli
higher
mortal
icu
howev
icp
independ
predictor
month
unfavor
outcom
conclus
elev
intracrani
pressur
common
complic
fi
rst
week
sah
associ
earli
brain
injuri
sever
icu
mortal
systemat
review
preval
aim
particularli
studi
low
risk
bia
method
search
embas
medlin
cochran
librari
trip
databas
refer
includ
studi
narr
review
includ
cohort
studi
crosssect
studi
rct
publish
languag
test
integr
pituitari
axi
adult
asah
studi
includ
nonaneurism
sah
exclud
studi
consid
low
risk
bia
author
defi
ned
inclusionexclus
criteria
avoid
voluntari
sampl
test
includ
patient
proper
detail
diagnost
criteria
studi
test
pituitari
axe
consid
evalu
hypopituitar
defi
ned
dysfunct
axi
use
freeman
tukeytyp
arcsin
squareroot
transform
pool
preval
use
dersimonianlaird
randomeff
ect
method
determin
degre
heterogen
valu
result
among
citat
includ
studi
patient
patient
mostli
femal
age
sixteen
studi
report
sever
asah
report
procedur
secur
aneurysm
report
locat
aneurysm
overal
hypopituitar
observ
patient
shortterm
month
midterm
month
longterm
month
tabl
insuffi
cient
number
studi
low
risk
bia
perform
sensit
analys
accord
studi
qualiti
conclus
exact
preval
pituitari
disord
follow
asah
remain
uncertain
mainli
due
high
heterogen
small
number
studi
low
risk
bia
howev
preval
seem
decreas
recoveri
phase
preval
risk
factor
clinic
signifi
canc
pituitari
disord
asah
requir
rigor
evalu
associ
high
morbid
mortal
although
uk
anaesthesia
guidelin
advoc
earli
coil
clip
aneurysm
within
fi
rst
hour
admiss
grade
asah
optim
time
treatment
whether
link
better
neurolog
longterm
outcom
subject
debat
aim
investig
whether
time
occlus
aneurysm
translat
better
outcom
method
retrospect
analysi
prospect
collect
data
tertiari
neurosci
centr
januari
septemb
patient
manag
accord
local
guidelin
manag
asah
outcom
assess
month
use
extend
glasgow
outcom
scale
gose
defi
ning
good
recoveri
gose
poor
outcom
gose
result
total
patient
includ
within
studi
period
three
patient
expect
surviv
fi
rst
hour
includ
studi
seventeen
patient
classifi
ed
good
grade
asah
wfn
iii
eight
poor
grade
iv
v
twentytwo
patient
underw
success
coil
three
requir
clip
due
unsuccess
coil
fi
nd
correl
time
coilingclip
gose
figur
total
patient
poor
gose
good
longterm
function
outcom
overal
mortal
rate
conclus
overal
mortal
patient
asah
low
aneurysm
treat
earli
post
ruptur
aneurysm
fi
nd
correl
time
occlus
aneurysm
function
outcom
patient
underw
neuropsycholog
evalu
earli
day
day
delay
time
point
month
month
patient
test
languag
verbal
fl
uenci
shortterm
longterm
memori
attent
execut
function
praxi
neglect
impair
activ
everyday
life
assess
use
activ
daili
live
scale
instrument
activ
daili
live
scale
use
assess
qualiti
life
month
sinc
complic
aneurysm
treatment
addit
asah
sever
may
signifi
cantli
aff
ect
cognit
statu
patient
evalu
accord
world
feder
neurolog
surgeon
score
treatment
wfnspt
wfnspt
patient
complet
neuropsycholog
test
time
point
wfnspt
wfn
patient
testabl
case
respect
earli
time
point
wfn
patient
testabl
time
point
testabl
patient
cognit
function
sever
impair
earli
time
point
month
wfn
good
recoveri
languag
defi
cit
partial
recoveri
attent
memori
execut
function
observ
time
point
wfn
patient
becam
testabl
wors
recoveri
cognit
function
month
sah
less
patient
return
work
month
approxim
despit
good
recoveri
everyday
life
activ
month
patient
qualiti
life
lower
normal
popul
conclus
cognit
dysfunct
diff
erent
time
cours
asah
signifi
cant
defi
cit
diff
erent
cognit
domain
wors
qualiti
life
diffi
culti
return
work
persist
patient
month
follow
sah
result
pretreat
mgkg
mgkg
asada
protect
ischem
neuron
death
damag
neuroprotect
eff
ect
much
pronounc
asa
da
alon
addit
treatment
mgkg
asada
reduc
ischemiainduc
activ
astrocyt
microglia
conclus
fi
nding
indic
asada
new
synthet
drug
prevent
transient
focal
cerebr
ischemia
provid
resourc
develop
clinic
applic
stroke
introduct
acut
neurolog
injuri
lead
caus
morbid
mortal
children
global
preval
region
dispar
etiolog
intervent
outcom
unknown
aim
pointpreval
studi
measur
burden
pediatr
neurolog
injuri
describ
variat
intervent
outcom
icu
method
one
hundr
three
icu
six
contin
enrol
subject
specifi
c
day
period
includ
subject
age
day
year
diagnos
acut
traumat
brain
injuri
stroke
cardiac
arrest
central
nervou
system
infect
infl
ammat
statu
epilepticu
spinal
cord
lesion
hydrocephalu
brain
mass
site
complet
secur
webbas
case
report
form
includ
subject
hospit
demograph
detail
neurolog
diseas
intervent
length
stay
pediatr
cerebr
perform
categori
pcpc
score
good
outcom
pcpc
mortal
hospit
discharg
result
subject
screen
met
enrol
criteria
mean
number
subject
enrol
per
site
studi
day
site
dedic
pediatr
icu
mean
number
icu
bed
rang
icu
resourc
invas
monitor
intracrani
pressur
continu
electroencephalographi
invas
noninvas
brain
tissu
oxygen
somatosensori
evok
potenti
averag
icu
faculti
six
fellow
per
site
nearli
onehalf
report
neurocrit
care
icu
team
subject
male
white
normal
preadmiss
pcpc
score
statu
epilepticu
cardiac
arrest
highest
preval
sixtyon
per
cent
subject
mechan
ventil
icu
admiss
icu
length
stay
mean
day
median
day
hospit
lo
mean
day
median
day
surviv
hospit
discharg
subject
discharg
home
inpati
rehabilit
conclus
acut
neurolog
diseas
signifi
cant
pediatr
health
issu
data
suggest
vital
need
increas
research
healthcar
resourc
assist
challeng
improv
outcom
children
newli
approv
oral
anticoagul
dabigatran
eff
ectiv
antidot
therefor
suspect
overal
increas
mortal
patient
present
emerg
depart
ed
bleed
complic
dabigatran
compar
warfarin
aspirin
method
conduct
post
hoc
analysi
databas
patient
admit
tertiarycar
ed
kind
bleed
suspicion
one
march
august
take
dabigatran
warfarin
aspirin
primari
endpoint
longterm
surviv
patient
censor
death
end
studi
period
decemb
perform
cox
proport
hazard
model
control
age
calcul
hazard
ratio
hr
dabigatran
versu
warfarin
one
warfarin
versu
aspirin
statist
signifi
canc
set
result
present
ci
result
total
patient
met
inclus
criteria
mean
followup
period
year
mean
age
year
men
total
death
record
within
followup
period
eight
dabigatran
compar
warfarin
aspirin
mortal
risk
patient
dabigatran
signifi
cantli
higher
patient
warfarin
hr
ci
p
control
age
aspirin
lower
statist
signifi
cant
mortal
risk
compar
warfarin
hr
ci
p
control
age
result
show
higher
overal
mortal
patient
present
ed
bleed
complic
take
dabigatran
compar
warfarin
aspirin
physician
awar
potenti
higher
mortal
dabigatran
warfarin
treat
bleed
patient
howev
singlecentr
retrospect
analysi
small
number
patient
take
dabigatran
n
studi
need
corrobor
result
introduct
dose
adjust
low
molecular
weight
heparin
lmwh
base
daili
antixa
measur
chromogen
assay
remain
controversi
daili
clinic
practic
one
major
obstacl
cost
test
aff
ordabl
reliabl
bedsid
test
could
chang
practic
individu
tailor
dose
lmwh
aim
studi
evalu
whether
prophylact
dose
regimen
mg
enoxaparin
cardiac
surgic
patient
increas
antixa
activ
level
necessari
effi
cient
prevent
thromboembol
event
secondarili
test
whether
reliabl
correl
bedsid
antixa
measur
compar
twostag
chromogen
assay
laboratori
open
singlecentr
prospect
nonrandom
clinic
trial
univers
hospit
patient
need
prophylact
dose
enoxaparin
cardiac
surgeri
duli
inform
give
written
consent
includ
patient
mean
euroscor
demograph
specifi
cation
medic
surgic
histori
patient
collect
antixa
activ
measur
three
diff
erent
point
time
determin
baselin
peak
trough
antixa
activ
preoper
respect
hour
third
dose
enoxaparin
minut
fourth
dose
measur
done
techniqu
twostag
chromogen
assay
laboratori
bedsid
assay
jr
result
dose
regimen
enoxaparin
achiev
onehalf
includ
patient
suffi
cient
antixa
activ
prevent
thromboembol
event
onehalf
patient
insuffi
cient
antixa
activ
bodi
mass
index
kgm
comparison
bedsid
assay
twostag
chromogen
assay
mean
pearson
correl
coeffi
cient
show
correl
two
test
variabl
taken
account
blandaltman
analysi
could
confi
rm
correl
conclus
bedsid
antixa
activ
assay
hemochron
devic
tend
show
correl
twostag
chromogen
assay
insuffi
cient
use
altern
small
uniform
patient
popul
use
standard
dose
protocol
enoxaparin
administr
prone
underdosag
postcardiac
surgeri
patient
may
increas
postop
morbid
refer
introduct
hypothes
higher
dose
enoxaparin
would
improv
thromboprophylaxi
without
increas
risk
bleed
critic
ill
patient
predispos
venou
thromboembol
lead
increas
risk
advers
outcom
peak
antifactor
xa
antixa
level
iuml
hour
post
administr
enoxaparin
refl
ect
adequ
thromboprophylaxi
medicosurg
patient
method
sampl
popul
consist
patient
random
receiv
subcutan
sc
enoxaparin
mg
control
group
versu
mg
mg
mgkg
test
group
period
day
antixa
activ
measur
baselin
hour
post
administr
day
patient
diff
er
signifi
cantli
group
result
day
administr
dose
mg
mg
yield
similar
mean
peak
antixa
iuml
iuml
respect
dose
mg
result
subtherapeut
level
antixa
iuml
patient
receiv
mgkg
enoxaparin
achiev
nearsteadyst
level
day
mean
peak
antixa
level
iuml
steadyst
antixa
achiev
dose
enoxaparin
day
steadi
state
mean
peak
antixa
level
iu
ml
iuml
achiev
dose
mg
mg
respect
increas
signifi
cantli
iuml
iuml
dose
mg
mgkg
enoxaparin
respect
p
figur
dose
mgkg
enoxaparin
yield
therapeut
antixa
level
studi
period
advers
eff
ect
introduct
unfraction
heparin
prefer
lmwh
icu
patient
lmwh
use
frequent
mani
european
icu
thromboprophylaxi
standard
dose
nadroparin
enoxaparin
shown
result
signifi
cantli
lower
antixa
icu
patient
compar
medic
patient
method
icu
patient
sap
mv
n
pressor
n
receiv
iu
group
n
iu
dalteparin
sc
group
n
twentynin
medic
patient
receiv
iu
dalteparin
serv
control
group
result
group
signifi
cantli
lower
area
xa
curv
auc
compar
group
tabl
diff
erenc
signifi
cant
group
peak
antixa
activ
c
max
antixa
delay
max
antixa
group
compar
group
tabl
conclus
icu
patient
sc
dose
iu
dalteparin
result
signifi
cantli
lower
xa
activ
compar
normal
ward
patient
sc
dose
iu
dalteparin
icu
patient
result
kinet
peak
antixa
activ
compar
medic
patient
receiv
iu
dalteparin
introduct
anemia
frequent
encount
icu
increas
hepcidin
product
one
cornerston
pathophysiolog
anemia
infl
ammat
fi
rstinclass
hepcidin
antagonist
pegyl
antihepcidin
lrna
oligonucleotid
develop
target
treatment
anemia
infl
ammat
investig
whether
prevent
infl
ammationinduc
serum
iron
decreas
experiment
human
endotoxemia
method
random
doubleblind
placebocontrol
trial
healthi
young
men
hour
ngkg
e
coli
endotoxin
administ
intraven
iv
follow
mgkg
placebo
iv
hour
blood
drawn
serial
endotoxin
administr
measur
infl
ammatori
paramet
cytokin
pharmacokinet
total
iron
paramet
diff
erenc
serum
iron
chang
baselin
hour
defi
ned
primari
endpoint
result
endotoxin
administr
led
fl
ulik
symptom
infl
ammatori
paramet
crp
bodi
temperatur
leucocyt
plasma
level
peak
markedli
similarli
treatment
group
well
toler
plasma
concentr
peak
hour
start
administr
declin
accord
twocompart
model
hour
placebo
group
serum
iron
increas
baselin
peak
hour
return
close
baselin
hour
decreas
baselin
concentr
hour
reach
lowest
point
hour
group
serum
iron
concentr
rose
hour
slowli
declin
hour
hour
post
lp
serum
iron
concentr
subject
signifi
cantli
higher
placebotr
subject
p
ancova
conclus
experiment
human
endotoxemia
induc
robust
infl
matori
respons
subsequ
decreas
serum
iron
treatment
eff
ect
innat
immun
eff
ectiv
prevent
infl
ammationinduc
drop
serum
iron
concentr
fi
nding
demonstr
clinic
potenti
antihepcidin
drug
develop
treat
patient
anemia
infl
ammat
associ
haemoglobin
concentr
mortal
studi
patient
variou
comorbid
studi
aim
determin
associ
haemoglobin
level
admiss
intens
care
patient
length
stay
mortal
method
retrospect
collect
data
patient
admiss
singl
fi
vebe
icu
period
identifi
ed
patient
april
novemb
patient
split
group
accord
haemoglobin
concentr
admiss
data
analys
determin
whether
relationship
haemoglobin
concentr
icu
admiss
outcom
measur
unit
hospit
mortal
unit
hospit
length
stay
result
patient
haemoglobin
concentr
gdl
gdl
use
mortal
comparison
patient
haemo
globin
concentr
gdl
increas
icu
mortal
compar
haemoglobin
level
gdl
ci
p
similar
diff
erenc
seen
hospit
mortal
gdl
vs
gdl
p
unit
length
stay
signifi
cantli
longer
patient
admiss
hb
g
dl
day
compar
admiss
hb
gdl
day
p
hospit
length
stay
also
signifi
cantli
longer
patient
hb
gdl
versu
hb
gdl
day
vs
day
p
seen
invers
correl
haemoglobin
concentr
patient
age
r
p
conclus
haemoglobin
concentr
gdl
admiss
icu
associ
increas
icu
mortal
hospit
mortal
unit
length
stay
hospit
length
stay
compar
patient
admit
haemoglobin
concentr
gdl
introduct
accord
mani
author
acut
necrot
pancreat
anp
still
remain
one
diffi
cult
problem
abdomin
surgeri
complex
pathogenesi
diseas
featur
pancrea
pathomorpholog
abdomin
hypertens
high
mortal
necessit
search
new
way
treat
diseas
studi
conduct
patient
anp
divid
two
group
accord
type
analgesia
epidur
opioid
patient
fi
rst
group
n
epidur
analgesia
ropivacain
mghour
day
second
group
n
opioid
analgesia
trimeperidin
mg
three
time
day
period
monitor
level
septic
thrombohemorrhag
complic
clinic
instrument
data
month
treatment
start
hemostat
system
evalu
use
indic
hemoviscoelastographi
analyz
result
found
patient
anp
initi
hypercoagul
fi
brinolysi
inhibit
level
hemostat
disord
correl
level
septic
complic
treatment
icu
mortal
fi
rst
group
note
deep
vein
thrombosi
two
pneumonia
seven
pseudopancreat
cyst
abscess
two
death
time
stay
icu
day
second
group
three
case
deep
vein
thrombosi
four
pneumonia
pseudopancreat
cyst
abscess
two
episod
gastroduoden
bleed
fi
death
time
stay
icu
day
conclus
use
epidur
anesthesia
patient
anp
reduc
number
septic
complic
reduc
mortal
rate
second
group
fi
rst
group
think
violat
blood
coagul
microcircul
basi
ischemia
necrosi
tissu
septic
complic
epidur
analgesia
eff
ectiv
method
decreas
level
septic
thrombohemorrhag
complic
mortal
anp
patient
method
ethic
approv
inform
consent
studi
function
state
hemostasi
group
healthi
volunt
receiv
drug
aff
ect
coagul
patient
postphlebothrombot
syndrom
ppt
ppt
patient
conduct
baselin
studi
coagul
state
daili
monitor
dynam
chang
function
state
hemostasi
compar
evalu
perform
lowfrequ
piezoelectr
vibrat
hemoviscoelastographi
lpvh
platelet
aggreg
test
pat
standard
coagul
test
sct
thromboelastogram
teg
found
lpvh
correl
sct
pat
teg
howev
propos
method
volumin
index
icc
intens
contact
phase
coagul
time
contact
phase
coagul
ao
initi
rate
aggreg
blood
consist
pat
index
icd
intens
coagul
drive
cta
constant
thrombin
activ
cp
clot
intens
polymer
consist
sct
teg
addit
advantag
method
determin
intens
fi
brinolysiswith
indic
iri
intens
retract
clot
lysi
conclus
lpvh
allow
one
make
total
assess
part
hemostasi
initi
viscos
platelet
aggreg
coagul
lysi
clot
well
interact
fi
gure
object
inform
evidenc
close
correl
perform
tradit
coagul
method
prophylaxi
orthoped
case
acut
coronari
syndrom
main
drawback
fond
routin
monitor
current
avail
could
problem
manag
critic
surgic
patient
especi
case
old
patient
renal
failur
aim
studi
evalu
abil
thromboelastographi
teg
determin
level
anticoagul
due
fond
surgic
popul
prospect
analyz
patient
elect
major
orthoped
surgeri
consecut
perform
period
patient
receiv
fond
mg
postop
period
accord
accp
guidelin
nativ
heparinas
hep
teg
haemoscop
corpor
nile
il
usa
test
activ
kaolin
perform
use
whole
blood
citrat
sampl
four
time
fond
administr
hour
administr
hour
administr
halflif
hour
administr
follow
nativ
hep
teg
paramet
analyz
reaction
time
r
angl
maximum
amplitud
coagul
index
ci
paramet
compar
level
antixa
unvari
analysi
spearman
test
appli
data
result
eighteen
patient
analyz
ten
patient
met
inclus
criteria
mean
r
valu
increas
mean
r
paramet
normal
rang
phase
studi
signifi
cant
diff
erenc
r
mean
valu
diff
erent
phase
lowest
valu
r
coincid
plasmat
peak
concentr
fond
valu
correl
antixa
mean
valu
show
highest
valu
time
signifi
cant
diff
erenc
mean
nativ
hep
r
valu
p
nativ
hep
angl
hep
p
ci
ci
hep
p
paramet
signifi
cant
variat
time
p
conclus
r
repres
time
necessari
thrombin
format
presenc
fond
hypothes
prolong
r
time
popul
teg
perform
citrat
kaolinactiv
whole
blood
abl
detect
prophylat
dose
fond
everi
phase
contrari
level
antixa
abl
reveal
exact
pharmacokinet
drug
studi
includ
larg
number
patient
necessari
introduct
coagulopathi
particularli
trend
toward
hypercoagula
biliti
hypofi
brinolysi
common
critic
ill
patient
correl
wors
outcom
avail
laboratori
coagul
test
assess
fi
brinolysi
expens
time
demand
investig
whether
modifi
ed
thromboelastographi
plasminogen
activ
urokinas
ukifteg
may
abl
evalu
fi
brinolysi
popul
critic
ill
patient
method
ukifteg
perform
follow
fi
rst
urokinas
ad
citrat
blood
give
fi
nal
concentr
uiml
thromboelastographi
teg
analysi
start
kaolin
activ
recalcifi
cation
calcium
chlorid
basal
teg
addit
urokinas
also
perform
fibrinolysi
determin
loss
clot
strength
maxim
amplitud
record
percentag
lysi
minut
percentag
lysi
minut
result
ukifteg
perform
healthi
volunt
critic
ill
patient
predict
accord
exponenti
function
use
indic
clot
lysi
basal
teg
show
increas
coagul
trend
toward
less
fi
brinolysi
critic
ill
patient
compar
healthi
volunt
reaction
time
minut
vs
minut
p
vs
p
reduct
fi
brinolysi
evid
urokinas
concentr
uiml
figur
conclus
ukifteg
could
feasibl
pointofcar
method
evalu
fi
brinolysi
critic
ill
patient
method
perform
random
doubleblind
studi
patient
underw
cesarean
section
patient
divid
two
group
fi
rst
group
n
receiv
preoper
minut
oper
tranexam
acid
mgkg
second
group
n
receiv
preoper
placebo
condit
hemostasi
monitor
haemoviscoelastographi
result
patient
includ
studi
surgeri
moder
hypercoagul
normal
fi
brinolysi
increas
intens
clot
format
icf
compar
normal
rate
intens
retract
clot
lysi
ircl
group
start
oper
patient
group
icf
decreas
p
ircl
decreas
p
compar
preoper
group
icf
decreas
p
ircl
increas
p
compar
preoper
end
oper
condit
hemostasi
group
came
almost
valu
moder
hypocoagul
depress
fi
brinolysi
group
thrombot
complic
intraop
blood
loss
fi
rst
group
second
conclus
use
tranexam
acid
surgeri
signifi
cantli
reduc
intraop
blood
loss
without
thrombot
complic
introduct
rotat
thromboelastographi
rotem
detect
dilut
hypotherm
eff
ect
coagul
evalu
correct
treatment
aim
vitro
studi
studi
whether
fi
brinogen
concentr
alon
combin
factor
xiii
could
revers
colloidinduc
crystalloidinduc
coagulopathi
presenc
absenc
hypothermia
method
citrat
venou
blood
healthi
volunt
dilut
use
hydroxyethyl
starch
ringer
acet
rotem
use
evalu
eff
ect
addit
either
fi
brinogen
concentr
correspond
kg
fi
brinogen
dose
combin
factor
xiii
equival
iukg
blood
analyz
rotem
extem
fibtem
reagent
result
signifi
cant
dilut
respons
shown
group
hypocoagul
greater
starch
group
hypothermia
lengthen
follow
extem
clot
time
ct
clot
format
time
angl
fibtem
maxim
clot
format
mcf
irrespect
temperatur
fi
brinogen
overcorrect
ringer
acet
eff
ect
rotem
paramet
partial
revers
starch
eff
ect
extem
ct
fibtem
mcf
fibtem
demonstr
factor
xiii
provid
addit
procoagul
eff
ect
ringer
acet
group
temperatur
starch
group
extem
paramet
improv
addit
factor
xiii
mcf
conclus
rotem
show
fi
brinogen
concentr
revers
dilut
coagul
defect
induc
colloid
crystalloid
addit
revers
provid
factor
xiii
higher
dose
fi
brinogen
factor
xiii
may
counteract
starch
eff
ect
clot
structur
introduct
natur
colloid
albumin
induc
lesser
degre
dilut
coagulopathi
synthet
colloid
fibrinogen
concentr
emerg
promis
strategi
treat
coagulopathi
factor
xiii
fxiii
work
synergist
fi
brinogen
correct
coagulopathi
follow
haemodilut
crystalloid
object
examin
abil
fi
brinogen
fxiii
concentr
revers
albumininduc
dilut
coagulopathi
high
low
concentr
fi
brinogen
fxiii
use
revers
coagulopathi
induc
dilut
vitro
albumin
blood
sampl
healthi
volunt
monitor
rotat
thromboelastometri
rotem
result
haemodilut
albumin
signifi
cantli
attenu
extem
maximum
clot
fi
rmness
mcf
angl
aa
clot
time
ct
clot
format
time
cft
fibtem
mcf
p
follow
haemodilut
dose
fi
brinogen
signifi
cantli
correct
rotem
paramet
p
except
lower
dose
correct
aa
compar
lower
dose
higher
dose
fi
brinogen
signifi
cantli
improv
fibtem
mcf
extem
mcf
aa
cft
p
lower
dose
fxiii
signifi
cantli
correct
rotem
paramet
high
dose
improv
extem
ct
p
combin
highlow
concentr
fi
brinogen
fxiii
signifi
cantli
improv
rotem
paramet
examin
p
fibrinogen
concentr
gener
greater
eff
ect
paramet
fxiii
concentr
best
correct
rotem
paramet
achiev
highdos
fi
brinogen
concentr
either
lowdos
highdos
fxiii
conclus
fibrinogen
concentr
success
correct
initi
propag
clot
fi
rmness
defi
cit
induc
haemodilut
albumin
fxiii
synergist
improv
fi
brinbas
clot
strength
result
ioc
use
sever
pph
sever
pph
control
manag
without
ioc
placenta
accreta
select
best
indic
rbc
restitut
ml
pph
allogen
transfus
decreas
ioc
group
versu
p
prbc
versu
p
ioc
spare
blood
bank
prbc
ml
total
transfus
need
amniot
fl
uid
embol
observ
group
ioc
wherea
one
case
appear
control
group
without
ioc
conclus
regard
literatur
studi
ioc
could
use
safe
pph
cs
leukocyt
fi
lter
retransfus
recommend
rhesu
isoimmun
must
preclud
monitor
repeat
fetal
rbc
test
bleed
use
protamin
infus
abolish
heparin
rebound
aim
studi
see
whether
use
postop
protamin
infus
cardiac
itu
associ
reduct
heparin
rebound
blood
loss
method
data
cardiac
surgeri
patient
retrospect
analys
routin
manag
bolu
protamin
correct
activ
clot
time
expect
manag
subsequ
bleed
also
protamin
infus
mghour
hour
postop
blood
loss
measur
hour
excess
bleed
investig
use
thromboelastographi
teg
rebound
heparinis
determin
ratio
rtime
heparinaseplain
mannwhitney
u
test
chisquar
test
use
assess
statist
signifi
canc
result
signifi
cant
diff
erenc
blood
loss
two
group
blood
loss
hour
infus
noninfus
group
ml
respect
p
hour
ml
p
hour
ml
p
hour
ml
p
also
signifi
cant
diff
erenc
get
heparin
rebound
infus
group
noninfus
group
p
conclus
unlik
teoh
colleagu
fi
nd
advantag
use
protamin
infus
still
case
heparin
rebound
infus
group
suggest
infus
eff
ectiv
expect
andor
dose
inadequ
howev
previou
studi
assess
heparin
rebound
use
isol
clot
paramet
use
teg
teg
measur
thrombodynam
properti
whole
blood
coagul
perhap
reliabl
indic
heparin
activ
retrospect
studi
limit
name
nonstandardis
manag
patient
potenti
bia
anaesthetist
select
patient
infus
group
may
inher
higher
risk
bleed
howev
heparin
rebound
common
protamin
simpl
rel
safe
lowcost
intervent
compar
transfus
studi
need
introduct
purpos
studi
evalu
whether
restrict
strategi
red
blood
cell
rbc
transfus
superior
liber
one
reduc
mortal
sever
clinic
complic
among
patient
undergo
major
cancer
surgeri
method
trial
design
phase
iii
random
control
parallelgroup
superior
trial
inclus
criteria
adult
patient
cancer
undergo
major
abdomin
surgeri
requir
postop
care
icu
patient
randomli
alloc
treatment
either
liber
rbc
transfus
strategi
transfus
hemoglobin
level
decreas
gdl
restrict
rbc
transfus
strategi
transfus
hemoglobin
level
decreas
gdl
primari
outcom
composit
endpoint
death
sever
complic
patient
monitor
day
result
total
patient
screen
elig
met
inclus
criteria
exclus
medic
reason
lack
consent
patient
includ
fi
nal
analysi
alloc
restrict
group
liber
group
primari
composit
endpoint
allcaus
mortal
cardiovascular
complic
acut
respiratori
distress
syndrom
acut
kidney
injuri
requir
renal
replac
therapi
septic
shock
reoper
day
occur
patient
liber
strategi
group
restrict
group
p
liber
strategi
group
signifi
cantli
lower
mortal
rate
compar
restrict
group
ci
vs
ci
respect
p
occurr
cardiovascular
complic
lower
liber
group
restrict
group
ci
vs
ci
respect
p
restrict
strategi
group
higher
mortal
rate
compar
liber
group
ci
vs
ci
respect
p
conclus
liber
rbc
transfus
strategi
hemoglobin
trigger
gdl
associ
fewer
major
postop
complic
patient
undergo
major
cancer
surgeri
compar
restrict
strategi
introduct
red
blood
cell
rbc
transfus
associ
morbid
mortal
critic
ill
patient
congenit
cardiac
surgeri
associ
high
rate
bleed
consequ
high
rate
allogen
transfus
aim
evalu
associ
transfus
wors
outcom
children
undergo
cardiac
surgeri
method
perform
prospect
cohort
studi
patient
undergo
cardiac
surgeri
congenit
heart
diseas
record
baselin
characterist
score
intraop
data
transfus
requir
sever
postop
complic
need
reoper
acut
kidney
injuri
arrhythmia
sever
sepsi
septic
shock
bleed
stroke
death
day
perform
univari
analysi
use
baselin
intraop
postop
variabl
select
variabl
p
includ
forward
stepwis
multipl
logist
regress
model
identifi
predict
factor
combin
endpoint
includ
mortal
sever
complic
result
one
hundr
thirtysix
patient
expos
rbc
transfus
intraop
room
patient
receiv
least
one
rbc
unit
icu
children
transfus
patient
present
combin
endpoint
patient
complic
higher
score
younger
month
vs
month
p
lower
weight
kg
vs
kg
p
longer
time
surgeri
minut
vs
p
longer
durat
cardiopulmonari
bypass
minut
vs
minut
p
lower
svo
end
surgeri
iqr
vs
p
higher
arteri
lactat
end
surgeri
mmoll
vs
mmoll
p
lower
intraop
hematocrit
vs
p
lower
hematocrit
end
surgeri
vs
p
compar
patient
without
complic
patient
complic
expos
rbc
transfus
intraop
room
vs
p
icu
vs
p
adjust
model
logist
regress
rbc
transfus
independ
risk
factor
combin
endpoint
ci
p
conclus
blood
transfus
pediatr
cardiac
surgeri
risk
factor
wors
outcom
includ
mortal
avoid
blood
transfus
must
goal
best
postop
care
introduct
enough
criteria
make
judgment
need
massiv
transfus
mt
sever
blunt
traumat
patient
score
system
predict
need
mt
usual
use
assess
blood
consumpt
score
abc
andor
traumaassoci
sever
hemorrhag
score
tash
howev
score
system
procedur
slightli
complic
aim
studi
establish
predictor
mt
use
coagul
fi
brinolysi
marker
method
retrospect
analysi
mt
conduct
patient
sever
blunt
traumat
injuri
defi
ned
injuri
sever
score
iss
admit
icu
june
decemb
blood
sampl
collect
patient
immedi
arriv
level
trauma
center
defi
ned
patient
receiv
unit
pack
red
blood
cell
prbc
within
fi
rst
hour
mt
group
receiv
less
unit
prbc
nonmt
group
demograph
data
number
unit
prbc
need
massiv
transfus
record
analyz
group
compar
data
two
group
result
patient
met
inclus
criteria
fifti
patient
receiv
blood
transfus
patient
mt
group
nonmt
group
mt
group
signifi
cantli
higher
ratio
femal
p
iss
p
ptinr
p
aptt
p
abc
p
tash
p
onmt
group
hand
mt
group
signifi
cantli
lower
ps
p
fi
brinogen
level
p
nonmt
group
receiv
oper
characterist
roc
analysi
area
curv
auc
distinguish
mt
highest
tash
p
follow
fi
brinogen
p
abc
p
fibrinogen
predictor
mt
without
score
system
abc
tash
optim
cutoff
valu
mgdl
conclus
found
level
fi
brinogen
valuabl
predictor
mt
coagul
fi
brinolysi
marker
certain
level
fi
brinogen
admiss
use
tash
predict
mt
studi
wherea
score
system
requir
assess
sever
factor
measur
fi
brinogen
simpl
easi
quick
strongli
suggest
level
fi
brinogen
use
predictor
mt
sever
blunt
traumat
patient
introduct
red
blood
cell
rbc
transfus
frequent
critic
ill
children
benefi
ts
clear
sever
situat
howev
issu
surround
safeti
emerg
past
decad
import
identifi
potenti
complic
associ
rbc
transfus
order
evalu
riskbenefi
ratio
better
method
singlecent
prospect
observ
studi
children
admit
pediatr
intens
care
unit
picu
period
variabl
possibl
relat
rbc
transfus
identifi
ed
studi
initi
presenc
assess
daili
child
transfus
case
tc
variabl
consid
possibl
outcom
relat
transfus
observ
fi
rst
transfus
result
studi
period
admiss
document
includ
studi
among
transfus
compar
tc
nontransfus
case
ntc
odd
ratio
new
progress
multipl
organ
dysfunct
syndrom
npmod
ci
p
associ
remain
statist
signifi
cant
multivari
analysi
children
admiss
prism
score
ci
p
tc
ventil
longer
ntc
day
vs
day
p
diff
erenc
still
signifi
cant
adjust
use
cox
model
moreov
observ
adjust
doseeff
ect
relationship
rbc
transfus
length
mechan
ventil
picu
length
stay
signifi
cantli
increas
tc
day
vs
day
p
even
multivari
adjust
hazard
ratio
picu
discharg
tc
ci
p
also
observ
adjust
doseeff
ect
relationship
rbc
transfus
picu
length
stay
pair
analysi
comparison
pretransfus
posttransfus
valu
show
arteri
partial
pressur
oxygen
signifi
cantli
reduc
fi
rst
transfus
mean
diff
erenc
mmhg
ci
p
pair
analysi
also
show
increas
proport
renal
replac
therapi
proport
sepsi
sever
sepsi
septic
shock
diff
er
conclus
rbc
transfus
associ
prolong
mechan
ventil
prolong
picu
stay
risk
npmod
increas
transfus
children
moreov
studi
question
abil
store
rbc
improv
oxygen
critic
ill
children
result
help
improv
transfus
practic
picu
introduct
microcirculatori
alter
sepsi
impair
tissu
oxygen
may
worsen
anemia
blood
transfus
prove
restor
deliveri
sepsi
impact
storag
lesion
andor
leukocytederiv
mediat
red
blood
cell
rbc
unit
yet
clarifi
ed
compar
eff
ect
leukoreduc
lr
versu
nonlr
pack
rbc
microcircul
tissu
oxygen
sepsi
method
prospect
random
studi
twenti
patient
either
sepsi
sever
sepsi
septic
shock
requir
rbc
transfus
randomli
receiv
nonlr
group
n
lr
group
n
fresh
rbc
day
old
hour
transfus
microvascular
densiti
fl
ow
assess
sidestream
darkfi
eld
imag
sublingu
thenar
tissu
satur
sto
measur
use
nearinfrar
spectroscopi
vascular
occlus
test
perform
result
de
backer
score
p
total
vessel
densiti
p
perfus
vessel
densiti
p
proport
perfus
vessel
p
microvascular
fl
ow
index
p
figur
increas
group
sto
upslop
figur
reperfus
increas
group
p
group
baselin
sto
sto
downslop
ischemia
increas
probabl
refl
ect
lower
consumpt
conclus
unlik
nonlr
rbc
transfus
fresh
lr
rbc
seem
improv
microvascular
perfus
might
help
restor
tissu
oxygen
sepsi
introduct
obstetr
haemorrhag
remain
lead
caus
matern
mortal
sever
morbid
cardiovascular
haemostat
physiolog
alter
pregnanc
massiv
transfus
protocol
implement
obstetr
haemorrhag
base
limit
evid
object
studi
examin
pattern
rate
blood
product
use
massiv
transfus
obstetr
haemorrhag
tertiari
obstetr
hospit
method
massiv
transfus
defi
ned
unit
red
blood
cell
within
hour
accord
australian
massiv
transfus
registri
defi
nition
follow
ethic
approv
case
fi
lling
criterion
identifi
ed
hospit
birth
blood
bank
system
data
extract
medic
histori
analys
use
spss
p
consid
statist
signifi
cant
result
twentyeight
women
three
year
underw
massiv
transfus
obstetr
haemorrhag
nine
receiv
unit
rbc
hour
eleven
admit
icu
underw
hysterectomi
six
admit
icu
median
estim
blood
loss
ml
iqr
median
blood
product
deliveri
rbc
unit
iqr
ffp
unit
iqr
platelet
unit
iqr
cryoprecipit
unit
iqr
onehalf
women
receiv
fi
rst
four
unit
rbc
less
minut
blood
product
start
median
minut
minut
minut
rbc
transfus
commenc
respect
eight
women
fi
brinogen
level
gl
initi
coagul
test
haemorrhag
remain
women
median
fi
brinogen
level
gl
iqr
diff
erenc
transfus
rbc
p
ffp
p
platelet
p
women
show
initi
low
fi
brinogen
although
diff
erenc
number
unit
cryoprecipit
p
median
lowest
hb
haemorrhag
gl
iqr
median
discharg
hb
gl
iqr
blood
product
reaction
note
one
death
conclus
massiv
transfus
obstetr
haemorrhag
involv
rapid
blood
product
administr
consist
pattern
ratio
product
administ
introduct
blood
transfus
associ
longer
icu
hospit
inpati
durat
increas
mortal
studi
undertaken
investig
whether
practic
pack
red
cell
critic
care
volum
suppl
http
prc
transfus
icu
accord
best
clinic
evid
number
studi
notabl
tricc
studi
shown
indic
icu
blood
transfus
haemoglobin
hb
level
gdl
evid
acut
haemorrhag
criteria
therefor
employ
method
studi
prospect
examin
episod
prc
unit
transfus
period
icu
larg
level
trauma
centr
tertiari
cardiac
unit
number
prc
unit
transfus
episod
record
nurs
along
propos
indic
concurr
hb
level
data
analys
assess
number
transfus
administ
contrari
guidelin
along
averag
hb
level
prc
unit
transfus
averag
number
unit
administ
per
episod
result
total
unit
prc
transfus
icu
episod
period
exclud
immedi
postop
transfus
ninetyfour
unit
administ
transfus
episod
occur
contrari
guidelin
case
record
reason
transfus
appar
low
hb
level
median
iqr
rang
hb
level
patient
transfus
within
guidelin
gdl
within
guidelin
exclud
case
acut
blood
loss
gdl
outsid
guidelin
gdl
one
unit
prc
transfus
episod
unit
prc
transfus
episod
unit
transfus
episod
twothird
latter
due
acut
haemorrhag
result
indic
liber
transfus
threshold
current
exist
icu
patient
frequent
receiv
excess
prc
transfus
hb
level
recommend
concentr
studi
period
associ
cost
approxim
recommend
increas
staff
awar
guidelin
reduc
number
unnecessari
transfus
would
decreas
exposur
icu
patient
unnecessari
risk
blood
transfus
reduc
cost
treatment
help
preserv
valuabl
resourc
introduct
transfusionrel
acut
lung
injuri
trali
high
incid
critic
ill
surgic
patient
contribut
advers
outcom
specifi
c
therapi
absent
recent
demonstr
complement
activ
play
pivot
role
trali
aim
determin
whether
inhibitor
benefi
cial
twohit
mous
model
antibodymedi
trali
method
balbc
mice
prime
lipopolysaccharid
lp
e
coli
administ
intraperiton
dose
mgkg
trali
induc
inject
mhci
antibodi
k
dose
mgkg
mice
infus
pb
lp
serv
control
concomitantli
mice
infus
mhci
antibodi
treat
inhibitor
sanquin
amsterdam
netherland
dose
iukg
intraven
infus
mice
mechan
ventil
lungprotect
pressurecontrol
mode
hour
sacrifi
ced
bronchoalveolar
lavag
bal
done
statist
analyz
oneway
anova
valu
express
mean
standard
deviat
result
inject
lp
mhci
antibodi
result
trali
indic
increas
level
protein
bal
fl
uid
wetdri
ratio
level
kc
inhibitor
signifi
cantli
reduc
total
protein
bal
fl
uid
p
tend
reduc
wetdri
ratio
p
also
reduc
balf
level
pgml
p
kc
level
aff
ect
conclus
model
antibodymedi
trali
inhibitor
attenu
pulmonari
infl
ammat
inhibit
may
potenti
benefi
cial
intervent
trali
introduct
transfusionrel
acut
lung
injuri
trali
syndrom
present
sudden
onset
respiratori
distress
hour
transfus
blood
product
diagnosi
base
clinic
radiograph
fi
nding
particularli
risk
trali
cardiac
surgeri
patient
howev
specifi
c
patient
risk
factor
data
outcom
larg
unknown
aim
studi
investig
incid
risk
factor
outcom
trali
cardiac
surgic
patient
cardiopulmonari
bypass
method
thorac
surgeri
patient
univers
hospit
netherland
year
older
admit
icu
januari
decemb
screen
includ
patient
observ
surgeri
fi
rst
hour
icu
onset
possibl
trali
canadian
consensu
confer
trali
defi
nition
use
two
independ
physician
blind
predictor
variabl
score
chest
radiograph
onset
bilater
interstiti
abnorm
monitor
interpret
diff
ere
chest
radiograph
review
third
physician
achiev
consensu
european
system
cardiac
oper
risk
evalu
euro
score
american
associ
anesthesiolog
asa
score
surgeri
calcul
acut
physiolog
chronic
health
evalu
apach
ii
iv
score
sever
ill
determin
arriv
icu
total
cardiac
surgic
patient
includ
total
patient
develop
trali
within
hour
follow
surgeri
patient
develop
trali
older
compar
patient
develop
trali
mean
age
respect
year
p
furthermor
patient
develop
trali
higher
apach
ii
apach
iv
euro
asa
score
p
p
p
p
introduct
volum
resuscit
essenti
restor
normovolemia
hemorrhag
shock
burn
sepsi
howev
synthet
colloid
caus
dilut
coagulopathi
aim
determin
whether
natur
colloid
albumin
induc
lesser
degre
coagulopathi
compar
synthet
colloid
compar
eff
ectiv
fi
brinogen
concentr
revers
coagulopathi
follow
dilut
solut
method
rotat
thromboelastometrybas
test
use
examin
coagul
paramet
sampl
healthi
volunt
undilut
blood
sampl
dilut
salin
seen
sampl
dilut
synthet
colloid
p
albumin
p
follow
addit
fi
brinogen
fibtem
mcf
extem
mcf
extem
aa
signifi
cantli
higher
extem
cft
signifi
cantli
shorter
sampl
dilut
albumin
versu
treat
he
dextran
p
conclus
hemodilut
use
albumin
induc
lesser
degre
coagulopathi
compar
synthet
colloid
he
dextran
addit
albumininduc
coagulopathi
eff
ectiv
revers
follow
addit
fi
brinogen
concentr
compar
coagulopathi
induc
synthet
colloid
compar
assess
diff
erent
fl
uid
modal
hamper
pauciti
direct
trial
present
network
metaanalysi
assess
rel
eff
ectiv
two
fl
uid
treatment
sepsi
compar
directli
random
trial
compar
common
treatment
method
systemat
review
trial
sepsi
yield
trial
assess
network
metaanalysi
indirect
comparison
albumin
he
crystalloid
conduct
use
bayesian
method
binomi
likelihood
fi
xedeff
ect
network
metaanalysi
mont
carlo
gibb
sampl
method
studi
septic
patient
crystalloid
refer
treatment
compar
formul
colloid
treatment
albumin
he
includ
direct
headtohead
trial
two
colloid
result
odd
ratio
diff
erent
treatment
obtain
figur
rank
intervent
demonstr
albumin
rank
highest
lower
mortal
probabl
compar
crystalloid
he
respect
conclus
albumin
fl
uid
therapi
sepsi
associ
lowest
mortal
three
modal
studi
sap
sv
co
record
directli
administr
colloid
everi
minut
next
hour
kolmogorovsmirnov
use
test
normal
distribut
data
anova
use
statist
analysi
p
consid
statist
signifi
cant
result
demograph
data
asa
classifi
cation
diff
er
statist
signifi
cant
among
six
group
studi
co
sv
hr
sap
show
statist
signifi
cant
evolut
compar
baselin
valu
studi
period
moreov
statist
signifi
cant
diff
erenc
among
six
studi
group
regard
record
paramet
conclus
accord
result
volum
replac
six
colloid
test
studi
result
hemodynam
respons
within
comparison
six
colloid
reveal
statist
signifi
cant
diff
erenc
paramet
record
accord
protocol
biochem
characterist
infus
fl
uid
may
import
regul
acidbas
balanc
modifi
plasmat
volum
strong
ion
diff
erenc
vitro
anim
studi
shown
volum
strong
ion
diff
erenc
infus
fl
uid
sidin
well
arteri
baselin
bicarbon
concentr
hco
infl
uenc
acidbas
variat
aim
verifi
chang
critic
ill
patient
surgeri
method
electronicded
databas
creat
retrospect
collect
volum
type
fl
uid
infus
plasmat
acidbas
balanc
variat
postop
icu
patient
admiss
day
sidin
calcul
averag
sid
fl
uid
infus
whole
studi
period
crystalloid
colloid
blood
product
arteri
base
excess
variat
comput
diff
erenc
valu
day
entri
report
data
patient
admit
patient
result
nine
patient
receiv
intraven
infus
exclud
remain
popul
divid
three
group
accord
sidin
distribut
group
group
group
meql
observ
progress
increment
group
vs
vs
mmoll
p
subdivid
group
median
valu
baselin
hco
mmoll
analyz
observ
greater
increas
patient
lower
baselin
hco
group
vs
mmoll
p
group
vs
mmoll
p
group
vs
mmoll
p
compar
higher
baselin
level
studi
popul
divid
quartil
diff
erenc
sidin
hco
appear
increas
rise
diff
erenc
p
conclus
sidin
aff
ect
acidbas
statu
per
se
relationship
hco
verifi
ed
hypothesi
critic
ill
patient
highlight
import
diff
erenc
sidin
hco
better
describ
predict
acidbas
modifi
cation
fl
uid
therapi
introduct
fluid
resuscit
improv
tissu
oxygen
hypovolemia
besid
restor
macrohemodynam
stabil
evalu
microvascular
respons
fl
uid
challeng
diff
erent
colloid
solut
relat
macrohemodynam
method
observ
studi
patient
receiv
fl
uid
challeng
ml
colloid
minut
accord
attend
physician
decis
infus
sublingu
microcircul
evalu
sidestream
darkfi
eld
imag
microscan
microvis
medic
amsterdam
netherland
microvascular
fl
ow
densiti
assess
small
vessel
cardiac
index
ci
intrathorac
blood
volum
index
itbvi
extravascular
lung
water
index
elwi
measur
seven
patient
pulsion
medic
system
munich
germani
result
ten
patient
two
sepsi
four
trauma
three
intracrani
bleed
one
post
surgeri
receiv
either
salinebas
hydroxyethyl
starch
he
bbraunspa
n
balanc
he
bbraunspa
n
ci
p
itbvi
p
tend
increas
evlwi
chang
microvascular
fl
ow
densiti
improv
whole
sampl
correl
found
macrocirculatori
microcirculatori
paramet
balanc
he
led
greater
increas
capillari
densiti
nacl
he
figur
conclus
balanc
he
may
effi
caciou
salinebas
he
recruit
microcircul
therebi
improv
tissu
deliveri
introduct
safeti
guidelin
follow
administ
procedur
sedat
emerg
depart
novemb
novemb
npsa
receiv
alert
patient
given
wrong
dose
midazolam
procedur
sedat
fi
rst
year
midazolam
use
death
relat
procedur
sedat
method
search
control
drug
book
resuscit
period
found
list
patient
receiv
midazolam
fentanyl
could
make
search
relev
e
note
patient
note
look
see
shorthand
tabl
verbal
consent
document
consent
past
medic
histori
record
pmhx
safe
initi
dose
midazolam
midaz
preprocedur
monitor
pre
postprocedur
monitor
post
monitor
hour
discharg
follow
introduct
remind
control
drug
book
sedat
room
staff
educ
case
note
analys
anoth
period
set
note
assess
practis
safeti
guidelin
result
see
tabl
key
shorthand
method
conclus
reaudit
notic
within
procedur
sedat
room
control
drug
book
front
cover
serv
remind
good
practis
visibl
remind
within
cd
book
help
ensur
better
adher
audit
standard
remind
kept
within
cd
book
introduct
daili
sedat
interrupt
protocol
implement
recommend
reduc
excess
sedat
howev
use
inconsist
hypothes
use
age
kidney
liver
function
adjust
sedat
protocol
would
associ
reduc
dose
improv
outcom
compar
standard
protocol
method
prospect
cohort
studi
compar
month
standard
protocol
control
group
month
adjust
protocol
intervent
group
adjust
protocol
patient
divid
three
categori
categori
age
year
normal
kidney
liver
function
categori
age
year
moder
kidney
liver
function
impair
categori
age
year
sever
kidney
liver
function
impair
upper
limit
analges
sed
dose
determin
age
kidney
liver
function
lowest
categori
lower
categori
categori
consecut
adult
mechan
ventil
patient
requir
infus
analges
andor
sed
hour
includ
studi
compar
main
outcom
group
includ
averag
daili
dose
analges
sed
averag
sedationagit
scale
sa
pain
gc
score
mechan
ventil
durat
mvd
sedationrel
complic
icu
stay
icu
hospit
length
stay
lo
icu
hospit
mortal
result
two
hundr
four
patient
includ
studi
control
group
adjust
protocol
group
diff
erenc
baselin
characterist
two
group
adjust
protocol
group
compar
control
group
receiv
signifi
cantli
lower
averag
daili
dose
fentanyl
vs
p
nonsignifi
cant
lower
averag
daili
dose
midazolam
dexmedetomidin
trend
toward
higher
averag
daili
dose
propofol
pain
score
higher
adjust
protocol
group
vs
p
diff
erenc
sa
gc
score
sedationrel
complic
icu
stay
diff
erent
two
group
howev
agit
sa
less
frequent
adjust
protocol
group
vs
p
icu
mortal
signifi
cantli
lower
introduct
aim
research
provid
clinic
relev
evid
ysite
compat
drug
infus
combin
use
picu
pharmacist
clinician
regularli
interpret
limit
publish
data
particularli
two
drug
ysite
risk
potenti
incompat
must
balanc
addit
line
insert
method
full
design
total
combin
use
investig
chemic
physic
compat
fi
drug
clonidin
morphin
ketamin
midazolam
furosemid
drug
studi
highest
commonli
infus
concentr
expos
three
variat
environment
condit
diluent
sodium
chlorid
glucos
temperatur
normal
room
light
blue
light
phototherapi
chemic
stabil
assess
use
hplc
reduct
concentr
indic
incompat
physic
incompat
confi
rmed
precipit
ph
colour
chang
result
environment
condit
eff
ect
drug
mixtur
precipit
observ
incompat
combin
due
either
chang
ph
ketamin
presenc
benzethonium
chlorid
possibl
drug
combin
incompat
three
combin
incompat
extrem
ph
concern
avoid
incompat
formul
contain
furosemid
combin
sed
agent
studi
chemic
physic
compat
conclus
work
provid
evid
ysite
compat
morphin
midazolam
clonidin
ketamin
combin
potenti
reduc
need
extra
intraven
line
furosemid
incompat
sed
drug
must
infus
via
separ
line
result
aid
clinic
decisionmak
help
satisfi
requir
recent
uk
depart
health
legisl
relat
mix
medicin
refer
introduct
light
interest
relationship
glycemia
control
critic
ill
subject
outcom
set
studi
investig
whether
benzodiazepin
commonli
use
anesthesia
icu
interfer
glucos
metabol
explor
mechan
method
total
sedat
paralyz
spraguedawley
rat
g
investig
four
consecut
studi
investig
eff
ect
diazepam
blood
glucos
rat
randomli
assign
intraperiton
anesthesia
tiopenth
mgkg
tiopenth
mgkg
diazepam
mgkg
tiopenth
mgkg
diazepam
mgkg
blood
level
glucos
gem
premier
il
measur
time
interv
hour
ten
anim
random
underw
intraven
glucos
toler
test
glucos
bolu
gkg
acut
insulin
respons
mean
valu
blood
insulin
insulin
elisa
kit
millipor
minut
glucos
bolu
measur
index
insulin
secret
hyperinsulinem
euglycem
clamp
obtain
continu
intraven
infus
insulin
mui
kgminut
run
anim
random
glucos
infus
rate
gir
mgkgminut
assess
introduct
report
experi
use
isofl
uran
prolong
sedat
sever
ard
patient
prolong
sedat
icu
may
diffi
cult
toler
drug
depend
withdraw
drug
interact
side
eff
ect
inhal
anesthet
propos
sedat
ventilatordepend
icu
patient
anaconda
devic
allow
safeti
easi
administr
inhal
anesthet
icu
method
januari
june
patient
sedat
isofl
uran
mean
anaconda
devic
consid
administr
isofl
uran
washout
period
common
sed
drug
patient
least
one
high
sed
drug
dosag
propofol
mghour
midazolam
mghour
reach
target
richmond
agit
sedat
score
rass
inadequ
paralysi
two
hypnot
drug
reach
target
rass
propofol
midazolam
hydroxyzin
haloperidol
diazepam
quetiapin
hypertriglyceridemia
isofl
uran
administr
previou
hypnot
drug
interrupt
retrospect
collect
data
administr
isofl
uran
hemodynam
paramet
renal
hepat
function
level
sedat
rass
sed
drug
dosag
data
report
mean
standard
deviat
otherwis
median
minimum
maximum
result
mean
age
year
sap
ii
patient
treat
ecmo
sever
ard
four
histori
drug
abus
median
icu
length
stay
day
ventil
day
due
sever
critic
ill
target
rass
patient
also
paralys
isofl
uran
administ
nine
patient
high
level
common
sed
drug
fi
patient
due
use
two
hypnot
drug
one
patient
hypertrigliceridemia
isofl
uran
administr
last
day
isofl
uran
administr
alter
renal
function
hemodynam
instabl
record
isofl
uran
washout
period
observ
reduct
sed
drug
dosag
patient
two
patient
quickli
wean
mechan
ventil
target
rass
rais
two
patient
isofl
uran
precautionarili
interrupt
concomit
alter
liver
function
suspect
seizur
respect
conclus
inhal
anesthet
could
success
use
icu
especi
case
inadequ
sedat
plan
exampl
patient
histori
drug
abus
young
sever
ard
patient
requir
deep
sedat
paralysi
long
period
introduct
pharmacolog
agent
use
treat
critic
ill
patient
may
alter
mitochondri
function
aim
present
studi
investig
whether
fentanyl
commonli
use
analges
drug
interact
hepat
mitochondri
function
method
human
hepatoma
cell
line
expos
fentanyl
ngml
hour
pretreat
naloxon
opioid
receptor
antagonist
ngml
specifi
c
inhibitor
mitochondri
atpsensit
k
katp
channel
minut
follow
incub
fentanyl
ngml
addit
hour
mitochondri
complex
idepend
iidepend
ivdepend
oxygen
consumpt
rate
permeabil
cell
measur
use
highresolut
oxygraph
oroboro
instrument
innsbruck
austria
respiratori
electron
transfer
capac
intact
cell
evalu
use
fccp
carbonyl
cyanid
ptrifl
uoromethoxyphenylhydrazon
obtain
maximum
fl
ux
result
incub
cell
fentanyl
hour
ngml
induc
reduct
complex
iidepend
ivdepend
respir
figur
cell
pretreat
addit
fentanyl
exhibit
signifi
cant
chang
complex
activ
comparison
control
pretreat
naloxon
tend
abolish
fentanylinduc
mitochondri
dysfunct
treatment
fentanyl
led
reduct
cellular
atp
content
control
vs
cellular
protein
stimul
cell
p
observ
diff
erenc
basal
fccpuncoupl
respir
rate
cell
treat
fentanyl
ngml
compar
control
data
shown
conclus
fentanyl
reduc
cultur
human
hepatocyt
mitochondri
respir
mechan
block
katp
channel
antagonist
contrast
antagon
naloxon
seem
complet
abolish
eff
ect
fentanyl
introduct
endotheli
dysfunct
endotoxemia
respons
function
breakdown
microvascular
perfus
microvessel
permeabl
cholinerg
antiinfl
ammatori
pathway
cap
neurophysiolog
mechan
regul
infl
ammatori
respons
inhibit
proinfl
ammatori
cytokin
synthesi
therebi
prevent
tissu
damag
endotoxemiainduc
microcirculatori
dysfunct
reduc
cholinerg
cap
activ
clonidin
improv
surviv
experiment
sepsi
reduc
sympathet
tone
result
parasympatheticmedi
cap
activ
aim
studi
determin
eff
ect
clonidin
microcirculatori
alter
endotoxemia
method
use
fl
uoresc
intravit
microscopi
determin
venular
wall
shear
rate
macromolecular
effl
ux
leukocyt
adhes
mesenter
postcapillari
venul
male
wistar
rat
endotoxemia
induc
minut
intraven
infus
lipopolysaccharid
lp
control
group
receiv
equival
volum
salin
clonidin
appli
iv
bolu
treatment
group
anim
receiv
either
salin
alon
ii
clonidin
minut
prior
salin
administr
iii
clonidin
minut
prior
lp
administr
iv
clonidin
minut
prior
lp
administr
v
clonidin
minut
lp
administr
vi
lp
alon
result
lp
group
iii
vi
show
signifi
cantli
reduc
venular
wall
shear
rate
compar
salin
group
minut
signifi
cant
diff
erenc
number
adher
leukocyt
clonidinelp
group
iii
iv
v
lp
group
minut
macromolecular
effl
ux
signifi
cantli
increas
group
time
period
minut
minut
diff
erenc
lp
group
clonidin
minut
prior
lp
administr
group
iv
wherea
group
ii
iii
v
show
signifi
cantli
reduc
macromolecular
effl
ux
compar
lp
group
conclus
clonidin
posit
eff
ect
microhemodynam
alter
leukocyteendotheli
interact
endotoxemia
reduct
capillari
leakag
clonidinetr
group
depend
time
interv
rel
initi
endotoxemia
endotheli
permeabl
leukocyt
activ
regul
diff
erent
pathway
stimul
clonidin
endotoxemia
conclud
clonidin
might
import
timedepend
antiinfl
ammatori
protect
eff
ect
endotheli
activ
infl
ammat
introduct
deliv
analges
via
conjunctiv
applic
could
provid
rapid
conveni
pain
relief
disast
medicin
sporad
report
usa
concern
inhal
administr
aerosol
variou
drug
produc
wide
varieti
eff
ect
anxiolysi
sedat
loss
aggress
immobilis
attempt
determin
anim
experi
whether
conjunctiv
administr
sketamin
could
produc
signifi
cant
eff
ect
without
side
eff
ect
method
ethic
committe
approv
rabbit
administ
conjunctiv
sketamin
mgkg
measur
paramet
spo
blood
pressur
bp
heart
rate
hr
administr
interv
immobilis
time
loss
right
refl
ex
specul
reason
stabil
cardiorespiratori
paramet
due
sympathoadrenerg
eff
ect
ketamin
due
method
administr
sign
conjunctiv
irrit
anim
sketamin
preservativefre
solut
conclus
conjunctiv
sketamin
mgkg
rabbit
produc
rapid
onset
without
chang
cardiorespiratori
paramet
without
sign
irrit
eye
result
project
warrant
research
increas
varieti
drug
method
administr
anxiolysi
sedat
analgesia
disast
medicin
introduct
procedur
sedat
use
emerg
depart
ed
facilit
short
pain
intervent
mani
patient
suitabl
discharg
complet
ideal
agent
use
achiev
sedat
prolong
eff
ect
allow
safe
discharg
shortest
time
frame
hypothesis
propofol
short
onset
set
may
reduc
length
stay
lo
comparison
tradit
benzodiazepin
method
data
prospect
registri
analys
period
august
januari
patient
underw
procedur
sedat
discharg
ed
identifi
ed
individu
group
receiv
propofol
midazolam
combin
two
discharg
fulli
alert
abl
eat
drink
demograph
detail
type
procedur
undertaken
extract
anova
perform
identifi
diff
erenc
length
stay
group
addit
descript
analysi
result
studi
period
patient
underw
procedur
sedat
discharg
ed
median
age
year
male
commonest
procedur
perform
shoulder
reduct
propofol
group
n
mean
lo
minut
compar
minut
receiv
midazolam
n
minut
receiv
combin
n
p
diff
erenc
advers
event
group
see
figur
conclus
propofol
increasingli
use
ed
procedur
sedat
due
short
durat
action
studi
suggest
shorter
durat
action
faster
recoveri
may
result
reduc
lo
ed
use
propofol
sedat
intens
care
associ
propofol
infus
syndrom
pri
characteris
cardiac
dysfunct
metabol
acidosi
renal
failur
rhabdomyolysi
hyperlipidaemia
prospect
monitor
biochem
marker
believ
demonstr
earli
sign
danger
often
fatal
syndrom
prepri
state
identifi
ed
propofol
withdrawn
whilst
syndrom
still
revers
method
prospect
audit
monitor
marker
period
propofolsed
patient
propofol
infus
rate
creatin
kinas
ck
triglycerid
tg
creatinin
lactat
ph
base
defi
cit
defi
ned
criteria
prepri
requir
ck
mmoll
doubl
base
level
rise
tg
iul
follow
trend
propofol
dose
conclus
propos
pair
rise
ck
tg
attribut
propofol
alon
repres
prepri
state
risk
develop
full
pri
note
patient
modest
dose
propofol
unclear
proport
patient
develop
full
syndrom
ethic
possibl
continu
propofol
situat
advoc
daili
monitor
ck
tg
identifi
prepri
propofol
reduc
substitut
avoid
morbid
mortal
full
syndrom
introduct
recent
guidelin
report
advers
event
ae
procedur
sedat
consensu
document
releas
world
siva
intern
sedat
task
forc
propos
benchmark
defi
ning
ae
analys
case
procedur
sedat
emerg
depart
method
studi
base
patient
receiv
procedur
sedat
propofol
emerg
depart
decemb
march
patient
select
sedat
strict
protocol
ed
consult
staff
appli
ae
tool
perform
search
patient
record
discuss
consult
perform
sedat
consensu
opinion
result
case
identifi
ed
sentinel
six
hypotens
fi
case
hypoxia
moder
minor
three
minim
risk
advers
event
studi
show
advers
event
rate
support
use
propofol
sedat
emerg
physician
within
limit
strict
govern
framework
safeti
analysi
use
world
siva
advers
event
tool
provid
refer
point
studi
introduct
physic
restraint
use
facilit
essenti
care
prevent
secondari
injuri
howev
physic
restraint
may
regard
humili
may
lead
local
injuri
increas
risk
delirium
posttraumat
stress
syndrom
research
physic
restraint
scarc
aim
studi
investig
scope
physic
restraint
use
method
twentyon
icu
rang
local
hospit
academ
centr
visit
twice
patient
includ
record
characterist
restrain
patient
motiv
awar
nurs
physician
result
physic
restraint
appli
patient
rang
diff
erent
hospit
frequent
motiv
restraint
use
possibl
threat
airway
pull
linesprob
restrain
subject
often
posit
camicu
vs
p
could
less
frequent
verbal
commun
vs
p
receiv
often
antipsychot
vs
p
benzodiazepin
vs
p
use
physic
restraint
regist
patient
fi
le
case
interview
nurs
familiar
physic
restraint
protocol
use
situat
thirti
percent
interview
physician
awar
physic
restraint
statu
patient
conclus
physic
restraint
frequent
use
dutch
icu
frequenc
diff
er
strongli
diff
erent
icu
attend
physician
often
awar
physic
restraint
use
introduct
physic
restraint
pr
use
critic
ill
patient
associ
delirium
unplan
extub
prolong
icu
length
stay
posttraumat
stress
disord
object
defi
ne
preval
pr
use
examin
patient
treatment
institut
factor
associ
use
canadian
icu
measur
aim
delirium
prevent
psychohygien
earli
mobil
carri
small
minor
document
implement
protocol
delirium
care
region
studi
multifacet
tailor
implement
program
need
introduct
object
studi
investig
eff
ect
intraop
administr
dexamethason
versu
placebo
incid
delirium
fi
rst
four
postop
day
cardiac
surgeri
method
within
context
larg
multicent
dexamethason
cardiac
surgeri
dec
trial
patient
random
mgkg
dexamethason
placebo
induct
anesthesia
monocent
substudi
conduct
primari
outcom
studi
incid
delirium
fi
rst
four
postop
day
secondari
outcom
durat
delirium
use
restrict
measur
sed
antipsychot
analges
requir
delirium
assess
daili
train
research
personnel
use
richmond
agit
sedat
scale
confus
assess
method
medic
nurs
medic
chart
evalu
sign
delirium
use
prespecifi
ed
medic
analysi
intent
treat
result
elig
patient
complet
data
delirium
could
collect
patient
incid
delirium
dexamethason
group
placebo
group
odd
ratio
ci
signifi
cant
diff
erenc
found
durat
delirium
intervent
median
day
interquartil
rang
day
placebo
median
day
interquartil
rang
day
group
p
use
restrict
measur
administr
sed
haloperidol
benzodiazepin
opiat
compar
group
conclus
intraop
inject
dexamethason
seem
aff
ect
incid
durat
delirium
fi
rst
day
cardiac
surgeri
suggest
regimen
safe
use
oper
set
respect
psychiatr
advers
event
refer
introduct
belief
knowledg
practic
regard
icu
delirium
among
icu
profession
may
vari
may
interfer
implement
dutch
icu
delirium
guidelin
aim
get
insight
potenti
barrier
facilit
delirium
guidelin
implement
may
help
fi
nd
eff
ectiv
implement
strategi
method
onlin
survey
sent
healthcar
profession
six
particip
icu
respond
includ
icu
physician
nurs
delirium
expert
psychiatrist
neurologist
geriatrician
nurs
expert
survey
consist
statement
belief
knowledg
practic
toward
icu
delirium
agreement
statement
respond
regard
facilit
item
agreement
lower
barrier
implement
protocol
care
survey
distribut
complet
major
respond
icu
nurs
delirium
consid
major
problem
requir
adequ
treatment
underdiagnos
respond
consid
routin
screen
delirium
improv
prognosi
howev
minor
answer
delirium
prevent
respond
receiv
train
delirium
previou
year
found
train
use
mean
delirium
knowledg
score
sd
group
mutual
compar
nurs
score
lower
delirium
expert
anova
p
respond
n
three
icu
indic
camicu
assess
depart
polici
howev
n
respond
felt
unfamiliar
camicu
n
indic
posit
camicu
use
treatment
decis
haloperidol
fi
rstchoic
pharmacolog
treatment
respond
knew
nation
icu
delirium
guidelin
exist
indepth
knowledg
gener
low
conclus
survey
show
healthcar
profession
consid
delirium
import
underdiagnos
form
organ
failur
contrast
screen
tool
delirium
scarc
use
knowledg
improv
protocol
treatment
base
posit
screen
often
lack
result
suggest
focu
implement
icu
delirium
manag
motiv
aspect
knowledg
improv
train
screen
tool
implement
treatment
prevent
protocol
introduct
delirium
acut
disturb
conscious
cognit
common
disord
icu
associ
impair
longterm
outcom
despit
frequenc
impact
delirium
poorli
recogn
icu
physician
nurs
use
delirium
screen
tool
complet
new
approach
detect
delirium
use
monitor
physiolog
alter
temperatur
variabl
measur
temperatur
regul
could
interest
paramet
monitor
icu
delirium
never
investig
aim
studi
investig
whether
temperatur
variabl
aff
ect
icu
delirium
method
includ
patient
day
delirium
could
compar
day
without
delirium
base
confus
assess
method
icu
inspect
medic
record
patient
condit
aff
ect
thermal
regul
includ
infecti
diseas
receiv
therapi
aff
ect
bodi
temperatur
exclud
twentyfour
icu
patient
includ
screen
deliri
icu
patient
daili
temperatur
variabl
determin
comput
mean
absolut
second
deriv
temperatur
signal
per
patient
temperatur
variabl
deliri
day
compar
nondelirium
day
use
wilcoxon
signedrank
test
linear
mix
model
diff
erenc
delirium
nondelirium
day
regard
temperatur
variabl
analys
adjust
daili
mean
richmond
agit
sedat
scale
score
daili
maximum
sequenti
organ
failur
assess
score
withinpati
correl
result
temperatur
variabl
increas
delirium
day
compar
day
without
delirium
mean
diff
erenc
ci
p
adjust
confound
alter
fi
nding
adjust
mean
diff
erenc
ci
p
conclus
temperatur
variabl
increas
delirium
icu
patient
refl
ect
encephalopathi
underli
delirium
opportun
delirium
monitor
use
temperatur
variabl
explor
particularli
combin
electroencephalographi
could
provid
input
object
tool
monitor
delirium
icu
patient
littl
research
perform
relationship
delirium
longterm
outcom
includ
healthrel
qualiti
life
hrqol
cognit
function
mortal
addit
result
seem
inconsist
furthermor
studi
report
increas
mortal
deliri
patient
proper
adjust
made
sever
ill
icu
admiss
studi
conduct
investig
associ
introduct
aim
clarifi
diff
erenc
primari
secondari
acut
gi
injuri
method
total
consecut
adult
patient
retrospect
studi
fi
rst
week
icu
patholog
gi
system
laparotomi
defi
ned
primari
gi
insult
gi
symptom
develop
without
primari
gi
insult
consid
secondari
gi
injuri
absent
bowel
sound
bs
vomitingregurgit
diarrhoea
bowel
distens
gi
bleed
high
gastric
residu
grv
hour
record
daili
result
total
patient
male
median
age
year
rang
studi
eightyfour
per
cent
ventil
receiv
vasopressorinotrop
median
iqr
apach
ii
score
sofa
fi
rst
day
total
primari
gi
patholog
fi
rst
week
patient
absent
bs
vomitingregurgit
diarrhoea
bowel
distens
high
grv
gi
bleed
symptom
except
diarrhoea
occur
often
patient
primari
gi
insult
eightyfi
per
cent
patient
primari
gi
insult
versu
without
develop
least
one
gi
symptom
incid
gi
symptom
signifi
cantli
higher
nonsurvivor
icu
mortal
lower
patient
primari
secondari
gi
injuri
vs
p
nonsurvivor
without
primari
gi
insult
develop
gi
symptom
later
figur
conclus
primari
secondari
acut
gi
injuri
diff
erent
incid
dynam
outcom
ventil
rel
risk
mortal
one
promot
factor
vap
increas
ph
gastric
acid
occur
antagonist
proton
pump
inhibitor
ppi
use
stress
ulcer
prophylaxi
result
pilot
studi
suggest
may
diff
erenc
incid
vap
gi
bleed
stress
ulcer
prophylaxi
perform
ppi
latter
expens
use
fi
rst
choic
critic
care
question
conclus
depend
resect
size
liver
resect
acut
increas
portal
venou
pressur
induc
neurohumor
activ
result
compromis
renal
function
increas
risk
develop
aki
introduct
sever
acut
pancreat
sap
requir
admiss
icu
associ
high
mortal
hospit
mortal
reach
long
length
stay
surviv
among
patient
predict
sap
admiss
shown
correl
durat
organ
failur
system
determin
sever
new
classifi
cation
acut
pancreat
ap
also
base
identifi
cation
patient
transient
persist
method
aim
studi
retrospect
determin
predictor
earli
persist
icu
patient
sap
analysi
involv
patient
median
time
interv
onset
ap
admiss
hour
patient
divid
two
group
fi
rst
group
n
transient
second
group
n
persist
abil
apach
ii
score
total
sofa
score
number
organsystem
failur
discrimin
transient
persist
explor
receiv
oper
characterist
roc
curv
result
hospit
mortal
signifi
cantli
higher
second
group
compar
fi
rst
group
vs
p
infecti
complic
versu
p
median
length
icu
stay
day
second
group
day
fi
rst
group
p
optimum
cutoff
level
roc
curv
analysi
apach
ii
score
sensit
specifi
citi
total
sofa
score
sensit
specifi
citi
failur
organssystem
sensit
specifi
citi
see
tabl
introduct
aim
studi
evalu
accuraci
thrombopoietin
tpo
plasma
level
biomark
clinic
sever
patient
acut
pancreat
ap
tpo
humor
growth
factor
stimul
megakaryocyt
prolifer
diff
erenti
furthermor
favor
platelet
aggreg
polymorphonuclear
leukocyt
activ
elev
plasmat
concentr
tpo
shown
patient
critic
diseas
includ
ac
burn
injuri
sepsi
particular
clinic
sever
major
determin
elev
tpo
level
patient
sepsi
ap
rel
common
diseas
whose
diagnosi
treatment
often
diffi
cult
especi
clinic
set
emerg
depart
ed
introduct
renal
ischemiareperfus
injuri
iri
common
caus
acut
kidney
injuri
occur
variou
clinic
condit
includ
shock
cardiovascular
surgeri
renal
iri
releas
proinfl
ammatori
cytokin
within
kidney
atrial
natriuret
peptid
anp
natriuret
diuret
antiinfl
ammatori
eff
ect
play
import
role
regul
blood
pressur
volum
homeostasi
hypothesi
renal
iri
induc
infl
ammat
kidney
also
remot
organ
lung
heart
anp
attenu
renal
injuri
infl
ammat
kidney
lung
heart
method
male
spraguedawley
rat
anesthet
pentobarbit
tracheostomi
perform
rat
ventil
vt
mlkg
cmh
peep
right
carotid
arteri
catheter
blood
sampl
continu
blood
pressur
measur
right
femor
vein
catheter
infus
salin
anp
rat
divid
three
group
iri
group
n
left
renal
pedicl
clamp
minut
irianp
group
n
left
renal
pedicl
clamp
minut
anp
hour
minut
start
minut
clamp
sham
group
n
shamoper
rat
hemodynam
arteri
blood
ga
plasma
lactat
level
measur
baselin
hour
hour
hour
declamp
mrna
express
kidney
lung
heart
measur
kidney
lung
heart
immunostain
examin
local
assign
express
score
wetdri
ratio
lung
also
measur
result
renal
iri
induc
metabol
acidosi
pulmonari
edema
mrna
express
kidney
lung
heart
renal
iri
increas
immunohistochem
local
proxim
convolut
tubul
left
kidney
bronchial
epitheli
cell
lung
anp
attenu
metabol
acidosi
pulmonari
edema
express
mrna
kidney
heart
lung
anp
decreas
immunohistochem
local
left
kidney
lung
conclus
fi
nding
suggest
infl
ammat
within
kidney
renal
iri
extend
lung
heart
anp
attenu
metabol
acidosi
infl
ammat
kidney
lung
heart
rat
model
renal
iri
anp
may
attenu
organ
crosstalk
kidney
lung
heart
refer
increas
urinari
ngal
patient
receiv
bicarbon
infus
observ
compar
control
p
incid
postop
rrt
similar
hospit
mortal
increas
patient
treat
bicarbon
compar
chlorid
vs
p
see
figur
conclus
basi
fi
nding
recommend
use
periop
infus
sodium
bicarbon
reduc
incid
sever
aki
patient
group
figur
excel
predict
valu
found
ungaluhepcidin
ratio
auc
figur
ratio
combin
aki
predict
marker
ngal
marker
protect
aki
hepcidin
potenti
individu
discriminatori
valu
contrarili
icu
admiss
none
plasma
biomark
good
earli
aki
predictor
aucroc
conclus
sever
urinari
marker
acut
tubular
damag
predict
aki
cardiac
surgeri
biolog
plausibl
combin
ngal
hepcidin
provid
excel
aki
predict
introduct
furosemid
one
employ
diuret
icu
abil
induc
neg
water
balanc
howev
one
common
side
eff
ect
metabol
alkalosi
aim
describ
time
cours
urinari
excret
chang
plasmat
acidbas
balanc
respons
administr
furosemid
method
connect
urinari
cathet
icu
patient
quasicontinu
urin
analyz
kidney
instant
allow
measur
ph
phu
sodium
chlorid
potassium
ammonium
concentr
nau
clu
ku
everi
minut
studi
period
last
hour
singl
intraven
bolu
furosemid
time
patient
receiv
two
administr
longer
period
hour
accord
clinic
need
review
data
fl
uid
therapi
hemodynam
acidbas
balanc
begin
end
observ
result
ten
minut
furosemid
administr
nau
clu
rose
meql
respect
ku
fell
meql
p
electrolyt
vs
time
consequ
increas
urinari
anion
gap
agu
nau
clu
ku
urinari
output
increas
minut
p
fi
rst
hour
clu
remain
higher
nau
progress
decreas
lead
reduct
agu
phu
time
parallel
progress
increment
observ
patient
receiv
one
administr
observ
increas
arteri
base
excess
vs
mmoll
p
plasmat
strong
ion
diff
erenc
sidpl
vs
meql
p
studi
period
chang
due
decreas
plasmat
clconcentr
vs
meql
p
plasmat
sodium
potassium
concentr
chang
patient
consid
total
amount
administ
fl
uid
urin
neg
water
chlorid
balanc
observ
ml
meq
respect
conclus
furosemid
act
immedi
administr
caus
rise
urinari
output
nau
clu
concentr
loopdiureticinduc
metabol
alkalosi
may
due
increas
urinari
chlorid
loss
associ
increas
sidpl
refer
introduct
given
signifi
cant
morbid
mortal
associ
acut
kidney
injuri
aki
need
fi
nd
factor
help
aid
decisionmak
regard
level
therapeut
support
prognost
biomark
red
cell
distribut
width
rdw
attract
interest
set
critic
care
ad
exist
score
system
examin
rdw
previous
studi
aki
cohort
aim
evalu
util
routin
blood
test
method
cohort
mix
critic
care
patient
receiv
renal
replac
therapi
aki
demograph
biochem
data
retriev
electron
databas
outcom
gather
icu
hospit
mortal
incomplet
dataset
discard
lead
complet
set
rdw
data
taken
fi
rst
sampl
admiss
icu
biochem
valu
apart
prerrt
creatinin
potassium
overal
cohort
characterist
gather
two
group
creat
rdw
valu
within
normal
rang
greater
normal
valu
subgroup
rdw
assess
correl
rise
level
icu
mortal
result
total
cohort
rdw
greater
normal
laboratori
rang
time
icu
admiss
key
baselin
characterist
age
apach
ii
score
length
stay
icu
mortal
diff
er
signifi
cantli
patient
normal
abnorm
rdw
subgroup
analysi
perform
statist
signifi
cant
correl
rise
rdw
icu
mortal
found
spearman
correl
p
conclus
cohort
critic
ill
patient
aki
rdw
found
predictor
mortal
result
contradict
recent
studi
howev
group
rdw
patient
studi
suff
ere
higher
icu
mortal
studi
explain
fi
nding
intend
perform
multivari
logist
regress
analysi
assess
eff
ect
social
depriv
rdw
introduct
intraabdomin
hypertens
iah
independ
predictor
renal
impair
mortal
organ
dysfunct
caus
pressur
eff
ect
iah
well
understood
modifi
ed
presenc
bowel
obstruct
unclear
aim
studi
determin
diff
erent
iah
model
caus
renal
dysfunct
pig
model
method
twentyfour
pig
divid
three
group
control
group
n
pneumoperitoneum
pn
n
intestin
occlus
oc
model
n
iap
maintain
hour
mmhg
time
creatinin
urea
urin
output
potassium
glomerular
fi
ltration
pressur
gfp
measur
statist
analysi
perform
use
repeatedmeasur
anova
result
fi
rst
hour
statist
signifi
cant
diff
erenc
control
group
iah
model
conclus
expect
iah
model
result
signifi
cantli
wors
renal
function
hour
earli
renal
dysfunct
may
result
earli
infl
ammatori
process
associ
pathophysiolog
acut
kidney
injuri
potassium
signifi
cantli
elev
pn
group
compar
oc
group
earli
chang
potassium
level
iah
may
marker
earli
renal
dysfunct
use
renal
biomark
ngal
prompt
investig
refer
introduct
oliguria
common
septic
patient
frequent
therapeut
address
loop
diuret
furosemid
diuret
treatment
shock
hypovolemia
ration
tri
oligur
patient
normovolemia
hypervolemia
without
hypotens
patient
still
alway
increas
dieresi
also
harm
resist
index
measur
pulsatil
blood
fl
ow
refl
ect
resist
blood
fl
ow
caus
microvascular
bed
distal
site
measur
refl
ect
function
statu
tissu
distal
point
measur
investig
whether
measur
renal
resist
index
ri
could
help
determin
patient
respond
furosemid
treatment
method
includ
medic
icu
patient
sepsi
oliguria
urin
output
mlkghour
prescrib
iv
furos
mide
patient
known
chronic
renal
failur
hypovolemia
cvp
mmhg
sever
hypotens
map
mmhg
exclud
resist
index
end
diastol
veloc
maximum
systol
veloc
measur
least
three
segment
arteri
kidney
averag
measur
report
result
repeat
assess
view
independ
separ
hour
furosemid
given
intraven
dose
mg
ri
measur
posit
respons
furosemid
defi
ned
doubl
hourli
dieresi
achiev
urin
output
mlkghour
drug
administr
includ
patient
total
measur
case
patient
posit
respons
furosemid
median
ri
respond
rang
nonrespond
rang
p
construct
receiv
oper
characterist
curv
show
sensit
specifi
citi
cutoff
ri
measur
patient
characterist
found
predict
respons
diuret
treatment
conclus
result
show
ri
could
use
guid
diuret
treatment
nonhypovolem
nonhypotens
septic
patient
studi
need
confi
rm
preliminari
result
introduct
proof
concept
potenti
ad
valu
chitinas
earli
specifi
c
diagnost
paramet
acut
kidney
injuri
aki
investig
adult
icu
patient
underw
elect
cardiac
surgeri
conclus
sdma
appear
accur
precis
estim
gfr
sensit
biomark
renal
dysfunct
scr
predict
sdma
perform
better
scr
biomark
aki
form
basi
futur
studi
introduct
grow
evid
hint
bidirect
interact
heart
failur
kidney
diseas
renal
insuffi
cienci
strong
predictor
mortal
well
causal
link
progress
heart
failur
neutrophil
gelatinaseassoci
lipocalin
ngal
earli
predictor
acut
kidney
injuri
aki
evalu
impact
ngal
morbid
mortal
patient
acut
heart
failur
method
seventysix
patient
present
symptom
consist
acut
heart
failur
median
age
year
male
enrol
plasma
ngal
level
measur
elisa
admiss
compar
glomerular
fi
ltration
rate
egfr
bnatriuret
peptid
bnp
level
primari
outcom
aki
develop
defi
ned
rifl
criteria
fall
gfr
creatinin
rise
baselin
fall
urin
output
mlkghour
secondari
outcom
durat
hospit
stay
inhospit
mortal
conclus
ngal
emerg
promis
biomark
aki
set
acut
heart
failur
elev
ngal
level
indic
poor
prognosi
popul
regard
morbid
mortal
introduct
aki
common
occurr
sick
hospit
patient
particular
admit
intens
care
publish
data
suggest
critic
ill
patient
develop
sever
aki
requir
initi
renal
replac
therapi
rrt
patient
high
mortal
rate
often
exceed
aim
review
outcom
patient
admit
icu
requir
renal
replac
therapi
aki
examin
whether
aetiolog
aki
comorbid
burden
hospit
length
stay
treatment
icu
signifi
cant
associ
surviv
studi
cohort
method
patient
identifi
ed
receiv
rrt
aki
admit
icu
royal
wolverhampton
hospit
nh
trust
computeris
paperbas
case
record
examin
patient
collect
data
akin
classifi
cation
use
classifi
sever
aki
conclus
individu
develop
dialysisdepend
aki
icu
set
gener
term
either
die
recov
sepsi
common
associ
death
need
mechan
ventil
inotrop
therapi
associ
increas
incid
death
introduct
studi
evalu
effi
cienci
earli
start
intermitt
substitut
renal
therapi
patient
polytrauma
complic
multipl
organ
failur
syndrom
method
fortytwo
patient
polytrauma
complic
multipl
organ
failur
syndrom
includ
studi
age
patient
year
year
averag
patient
divid
two
equal
group
control
group
cg
criteria
start
substitut
renal
therapi
hyperkalemia
mmoll
plasma
creatinin
diuresi
mlhour
investig
group
ig
subtest
carri
substitut
renal
therapi
allow
one
start
earlier
period
multipl
organ
failur
progress
increas
na
mmoll
osmolar
mosml
elev
plasma
toxic
accord
averag
molecul
concentr
diuresi
decreas
mlhour
examin
lethal
quantiti
substitut
renal
therapi
procedur
mechan
lung
ventil
durat
mlv
intens
care
hospit
durat
substitut
renal
therapi
carri
apparatu
gambro
sweden
statist
analysi
realiz
use
statistica
mannwhitney
u
test
averag
quantiti
substitut
renal
therapi
procedur
cg
ig
p
recuper
renal
excretori
function
day
patient
cg
day
ig
moment
substitut
renal
therapi
start
p
lethal
cg
nine
patient
ig
six
patient
p
durat
mlv
cg
ig
day
respect
p
ig
durat
icu
lower
hospit
durat
lower
p
conclus
effi
cienci
substitut
renal
therapi
depend
directli
hydroelectrolyt
metabol
chang
toxicosi
degre
polytrauma
complic
multipl
organ
failur
syndrom
earli
start
dialysi
method
treatment
allow
one
achiev
earlier
recuper
renal
function
decreas
lethal
level
treatment
molecular
adsorb
recircul
system
solut
type
introduct
suggest
fl
uid
balanc
biomark
critic
ill
patient
pauciti
random
trial
examin
eff
ect
daili
fl
uid
balanc
outcom
patient
continu
renal
replac
therapi
crrt
renal
trial
fi
nd
mortal
diff
erenc
higher
crrt
dose
investig
eff
ect
daili
fl
uid
balanc
patient
outcom
post
hoc
analysi
suggest
surviv
benefi
patient
neg
fl
uid
balanc
studi
hypothes
daili
fl
uid
balanc
independ
predictor
mortal
critic
ill
patient
conduct
retrospect
cohort
studi
eight
icu
tertiari
academ
center
construct
robust
cluster
linear
regress
model
daili
fl
uid
balanc
allcaus
hospit
mortal
among
critic
ill
patient
receiv
crrt
adjust
model
charlson
comorbid
score
daili
sofa
score
fi
rst
week
initi
crrt
well
type
icu
result
adjust
type
icu
daili
sever
ill
patient
die
averag
ml
higher
daili
fl
uid
balanc
compar
patient
surviv
p
ci
ml
figur
sever
ill
predict
daili
fl
uid
accumul
addit
point
sofa
score
predict
addit
ml
extra
daili
fl
uid
p
balanc
intradialyt
hypotens
mortal
recoveri
renal
function
method
conduct
retrospect
cohort
studi
among
patient
age
year
rrt
initi
continu
day
level
icu
two
academ
centr
fl
uid
balanc
data
avail
patient
endstag
kidney
diseas
within
year
renal
transplant
rrt
initi
treat
toxic
ingest
exclud
use
multivari
logist
regress
determin
relationship
mean
daili
fl
uid
balanc
fi
rst
day
follow
rrt
initi
outcom
mortal
rrt
depend
survivor
introduct
acut
kidney
injuri
aki
common
complic
critic
ill
sepsi
dose
antibacteri
agent
septic
patient
complic
alter
pharmacokinet
due
acut
renal
failur
critic
ill
current
dose
regimen
administr
gentamicin
vancomycin
septic
patient
aki
continu
venoven
hemofi
ltration
cvvh
fi
ltration
rate
mlkghour
miss
method
seventeen
septic
patient
aki
treat
vancomycin
seven
patient
gentamicin
cvvh
includ
vancomycin
group
patient
receiv
fi
rst
dose
g
intraven
follow
hour
adjust
gentamicin
group
patient
receiv
load
dose
mg
follow
mainten
dose
everi
hour
vancomycin
mainten
dose
optim
achiev
auc
mic
cmin
mgl
gentamicin
target
cmaxmic
mainten
dose
adjust
accord
drug
level
simul
use
pharmacokinet
programm
median
vancomycin
total
clearanc
cltot
mlminutekg
fi
rst
second
day
studi
crrt
clearanc
account
vancomycin
cltot
found
popul
normal
renal
function
mlminutekg
vancomycin
serum
concentr
fi
rst
dose
requir
target
mgl
earli
hour
patient
auc
mic
ratio
achiev
patient
fi
rst
day
median
gentamicin
cltot
mlminutekg
fi
rst
second
day
studi
crrt
clearanc
account
gentamicin
cltot
found
popul
without
renal
impair
mlminutekg
target
cmaxmic
ratio
achiev
patient
fi
rst
dose
conclus
cvvh
fi
ltration
rate
mlkghour
lead
high
remov
antibiot
due
rapid
chang
patient
clinic
statu
imposs
predict
fi
xed
dosag
regimen
recommend
administr
unreduc
load
dose
blood
sampl
earli
hour
fi
rst
vancomycin
dose
blood
sampl
minut
gentamicin
administr
next
dose
mainten
dose
base
druglevel
monitor
crrt
aim
evalu
eff
ect
electrolyt
acidbas
statu
new
rcacvvh
protocol
use
mmoll
citrat
solut
combin
phosphatecontain
replac
fl
uid
compar
previous
adopt
rcacvvh
protocol
combin
mmoll
citrat
solut
convent
replac
fl
uid
method
septemb
rcacvvh
routin
perform
centr
mmoll
citrat
solut
postdilut
replac
fl
uid
bicarbon
hco
ca
mg
k
mmoll
protocol
case
metabol
acidosi
relat
inappropri
citrat
metabol
persist
optim
rcacvvh
paramet
set
bicarbon
infus
schedul
start
septemb
order
optim
buff
er
balanc
reduc
need
phosphat
supplement
new
rcacvvh
protocol
design
use
mmoll
citrat
solut
combin
recent
introduc
phosphatecontain
replac
fl
uid
bicarbon
hco
conclus
protocol
b
provid
buff
er
balanc
posit
protocol
allow
one
adequ
control
acidbas
statu
without
addit
bicarbon
infus
absenc
alkalosi
despit
use
standard
bicarbon
concentr
replac
solut
furthermor
combin
phosphatecontain
replac
fl
uid
appear
eff
ectiv
prevent
hypophosphatemia
introduct
aim
studi
establish
intraobserv
interobserv
variat
ultrasonograph
measur
rectu
femori
muscl
crosssect
area
rfcsa
muscl
wast
frequent
icu
aff
ect
onehalf
patient
sever
sepsi
muscl
mass
reduc
rapidli
lost
within
fi
rst
week
monitor
muscl
mass
ultrasound
benefi
ts
readili
avail
icu
noninvas
ultrasonograph
measur
rfcsa
almost
perfect
correl
mri
mean
interclass
correl
icc
rfcsa
linearli
relat
maximum
voluntari
contract
strength
healthi
subject
copd
patient
r
method
studi
two
purpos
determin
intraobserv
variat
rfcsa
one
observ
scan
healthi
adult
volunt
three
time
interv
determin
interobserv
variat
rfcsa
two
observ
scan
adult
icu
patient
day
patient
supin
posit
leg
passiv
extens
transduc
place
perpendicular
long
axi
right
thigh
rf
twothird
distanc
anterior
superior
iliac
spine
superior
patellar
border
rfcsa
calcul
planimetri
scan
three
measur
made
intraobserv
variat
scan
analyz
use
interclass
correl
coeffi
cient
interobserv
variat
three
measur
observ
averag
compar
use
blandaltman
statist
result
intraobserv
variat
healthi
adult
age
year
weight
kg
sex
three
femal
icc
ci
interobserv
variat
icu
patient
age
year
weight
kg
sex
nine
malesix
femal
blandaltman
bia
cm
limit
agreement
cm
conclus
ultrasonograph
measur
rfcsa
easili
learn
quickli
perform
low
intraobserv
interobserv
variat
recommend
reliabl
method
monitor
muscl
wast
icu
artifi
cialli
fed
critic
ill
patient
adipos
tissu
reveal
increas
number
small
adipocyt
accumul
macrophag
hypothes
nutrientindepend
factor
critic
ill
explain
fi
nding
also
accumul
critic
ill
may
limit
adipos
tissu
method
perform
random
investig
septic
mous
model
critic
ill
studi
icu
patient
biopsi
critic
ill
mous
compar
eff
ect
parenter
nutrit
n
fast
n
bodi
composit
adipocyt
cell
size
macrophag
accumul
adipos
tissu
liver
lung
fed
healthi
control
mice
n
studi
comparison
vivo
adipos
tissu
harvest
week
ill
human
patient
n
particip
rct
earli
parenter
nutrit
versu
toler
nutrient
restrict
adipos
tissu
morpholog
character
compar
healthi
control
n
result
irrespect
nutrit
intak
critic
ill
mice
lost
bodi
weight
total
fat
fatfre
mass
part
fat
loss
explain
reduc
ectop
fat
accumul
adipocyt
cell
number
adipogen
marker
peroxisom
proliferatoractiv
receptor
ccatenhanc
bindingprotein
increas
ill
irrespect
nutrit
intak
macrophag
accumul
predomin
observ
adipos
tissu
liver
lung
critic
ill
mice
accentu
fast
viscer
tissu
macrophag
correl
chemoattract
factor
express
studi
tissu
human
subcutan
adipos
tissu
biopsi
critic
ill
patient
increas
adipogen
marker
macrophag
accumul
present
irrespect
nutrit
intak
conclus
adipogenesi
accumul
hallmark
critic
ill
irrespect
nutrit
manag
human
mice
critic
ill
evok
macrophag
polar
adipos
tissu
also
liver
lung
accentu
fast
introduct
intraven
magnesium
sulfat
commonli
use
obstetr
patient
preeclampsia
follow
case
acut
symptomat
hypocalcemia
retrospect
examin
cohort
patient
investig
frequenc
hypocalcemia
method
obstetr
patient
identifi
ed
icu
admiss
databas
divid
two
group
treat
magnesium
suspect
preeclampsia
admit
obstetr
indic
postpartum
hemorrhag
infect
etc
baselin
calcium
valu
compar
well
lowest
discharg
valu
albumin
magnesium
valu
also
compar
comparison
use
student
test
result
data
collect
parturi
admit
year
includ
receiv
magnesium
magnesiumtr
women
younger
age
vs
year
p
baselin
calcium
concentr
similar
two
group
vs
mmoll
p
patient
receiv
magnesium
signifi
cantli
higher
magnesium
concentr
vs
mmoll
p
signifi
cantli
lower
calcium
concentr
therapi
vs
mmoll
p
discharg
calcium
level
closer
magnesium
treat
vs
untreat
mmoll
p
albumin
concentr
diff
er
two
group
magnesium
treat
vs
nontreat
gl
p
normal
valu
calcium
mmoll
magnesium
mmoll
albumin
gl
conclus
magnesium
therapi
associ
hypocalcemia
potenti
caus
mechan
includ
renal
excret
interact
magnesiuminduc
suppress
parathyroid
hormon
secret
physician
awar
potenti
symptomat
hypocalcemia
magnesium
therapi
introduct
disord
sodium
na
water
homeostasi
common
hospitalis
patient
hyponatremia
particular
associ
wors
hospit
outcom
length
stay
aim
defi
ne
incid
hyponatremia
serum
na
mmoll
intens
care
popul
determin
whether
associ
icu
outcom
length
stay
method
demograph
apach
ii
score
outcom
data
admiss
sodium
retriev
ward
watcher
system
victoria
infi
rmari
icu
consecut
admiss
januari
present
divid
patient
three
group
depend
serum
na
mmoll
mmoll
mmoll
compar
apach
ii
score
length
stay
icu
outcom
patient
low
versu
normal
serum
na
data
analys
use
chisquar
test
student
test
mannwhitney
test
appropri
result
patient
studi
apach
ii
data
serum
na
record
includ
analysi
total
patient
serum
na
mmoll
patient
serum
na
mmoll
patient
low
na
higher
mortal
ci
p
higher
apach
ii
score
vs
p
higher
mean
age
year
vs
year
p
patient
normal
serum
na
mean
length
stay
patient
low
serum
na
also
longer
day
vs
day
although
statist
signifi
cant
p
conclus
summari
hyponatremia
use
index
sever
ill
icu
popul
whether
direct
advers
eff
ect
low
serum
sodium
level
hyponatremia
simpli
marker
sicker
patient
known
refer
introduct
anion
gap
ag
use
routin
assess
metabol
acidosi
mislead
patient
hypoalbuminemia
disord
commonli
encount
intens
care
approach
acidbas
analysi
reli
assess
ph
pco
sodium
bicarbon
chlorid
lead
underestim
overestim
true
electrochem
statu
patient
includ
import
ion
lactat
calcium
magnesium
albumin
strong
ion
gap
sig
altern
ag
base
upon
stewart
physic
chemistri
approach
howev
sig
cumbersom
calcul
number
shortcut
equat
develop
eff
ort
approxim
sig
sought
compar
three
equat
kellum
correct
anion
gap
kellagc
moviat
equat
ezsig
eff
ort
evalu
precis
accuraci
method
conduct
retrospect
chart
review
consecut
patient
admit
icu
georg
washington
univers
medic
center
septemb
march
patient
screen
met
inclus
criteria
includ
avail
laboratori
compon
calcul
sig
obtain
within
hour
demograph
data
serum
valu
ph
pco
albumin
lactat
sodium
potassium
chlorid
bicarbon
magnesium
phosphat
calcium
collect
ag
sig
kellagc
ezsig
moviat
equat
subsequ
calcul
compar
use
pearson
correl
blandaltman
analysi
result
mean
sig
mean
valu
kellagc
moviat
ezsig
respect
pearson
correl
coeffi
cient
kellagc
moviat
ezsig
compar
sig
r
p
r
p
r
p
respect
blandaltman
analysi
mean
bia
test
equat
versu
sig
kellagc
moviat
ezsig
conclus
three
equat
correl
highli
sig
ezsig
moviat
outperform
kellagc
pearson
blandaltman
analysi
ezsig
smaller
bia
moviat
equat
slightli
better
correl
vs
assess
critic
ill
patient
ezsig
candid
scan
equat
measur
sig
sig
compon
avail
universityaffi
liat
teach
hospit
tuni
patient
admit
within
fi
rst
hour
post
burn
greater
total
bodi
surfac
area
tbsa
burn
enrol
studi
januari
june
exclus
criteria
pregnanc
histori
adren
insuffi
cienci
steroid
therapi
within
month
prior
burn
short
corticotrophin
test
perform
cortisol
level
measur
baselin
cs
minut
post
test
adren
insuffi
cienci
defi
ned
respons
rel
adren
insuffi
cienci
defi
ned
baselin
cortisol
result
patient
assign
two
group
rai
n
absenc
ai
n
compar
studi
two
group
show
result
present
tabl
conclus
rai
common
sever
burn
patient
acut
phase
associ
shock
prospect
control
studi
necessari
establish
risk
factor
rai
sever
burn
patient
impact
prognosi
albuminadjust
calcium
concentr
use
identifi
hypocalcaemia
critic
ill
steel
r
introduct
hypocalcaemia
common
critic
ill
accur
assess
crucial
small
studi
shown
albuminadjust
calcium
adjca
accur
predict
ionis
calcium
ica
concentr
critic
ill
patient
yet
adjca
continu
wide
use
investig
reliabl
use
adjca
identifi
hypocalcaemia
larg
divers
popul
requir
intens
care
method
retrospect
studi
patient
admit
icu
tertiari
care
hospit
januari
ica
ph
extract
routin
blood
ga
result
total
calcium
albumin
phosphat
routin
biochemistri
result
adjca
calcul
use
formula
deriv
valid
local
popul
sensit
specifi
citi
posit
neg
predict
valu
ppv
npv
area
curv
auc
adjca
predict
hypocalcaemia
ica
mmoll
calcul
result
total
patient
includ
mean
age
year
mean
weight
kg
apach
ii
score
patient
suff
ere
pneumosepsi
fi
rst
day
intub
total
free
testosteron
level
extrem
low
patient
remain
low
fi
rst
week
figur
level
elev
day
decreas
fi
rst
week
lh
fsh
level
inappropri
low
lipoprotein
fraction
apoprotein
reduc
well
dhea
dhea
contrast
androstenedion
adion
level
elev
suggest
preferenti
stimul
synthesi
androstenedion
figur
high
level
indic
androstenedion
shunt
estrogen
pathway
process
requir
high
aromatas
activ
high
estradioltot
testosteron
ratio
support
conclus
conclus
hyperestrogen
hypotestosteronemia
frequent
fi
nding
acut
phase
sever
sepsi
male
patient
respiratori
failur
suggest
caus
decreas
androgen
product
shunt
androgen
estrogen
synthesi
result
increas
aromatas
activ
clinic
relev
gonad
hormon
substitut
need
studi
introduct
melatonin
could
meaning
role
critic
ill
patient
immunomodulatori
antioxid
sleep
regul
properti
reduc
critic
ill
purpos
studi
describ
endogen
blood
melatonin
valu
icu
patient
correl
clinic
paramet
method
seventythre
highrisk
critic
ill
patient
mechan
ventil
hour
enrol
blood
sampl
melatonin
assay
collect
day
icu
stay
melatonin
determin
radioimmunoassay
elisa
peak
area
curv
auc
calcul
patient
correl
clinic
paramet
use
regress
quantil
test
result
endogen
melatonin
found
lower
critic
ill
patient
compar
healthi
subject
figur
although
show
great
individu
variabl
gener
maintain
nighttim
increas
univari
analysi
peak
found
relat
blood
creatinin
p
patient
coma
p
hospit
mortal
p
auc
found
relat
sap
ii
p
creatinin
p
ast
p
alt
p
hospit
mortal
p
peak
auc
found
higher
nonsurvivor
patient
accord
previou
studi
endogen
blood
melatonin
found
reduc
icu
patient
higher
melatonin
peak
renal
failur
may
due
increas
distribut
volum
greater
auc
patient
liver
failur
could
due
less
effi
cient
remov
hormon
system
circul
fi
nding
increas
peak
auc
nonsurvivor
patient
could
due
hormon
respons
increas
bodi
stress
reaction
potenti
similar
cortisol
higher
product
physiolog
antioxid
decreas
abil
use
introduct
metformin
intox
inhibit
mitochondri
complex
oxygen
consumpt
vo
succin
bypass
complex
donat
electron
complex
ii
aim
studi
clarifi
whether
succin
amelior
mitochondri
vo
metforminintox
human
platelet
method
plateletrichplasma
incub
hour
metformin
fi
nal
concentr
mgl
control
mgl
therapeut
dose
mgl
toxic
dose
platelet
vo
measur
clarktyp
electrod
presenc
glutam
plu
malat
complex
electron
donor
fi
nal
concentr
mmoll
succin
complex
ii
electron
donor
mmoll
ad
cyanid
mmoll
mitochondri
cyanidesensit
extramitochondri
cyanideinsensit
vo
correct
platelet
count
main
result
four
preliminari
experi
shown
figur
presenc
glutam
plu
malat
platelet
incub
high
dose
metformin
mitochondri
vo
signifi
cantli
lower
control
presenc
succin
mitochondri
vo
control
chang
signifi
cantli
wherea
platelet
incub
metformin
eff
ect
succin
tend
becom
larger
dose
metformin
increas
mgl
vs
vs
nmolminut
cell
p
even
mitochondri
vo
platelet
incub
highest
dose
metformin
return
level
control
extramitochondri
vo
alway
introduct
metformin
wide
use
antidiabet
drug
activ
amp
activ
protein
kinas
key
regul
metabol
provid
protect
fuel
defi
cienci
chronic
metformin
therapi
shown
longterm
followup
clinic
studi
reduc
cardiovascular
mortal
anim
experi
acut
metformin
pretreat
shown
reduc
ischemiareperfus
injuri
cardiomyocyt
want
evalu
whether
outcom
aff
ect
coronari
arteri
bypass
graft
cabg
surgeri
introduct
metformin
oral
hypoglycem
drug
belong
biguanid
class
gener
accept
fi
rstline
treatment
type
diabet
mellitu
especi
overweight
patient
predispos
condit
use
metformin
may
result
metforminassoci
lactic
acidosi
mala
rare
advers
event
associ
high
mortal
rate
aim
studi
assess
risk
factor
prognost
factor
patient
mala
studi
higher
plasma
concentr
lactat
repres
main
neg
prognost
factor
point
studi
prothrombin
activ
consid
decis
prognost
factor
studi
peter
colleagu
impair
patient
poor
outcom
introduct
stress
hyperglycemia
critic
ill
complex
process
insulin
signal
systemat
hijack
provid
energi
substrat
metabol
prioriti
cell
heal
infect
contain
fluctuat
level
plasma
glucos
associ
increas
mortal
icu
develop
multiscal
mathemat
model
character
sever
stress
hyperglycemia
base
fundament
understand
signal
molecul
involv
method
insulin
resist
follow
insult
shown
driven
primarili
immun
respons
via
cytokin
creat
multiscal
mathemat
model
link
circul
glucos
insulin
concentr
dynam
extend
minim
model
cellular
insulin
respons
model
captur
insulinmedi
glucos
uptak
insulinrespons
cell
result
inhibitori
dynam
driven
incorpor
cellular
model
attenu
insulin
signal
intermedi
insulin
receptor
substrat
accord
propos
biolog
mechan
percentag
reduct
glucos
uptak
function
concentr
fi
data
patient
underw
elect
abdomin
surgeri
shown
figur
overal
multiscal
model
captur
decreas
insulin
signal
result
increas
level
subsequ
hyperglycemia
may
ensu
introduct
hyperglycemia
frequent
encount
critic
ill
patient
associ
advers
outcom
improv
glucos
protocol
adher
may
accomplish
use
electron
alert
confi
gure
nonintrus
realtim
electron
alert
call
glyc
sniff
er
part
intens
care
inform
system
ici
continu
evalu
occurr
persist
hyperglycemia
hypoglycemia
conclus
realtim
electron
persist
glycemia
sniff
er
result
signifi
cantli
higher
proport
normoglycemia
without
increas
variabl
furthermor
hypoglycem
event
occur
less
frequent
resolv
time
smart
alert
abl
improv
qualiti
care
diminish
problem
alert
fatigu
introduct
recent
studi
show
hyperglycaemia
blood
glucos
mmoll
nondiabet
patient
hospitalis
medic
icu
associ
increas
risk
diabet
investig
larg
mix
icu
popul
confi
rm
result
method
studi
retrospect
includ
patient
neg
histori
diabet
admit
icu
year
exclud
patient
receiv
steroid
newli
diagnos
diabet
endstag
diseas
patient
followedup
year
index
admiss
diagnosi
diabet
within
month
index
admiss
presum
reveal
dm
inclus
exclud
patient
patient
take
glucocorticoid
followup
period
exclud
diabet
identifi
ed
document
propens
score
death
pdead
comput
either
mimicii
apach
iii
hiden
assess
risk
death
hypoglycemia
defi
ned
avg
mgdl
avg
comput
area
glucos
curv
throughout
icu
admiss
mortal
examin
within
bin
bin
categor
mgdl
increas
avg
compar
adjac
categori
use
chisquar
test
method
repeat
among
diabet
nondiabet
patient
lower
pdead
greater
median
higher
pdead
lower
presenc
decub
admiss
icu
associ
longer
hospit
even
adjust
age
acuiti
organ
support
therapi
du
admiss
icu
provid
uniqu
unambigu
marker
increas
resourc
util
introduct
aim
analyz
prognosi
aid
patient
organ
dysfunct
icu
admiss
method
prospect
cohort
studi
includ
patient
hiv
aid
diagnosi
admit
special
icu
novemb
may
patient
less
hour
icu
stay
exclud
demograph
nutrit
statu
collect
organ
dysfunct
classifi
ed
accord
sofa
score
categor
absent
sofa
point
mild
point
sever
point
express
numer
variabl
median
interquartil
interv
perform
multivari
analysi
possibl
variabl
associ
hospit
mortal
p
explor
surviv
patient
without
independ
risk
factor
includ
patient
hivaid
admit
icu
median
age
year
male
sever
malnutrit
common
cell
count
cellsmm
viral
load
copiesml
least
one
opportunist
infect
use
antiretrovir
therapi
previou
icu
admiss
mechan
ventil
use
patient
hospit
mortal
total
sofa
score
point
cardiovascular
dysfunct
common
fi
rst
day
stay
follow
respiratori
neurolog
renal
hematolog
hepat
cardiovascular
renal
dysfunct
present
higher
rate
sever
dysfunct
respect
rate
neurolog
p
renal
p
hematolog
p
dysfunct
higher
nonsurvivor
age
cell
count
malnutrit
opportunist
infect
includ
multivari
analysi
neurolog
dysfunct
independ
risk
factor
hospit
mortal
odd
presenc
neurolog
dysfunct
dichotom
associ
primari
neurolog
diagnosi
surviv
lower
patient
neurolog
dysfunct
without
primari
neurolog
diagnosi
logrank
test
analysi
sixtyday
surviv
similar
primari
secondari
neurolog
dysfunct
remain
lower
patient
without
neurolog
impair
conclus
neurolog
dysfunct
independ
associ
hospit
surviv
mainli
aid
critic
patient
without
primari
neuropathi
result
total
chart
review
total
categor
n
b
n
c
n
n
consist
mainli
patient
hematolog
malign
n
patient
chemotherapi
immunosuppress
treatment
n
group
diff
ere
length
stay
b
c
fi
rst
day
sofa
score
higher
compar
c
b
compar
c
durat
antibiot
therapi
longer
b
c
compar
diff
erenc
mortal
b
c
howev
proport
patient
die
day
higher
b
c
compar
conclus
retrospect
materi
possibl
categor
patient
primari
secondari
tertiari
sepsi
categori
diff
ere
clinic
pictur
present
well
outcom
prospect
studi
warrant
valid
result
studi
conclus
older
peopl
repres
grow
proport
popul
although
represent
critic
care
popul
remain
constant
studi
patient
slightli
higher
median
apach
ii
score
greater
critic
care
mortal
younger
patient
major
survivor
abl
go
home
howev
die
within
month
signifi
cant
life
expect
curtail
surviv
averag
month
discharg
chang
last
year
surviv
initi
period
much
better
outlook
inform
may
vital
patient
physician
discuss
admiss
critic
care
refer
method
potenti
risk
factor
psycholog
problem
prospect
collect
icu
discharg
two
month
icu
discharg
icu
survivor
receiv
questionnair
posttraumat
stress
symptom
hospit
anxieti
depress
scale
had
estim
degre
posttraumat
stress
anxieti
depress
respond
advers
psycholog
outcom
defi
ned
andor
had
subscal
analysi
six
predictor
weight
risk
score
includ
screen
instrument
major
preexist
diseas
parent
children
younger
year
age
previou
psycholog
problem
inicu
agit
unemploy
sicklist
icu
admiss
appear
depress
icu
predictor
correspond
given
risk
score
total
risk
score
sum
individu
risk
score
relat
probabl
advers
psycholog
outcom
individu
patient
predict
accuraci
screen
instrument
assess
area
receiv
oper
curv
categor
patient
three
risk
probabl
group
low
moder
high
risk
actual
preval
advers
psycholog
outcom
respect
group
conclus
preliminari
screen
instrument
may
aid
icu
clinician
identifi
patient
risk
advers
psycholog
outcom
critic
ill
prior
wider
clinic
use
extern
valid
need
multiorgan
dysfunct
syndrom
mod
dynam
process
involv
simultan
consecut
two
organ
system
organ
dysfunct
degre
assess
three
sever
score
sofa
mod
lod
limit
allow
evalu
clinic
cours
patient
reliabl
popul
diff
erent
refer
one
support
clinician
decis
mod
impli
system
infl
ammatori
reaction
lead
microcirculatori
dysfunct
hypothesi
organ
failur
follow
predict
sequenc
appear
aim
verifi
presenc
like
organ
failur
sequenc
assess
onlin
method
predict
evolut
mod
patient
high
mortal
morbid
rate
mod
icu
fact
reduc
prompt
welltim
treatment
method
select
patient
consecut
admit
icu
santandrea
hospit
januari
june
inclus
criteria
least
two
organ
system
sofa
icu
length
stay
hour
patient
calcul
sofa
sinc
begin
inclus
criteria
daili
day
statist
analysi
use
dynam
bayesian
network
dbn
dbn
appli
model
sofa
chang
order
identifi
probabl
sequenc
organ
failur
patient
experienc
fi
rst
known
failur
creat
dbn
analysi
mod
studi
relat
organ
failur
diff
erent
time
dbn
made
organ
failur
depend
previou
one
also
consid
correct
factor
take
account
patient
complet
observ
use
softwar
geni
obtain
probabl
organ
failur
sequenc
conclus
use
dbn
although
limit
set
data
allow
us
identifi
like
organ
dysfunct
sequenc
associ
fi
rst
known
one
capabl
predict
sequenc
patient
make
dbn
promis
prognost
tool
physician
order
treat
patient
time
manner
test
treatment
effi
caci
introduct
assess
whether
critic
ill
patient
admit
icu
remain
diffi
cult
mortal
amongst
icu
patient
high
render
intens
care
prospect
success
immens
emot
burden
patient
rel
great
socioeconom
burden
societi
well
therefor
valid
strategi
help
identifi
patient
benefi
intens
care
demand
studi
seek
investig
whether
preadmiss
qualiti
life
act
predictor
mortal
amongst
patient
admit
icu
method
patient
year
admit
icu
hour
includ
order
assess
preadmiss
qualiti
life
patient
close
rel
complet
shortform
within
hour
icu
admiss
mortal
evalu
icu
admiss
day
hereaft
logist
regress
receiv
oper
characterist
analys
employ
assess
predict
valu
mortal
use
fi
model
introduct
longterm
compromis
traumat
injuri
signifi
cant
howev
modifi
abl
factor
infl
uenc
outcom
identifi
ed
aim
studi
identifi
acut
earli
postacut
predictor
longterm
recoveri
amen
chang
intervent
method
adult
year
admit
icu
princess
alexandra
hospit
australia
follow
injuri
prospect
follow
data
collect
demograph
preinjuri
health
injuri
characterist
acut
care
factor
psychosoci
measur
selfeffi
caci
se
ill
percept
ip
posttraumat
stress
disord
ptsd
symptom
psycholog
distress
health
statu
collect
via
questionnair
month
post
injuri
outcom
interest
physic
function
pf
mental
health
mh
subscal
regress
model
use
estim
predictor
physic
function
mental
health
period
subjectspecifi
c
intercept
mix
model
use
account
repeat
data
particip
time
result
particip
n
young
median
iqr
year
predominantli
male
spent
averag
day
icu
week
hospit
respons
rate
followup
respond
similar
nonrespond
except
gener
older
pf
mh
score
improv
time
although
averag
remain
australian
norm
month
predictor
pf
includ
ip
ci
p
se
ci
p
hospit
length
stay
ci
p
never
marri
ci
p
injuri
insur
ci
p
predictor
mh
includ
ptsd
symptom
ci
p
psycholog
distress
ci
p
se
ci
p
unemploy
ci
p
conclus
trauma
icu
patient
experi
compromis
physic
function
mental
health
month
injuri
psycholog
distress
selfeffi
caci
ill
percept
infl
uenc
outcom
potenti
amen
chang
respons
intervent
initi
hospit
stay
introduct
swiss
diagnosi
relat
group
swissdrg
eff
ectiv
sinc
januari
infl
uenc
new
system
patient
discharg
characterist
larg
icu
known
introduct
drg
expect
patient
discharg
shorter
length
stay
icu
higher
sever
ill
method
icu
citi
hospit
triemli
zurich
interdisciplinari
organ
surgic
intern
medic
patient
maximum
occup
bed
center
function
surround
hospit
ongo
prospect
observ
studi
collect
analyz
anonym
data
patient
discharg
icu
prior
introduct
swissdrg
primari
endpoint
length
stay
icu
hour
secondari
endpoint
sever
ill
patient
time
discharg
detect
score
system
sap
ii
well
measur
number
readmiss
icu
initi
patient
analyz
second
step
patient
within
percentil
consid
also
analyz
subgroup
patient
refer
intern
patient
sent
back
refer
hospit
patient
region
homebas
hospit
statist
done
spss
p
consid
signifi
cant
result
present
result
period
month
prior
month
introduct
swissdrg
data
patient
analyz
respect
patient
includ
found
prior
introduct
drg
compar
length
stay
icu
mean
sd
hour
vs
hour
diff
erenc
sever
ill
discharg
detect
sap
ii
mean
sd
vs
number
readmiss
vs
also
signifi
cant
diff
erenc
percentil
includ
three
subgroup
analyz
conclus
introduct
swissdrg
infl
uenc
patient
discharg
characterist
larg
icu
data
assess
continu
data
analysi
perform
data
infl
uenc
drg
icu
patient
expect
introduct
drg
switzerland
chang
number
admiss
extern
hospit
larg
icu
centr
function
infl
uenc
sever
diseas
admit
patient
icu
triemli
citi
hospit
zurich
interdisciplinari
organis
surgic
intern
medic
patient
maximum
occup
bed
centr
function
surround
hospit
region
prospect
ongo
observ
studi
collect
analys
anonymis
data
patient
admit
icu
extern
hospit
month
prior
januari
decemb
januari
decemb
introduct
drg
switzerland
exclus
criteria
admiss
emerg
depart
selfassign
hospit
intern
reloc
primari
endpoint
number
admiss
extern
hospit
icu
secondari
endpoint
sever
diseas
admit
patient
detect
score
system
sap
ii
apach
ii
well
length
stay
extern
hospit
admiss
statist
analysi
descript
result
present
preliminari
data
month
case
januari
octob
introduct
drg
observ
increas
vs
patient
admiss
icu
introduct
drg
sever
diseas
determin
sap
ii
score
unchang
mean
vs
point
p
sever
diseas
determin
apach
ii
score
signifi
cantli
lower
vs
point
p
also
note
introduct
drg
patient
earlier
transfer
extern
hospit
icu
mean
time
transfer
vs
hour
valu
signifi
cant
p
conclus
introduct
drg
switzerland
complex
infl
uenc
number
kind
patient
lwp
n
patient
whose
wait
time
equal
less
period
short
wait
period
swp
n
result
total
patient
includ
belong
lwp
group
entir
cohort
mean
apach
ii
score
mean
age
year
patient
male
lwp
group
show
diff
erenc
apach
ii
score
vs
p
older
vs
p
lwp
also
higher
incid
primari
bloodstream
infect
vs
p
catheterassoci
urinari
tract
infect
vs
p
lwp
patient
higher
mortal
vs
p
longer
icu
lo
vs
day
p
rel
risk
death
lwp
ci
conclus
despit
show
signifi
cant
diff
erenc
apach
ii
score
swp
group
patient
lwp
group
present
greater
incid
primari
bloodstream
infect
catheterassoci
urinari
tract
infect
higher
mortal
outcom
longer
icu
lo
refer
intensivist
expect
mani
role
major
disastercatastroph
triag
intens
care
educ
peopl
forth
role
intensivist
special
disast
nuclear
disast
studi
base
actual
experi
method
sever
disast
studi
fukushima
daiichi
nuclear
plant
explos
higashinihon
earthquak
medic
review
base
total
stay
onsit
addit
sever
day
around
site
chernobyl
incid
inspect
year
incid
nuclear
disast
includ
result
mani
seriou
problem
reveal
medic
team
follow
inappropri
basic
prepared
larg
special
disast
includ
nuclear
disast
lack
appropri
educ
train
medic
team
nuclear
disasterthat
member
japan
dmat
disast
medic
assist
team
still
layperson
incorrect
standardrul
japan
dmat
excess
focus
upon
cure
usual
type
injuri
plan
short
period
nearli
hour
abandon
insuffi
cient
consider
weakvulner
peopl
cwap
children
pregnant
women
age
peopl
poor
peoplesick
patient
mani
die
insuffi
cient
emerg
transport
system
contamin
hous
hospit
conclus
order
cope
special
disast
nbc
nuclear
biolog
chemic
disast
insuffi
cient
take
makeshift
measur
use
cheap
trick
work
systemat
disast
medicin
base
upon
academ
viewpoint
philosophyreli
essenti
protect
peopl
nation
variat
acut
care
burden
suppli
across
divers
urban
set
murthi
austin
h
wunsch
nk
adhikari
v
karir
k
rowan
st
jacob
j
salluh
f
bozza
b
du
b
lee
f
wu
c
oppong
r
venkataraman
v
velayutham
angu
world
bank
warn
rapid
growth
world
urban
popul
accommod
safe
citi
adequ
develop
key
infrastructur
provis
acut
care
resourc
yet
even
basic
descript
inform
urban
acut
care
suppli
demand
extrem
limit
therefor
conduct
pilot
assess
across
seven
divers
urban
set
across
world
select
conveni
sampl
seven
larg
citi
vari
geograph
socioeconom
characterist
boston
pari
bogota
recif
liaocheng
chennai
kumasi
estim
acut
care
suppli
develop
instrument
collect
data
acut
critic
care
infrastructur
collect
data
municip
author
local
research
collabor
express
burden
acut
diseas
number
death
due
acut
ill
estim
global
burden
diseas
studi
result
express
acut
care
suppli
acut
death
per
popul
acut
care
suppli
per
acut
death
suppli
hospit
bed
vari
popul
kumasi
boston
icu
bed
capac
invas
mechan
ventil
intens
nurs
servic
rang
kumasi
popul
boston
number
ambul
vari
citi
gap
citi
widen
demand
estim
base
diseas
burden
diff
erenc
citi
icu
bedsacut
death
gener
data
unavail
municip
author
conclus
provis
acut
care
servic
key
aspect
urban
infrastructur
vari
substanti
across
seven
divers
urban
set
studi
furthermor
local
municip
author
gener
appear
littl
knowledg
acut
care
infrastructur
implic
futur
plan
develop
resourc
may
alway
alloc
sever
ill
custom
habit
particularli
diff
erent
group
administ
bed
control
triag
specialtyspecifi
c
diff
erenc
may
exist
even
singl
team
control
triag
variabl
resourc
util
import
implic
costcontain
triag
method
patient
admit
singl
close
medicalsurg
icu
fulltim
intensivist
unifi
ed
triag
control
larg
universityaffi
liat
hospit
evalu
patient
die
icu
exclud
day
discharg
dc
sever
use
apach
iv
relat
acut
physiolog
score
ap
compon
calcul
daili
fi
rst
day
trend
assess
across
day
cuzick
test
result
total
surgic
medic
patient
met
inclus
criteria
total
surgic
medic
patient
icu
lo
p
admiss
sever
correl
length
stay
p
medic
surgic
patient
medic
patient
sicker
admiss
dc
icu
surgic
patient
p
figur
conclus
icu
util
diff
ere
patient
type
even
unifi
ed
triag
control
within
singl
unit
surgic
patient
less
sever
ill
admiss
dc
icu
signifi
cant
percentag
medic
surgic
patient
dc
within
day
may
effi
cientli
serv
less
resourceintens
environ
reason
diff
erenc
icu
util
surgic
versu
medic
patient
requir
clarifi
cation
may
implic
resourc
util
cost
introduct
interest
safeti
clinic
outcom
inpati
grow
japan
live
campaign
introduc
japanes
patient
safeti
act
act
introduct
rapid
respons
system
rr
one
mainstream
inpati
care
howev
mani
japanes
healthcar
provid
understand
achiev
introduct
rr
knowledg
system
therefor
develop
new
introductori
train
cours
rr
educ
eff
ectiv
analyz
surveil
questionnair
cours
method
educ
program
includ
lectur
seri
con
cern
outlin
manag
method
introduct
facil
alreadi
deploy
small
group
discuss
teach
methodsoftrain
medic
emerg
team
use
simul
evalu
made
fi
vepoint
scale
particip
physician
nurs
eight
profess
throughout
seven
cours
questionnair
understand
rr
b
knowledg
acquisit
patient
safeti
c
expect
decreas
cardiopulmonari
arrest
rr
expect
decreas
psycholog
burden
rr
result
seventythre
particip
answer
questionnair
number
particip
score
four
point
follow
b
c
respect
major
particip
obtain
correct
knowledg
solid
understand
rr
evid
provid
abund
materi
didact
lectur
trace
introduct
manag
collect
resolv
question
promot
comprehens
howev
limit
whether
particip
introduc
rr
institut
essenti
improv
cours
continu
support
activ
particip
conclus
train
cours
may
promot
introduct
dissemin
rr
japan
introduct
teach
medic
ethic
issu
includ
confi
dentia
liti
consent
long
small
part
medic
curriculum
issu
complex
icu
patient
may
lack
capac
document
good
medic
practic
confi
dential
mental
capac
act
give
guidanc
medic
profession
matter
uk
method
questionnair
distribut
amongst
staff
four
icu
south
london
result
analys
accord
level
experi
background
medicalnurs
alli
health
profession
ahp
questionnair
distribut
respons
rate
doctor
nurs
ahp
staff
either
less
year
experi
greater
year
experi
greatest
exposur
mental
capac
act
data
protect
act
suggest
gap
knowledg
staff
intermedi
experi
knowledg
caldicott
principl
unaff
ect
experi
mani
experienc
respond
idea
major
respond
unaff
ect
experi
felt
give
inform
rel
face
face
rel
kept
fulli
inform
give
inform
telephon
doctor
felt
respons
tailor
knowledg
person
spoken
whilst
nurs
split
tailor
respons
give
full
inform
set
password
system
give
inform
respond
felt
date
birth
hospit
number
constitut
patient
identifi
abl
inform
howev
experienc
staff
appreci
import
unusu
diagnosi
clinic
photograph
also
abl
identifi
patient
similarli
major
knew
patient
identifi
ed
next
kin
unaff
ect
experi
felt
decid
famili
felt
famili
could
decid
resuscit
statu
consent
requir
elect
procedur
patient
lack
capac
doctor
tend
better
understand
need
delay
procedur
possibl
nurs
major
felt
could
decid
next
kin
two
consult
doctor
doctor
felt
act
patient
best
interest
would
mean
would
give
patient
best
outcom
rather
patient
would
want
unaff
ect
experi
major
staff
answer
questionnair
felt
lack
suffi
cient
knowledg
subject
felt
annual
remind
would
use
icu
environ
issu
consent
confi
dential
disclosur
inform
occur
daili
staff
feel
lack
knowledg
area
unaff
ect
experi
need
ensur
staff
necessari
knowledg
deal
situat
introduct
alcoholrel
hospit
icu
admiss
known
huge
impact
healthcar
resourc
uk
excess
use
alcohol
independ
associ
sepsi
septic
shock
hospit
mortal
among
icu
patient
studi
assess
relationship
alcohol
abus
intens
care
resourc
utilis
mix
medic
surgic
neurosurg
icu
method
prospect
survey
emerg
alcoholrel
admiss
period
undertaken
tertiari
univers
adult
gener
neurosurg
icu
patient
screen
acut
chronic
alcohol
abus
admiss
acut
alcohol
abus
defi
ned
intox
alcohol
time
admiss
chronic
alcohol
abus
defi
ned
chronic
alcohol
use
exceed
recommend
uk
nation
guidelin
consumpt
amount
alcohol
consumpt
obtain
diagnosi
admiss
icu
hospit
mortal
length
stay
total
cost
record
patient
screen
alcoholrel
comorbid
compar
retrospect
data
obtain
time
period
nonalcoholrel
emerg
icu
admiss
data
analyz
use
spss
result
total
patient
admit
histori
acutechron
alcohol
excess
sixtyseven
per
cent
alcoholrel
admiss
due
acut
alcohol
excess
neurosurg
patient
admit
due
alcohol
excess
higher
itu
mortal
nonalcoholrel
neurosurg
patient
versu
p
respect
ninetythre
per
cent
alcoholrel
neurosurg
admiss
caus
acut
alcohol
intox
intens
care
cost
signifi
cantli
higher
alcoholrel
per
patient
compar
nonalcoholrel
neurosurg
admiss
per
patient
medic
patient
admit
admiss
due
acut
alcohol
excess
cost
intens
care
treatment
lower
alcoholrel
medic
admiss
conclus
one
largest
studi
alcoholrel
admiss
critic
care
survey
confi
rm
alcoholrel
admiss
icu
commonplac
howev
frequenc
signifi
cantli
less
previous
report
studi
reveal
interspecialti
variat
demograph
data
apach
ii
score
mortal
cost
admiss
neurosurg
alcoholrel
admiss
bear
higher
mortal
result
greater
resourc
utilis
rel
nonalcoholrel
neurosurg
admiss
alcohol
continu
burden
patient
critic
care
fi
rst
three
postop
day
preoper
ahi
associ
prolong
wean
time
reduc
oxygen
index
arteri
po
fio
impair
kidney
function
augment
infl
ammatori
respons
overal
increas
length
stay
icu
observ
associ
high
preoper
ahi
valu
postop
clinic
characterist
remain
statist
signifi
cant
throughout
fi
rst
three
postop
day
conclus
undiagnos
sdb
highli
preval
among
cardiac
surgic
patient
clinic
trajectori
individu
sever
sdb
describ
prolong
recoveri
pulmonari
function
delay
wean
pronounc
infl
ammatori
respons
surgeri
screen
sdb
might
identifi
patient
suscept
complic
postop
cours
introduct
literatur
review
perform
assess
whether
massag
benefi
ts
patient
postop
follow
coronari
bypass
graft
cabg
valv
replacementrepair
case
studi
patient
suff
ere
hypox
brain
post
cardiac
arrest
conduct
method
review
medlin
cochran
use
search
term
massag
cardiac
icu
identifi
ed
nine
research
paper
benefi
ts
massag
postop
aforement
patient
group
paper
list
unrel
cardiac
surgeri
none
nine
paper
identifi
ed
review
icu
specifi
c
titl
icu
mention
main
text
bodi
purpos
review
select
paper
research
eff
ect
massag
physiolog
paramet
anxieti
pain
calm
perceiv
stress
indic
cabg
andor
valv
repairreplac
nine
paper
one
british
five
american
two
brazilian
one
indian
paper
paper
randomis
control
trial
rct
paper
written
prior
exclud
literatur
review
introduct
vap
continu
major
caus
morbid
mortal
critic
ill
patient
thailand
decad
previou
research
found
implement
vap
care
bundl
educ
program
reduc
vap
incid
icu
research
aim
observ
reduct
vap
incid
implement
vap
care
bundl
icu
medic
personnel
method
inclus
criteria
adult
surgic
patient
year
old
ventilatori
support
surgic
icu
siriraj
hospit
two
group
divid
preeduc
group
group
posteduc
group
group
ii
n
also
observ
adher
rate
vap
care
bundl
accord
educ
program
pretest
posttest
determin
effi
caci
educ
program
done
vap
care
bundl
consist
wean
accord
wean
protocol
sedat
vacat
headofb
elev
measur
cuff
pressur
four
timesday
chlorhexidin
use
mouth
care
empti
ventil
circuit
condens
result
episod
vap
per
ventilatorday
group
group
ii
respect
p
incid
vap
group
group
ii
p
signifi
cant
reduct
length
ventilatori
support
per
person
group
group
ii
median
p
ci
mortal
rate
group
group
ii
p
signifi
cant
diff
erenc
loi
loh
atb
cost
pretest
score
averag
medic
personnel
group
group
ii
respect
p
headofb
elev
adher
rate
improv
educ
program
group
group
ii
p
adher
bundl
improv
see
tabl
introduct
follow
studi
sever
sepsi
care
across
three
centr
aim
introduc
rapid
feedback
mechan
roll
audit
programm
whilst
previou
audit
rais
awar
sever
sepsi
whole
organis
perform
report
feedback
given
individu
clinician
recognis
feedback
loop
improv
clinic
practic
method
patient
admit
critic
care
bed
four
unit
primari
admiss
diagnosi
infect
screen
sever
sepsi
preicu
care
audit
surviv
sepsi
guidelin
time
zero
defi
ned
criteria
sever
sepsi
fi
rst
met
individualis
traffi
clight
report
gener
email
patient
consult
stakehold
involv
care
figur
aim
report
case
within
day
critic
care
admiss
cumul
report
gener
monthli
track
organisationwid
perform
sinc
novemb
case
sever
sepsi
audit
report
back
clinician
complianc
antibiot
hour
risen
complianc
preicu
element
resuscit
bundl
risen
figur
feedback
clinician
encourag
report
highlight
posit
neg
exampl
practic
conclus
individualis
feedback
sepsi
care
led
substanti
improv
guidelin
complianc
concept
could
translat
timedepend
patient
pathway
introduct
talk
safeti
cultur
speak
awar
thing
go
wrong
must
abl
recogn
mistak
learn
share
inform
fairli
imparti
tri
prevent
recurr
organ
agenc
healthcar
research
qualiti
ahrq
develop
tool
help
organ
measur
safeti
cultur
littl
inform
countri
method
descript
survey
studi
sent
spanish
version
questionnair
patient
safeti
cultur
ahrq
nurs
staff
polyval
icu
bed
tertiari
hospit
questionnair
sent
nurs
receiv
correctli
answer
survey
respons
rate
scale
point
obtain
estim
safeti
climat
staff
respond
item
best
score
teamwork
unit
detect
fortress
commun
nurs
shift
chang
posit
respons
worst
rate
obtain
section
human
resourc
follow
manag
support
fi
eld
patient
safeti
conclus
percept
safeti
cultur
icu
nurs
staff
far
optim
level
team
work
dimens
identifi
ed
valu
worker
transmiss
inform
shift
chang
valu
item
method
compar
number
admiss
relat
activ
casemix
indic
year
geograph
chang
done
analyz
whole
number
patient
admit
icu
use
chisquar
test
categor
variabl
oneway
analysi
varianc
quantit
data
minitab
statba
statist
program
use
plot
activ
data
use
barberjohnson
diagram
result
total
case
male
mean
age
year
admit
icu
period
year
transfer
diff
erenc
group
found
demograph
data
knau
score
nyha
statu
regard
origin
found
patient
admit
hospit
center
vs
p
apach
ii
score
increas
p
slight
increas
chang
sap
score
also
found
p
sever
defi
nition
level
care
refer
group
risk
clinic
deterior
ward
evid
ward
patient
becom
acut
unwel
often
receiv
suboptim
care
region
studi
commiss
norfolk
suff
olk
cambridgeshir
critic
care
network
nscccn
found
major
ward
patient
may
depend
death
rate
appear
correl
statu
aim
examin
relationship
ward
distribut
ill
acuiti
staffi
ng
patient
outcom
method
data
collect
part
nscccn
observ
preval
studi
ward
survey
includ
acuiti
ill
staffi
ng
level
skill
mix
secondari
data
obtain
patient
administr
system
emerg
oncolog
paediatr
matern
unit
exclud
result
complet
dataset
obtain
patient
ward
univers
hospit
two
season
constitut
inpati
ward
mean
ward
occup
rate
percentil
least
one
acuiti
criterion
score
patient
geriatr
follow
orthopaed
gener
surgeri
ward
averag
eight
qualifi
ed
nurs
staff
rang
equat
averag
staff
patient
ratio
spr
correl
ward
occup
nurs
staff
pearson
correl
corr
preval
criteria
staffi
ng
corr
admiss
rate
intens
care
note
higher
patient
nurs
ward
lower
averag
spr
compar
higher
spr
vs
p
fisher
exact
statist
signifi
cant
senior
nurs
band
staff
part
skill
mix
nine
ward
survey
conclus
better
outcom
improv
spr
may
unsurpris
although
proven
conclus
would
signifi
cantli
inform
workforc
plan
lack
correl
staffi
ng
level
occup
acuiti
also
interest
given
know
criteria
associ
wors
outcom
introduct
prolong
shift
workload
stress
diff
erent
confl
ict
associ
burnout
loss
psycholog
wellb
probabl
inadequ
sleep
qualiti
isq
relev
disturb
lead
deterior
work
perform
may
impair
qualiti
care
provid
patient
increas
incid
seriou
advers
event
object
determin
preval
isq
sleepi
among
uruguayan
icu
worker
evalu
risk
factor
associ
isq
method
survey
conduct
six
uruguayan
icu
sleep
qualiti
evalu
basi
pittsburgh
score
ps
sleepi
identifi
ed
epworth
scale
isq
defi
ned
ps
greater
point
sleepi
epworth
scale
higher
point
icu
patient
clinician
characterist
assess
associ
preval
isq
variabl
p
univari
analysi
includ
model
ordin
regress
p
consid
statist
signifi
cant
result
survey
complet
icu
worker
global
preval
isq
icu
isq
observ
physician
nurs
nurs
assist
p
sleep
medic
use
icu
team
univari
analysi
show
isq
signifi
cantli
associ
sex
vs
p
women
men
respect
marit
statu
vs
p
singl
coupl
worker
respect
hour
work
last
week
vs
p
less
sleep
hour
vs
p
multivari
analysi
demonstr
sleep
durat
less
hour
independ
associ
isq
ci
p
furthermor
patholog
sleepi
present
icu
worker
sleepi
independ
associ
use
sleep
medic
ci
p
conclus
preval
isq
sleepi
high
among
icu
worker
disturb
independ
associ
sleep
durat
less
hour
sleep
medic
use
respect
result
highlight
strategi
decreas
isq
sleepi
icu
clinician
urgent
need
improv
work
perform
improv
qualiti
care
provid
prevent
advers
event
introduct
workrel
stress
potenti
problem
among
doctor
associ
anxieti
depress
reduc
job
satisfact
day
work
error
near
miss
compar
stress
level
diff
erent
group
doctor
identifi
caus
stress
conduct
survey
univers
hospit
lewisham
use
uk
health
safeti
execut
manag
standard
hsem
hsem
valid
tool
develop
identifi
work
condit
warrant
intervent
reduc
stress
level
across
organis
method
conduct
anonym
survey
doctor
work
anaesthet
intens
care
gener
medicin
accid
emerg
e
depart
week
use
hsem
question
nair
also
survey
awar
trust
stress
manag
servic
whether
staff
design
supervisor
mentor
result
analys
use
hsem
analysi
tool
rate
stressor
score
repres
lowest
amount
stress
compar
trust
result
hsem
nation
standard
result
seventytwo
doctor
complet
survey
lowest
stress
level
found
doctor
work
intens
care
n
mean
sd
follow
medicin
n
mean
sd
anaesthet
n
mean
sd
e
n
mean
sd
highest
stress
level
signifi
cant
diff
erenc
stress
level
diff
erent
grade
doctor
compar
hsem
target
staff
relationship
peer
support
exceed
nation
standard
howev
manag
organis
chang
demand
work
need
improv
major
doctor
idea
stress
manag
servic
provid
trust
seventynin
per
cent
doctor
alloc
supervisor
mentor
felt
abl
approach
supervisor
conclus
survey
result
provid
reassur
stress
level
intens
care
compar
well
despit
critic
unwel
patient
higher
mortal
rate
identifi
ed
area
need
improv
within
trust
present
result
relev
depart
support
hospit
manag
initi
hsemsvalid
measur
reduc
stress
introduct
although
recent
report
show
improv
outcom
pediatr
hematolog
patient
requir
intens
care
respiratori
failur
remain
one
major
risk
pediatr
mortal
studi
conduct
assess
hypothesi
mortal
associ
respiratori
failur
higher
organ
failur
pediatr
hematolog
patient
admit
icu
method
retrospect
studi
analyz
children
hematolog
disord
admit
icu
april
june
includ
children
requir
emerg
admiss
invas
mechan
ventil
need
intub
requir
intub
therapeut
intervent
die
within
hour
icu
admiss
exclud
surviv
group
defi
ned
patient
discharg
icu
nonsurviv
group
defi
ned
die
icu
within
day
discharg
icu
pelod
score
pimii
appli
morbid
score
system
result
twentyseven
patient
includ
male
nine
femal
median
age
year
rang
year
analyz
sixteen
patient
leukemia
fi
hemophagocyt
syndrom
six
solid
tumor
averag
predict
mortal
rate
pimii
surviv
group
includ
patient
nonsurviv
group
includ
patient
surviv
group
compar
nonsurviv
group
signifi
cant
diff
erenc
systol
blood
pressur
mmhg
vs
mmhg
p
proport
patient
requir
continu
renal
replac
therapi
vs
p
pelod
score
vs
p
nonsurviv
group
pimii
higher
surviv
group
vs
p
pao
fio
vs
p
oxygen
index
vs
p
signifi
cantli
wors
nonsurviv
group
surviv
group
conclus
data
show
respiratori
failur
strongli
associ
mortal
organ
failur
pediatr
hematolog
patient
requir
intens
care
result
also
suggest
mechan
ventil
intervent
patient
respiratori
failur
must
occur
earlier
improv
outcom
patient
introduct
critic
ill
patient
haematolog
malign
hm
high
hospit
mortal
sever
ill
score
may
underestim
mortal
patient
method
data
collect
conduct
three
hospit
patient
activ
hm
condit
match
two
control
patient
two
hospit
one
control
christi
hospit
control
patient
apach
ii
within
point
admiss
diagnosi
hm
readmiss
plan
surgic
case
exclud
result
total
patient
hm
compar
control
patient
seventyfour
admiss
hm
identifi
ed
two
hospit
match
two
control
patient
eightynin
admiss
hm
christi
hospit
identifi
ed
match
control
patient
hm
spent
signifi
cantli
longer
hospit
icu
admiss
tabl
unit
hospit
mortal
rate
statist
diff
erent
patient
hm
without
hm
tabl
conclus
unit
mortal
critic
ill
patient
hm
similar
without
hm
hospit
mortal
patient
hm
higher
without
hm
although
statist
signifi
cant
sever
ill
present
critic
care
main
determin
outcom
patient
hm
group
requir
emerg
admiss
icu
tertiari
cancer
centr
method
retrospect
review
medic
note
result
total
patient
admit
one
admiss
episod
total
leukaemia
n
lymphoma
n
myeloma
n
compar
characterist
surviv
icu
admiss
fail
surviv
discharg
icu
two
popul
similar
age
vs
male
vs
surviv
lower
apach
ii
score
admiss
vs
p
lower
mean
organ
failur
score
vs
p
lower
requir
inotrop
vs
p
ventil
vs
p
fi
ltration
vs
p
diff
erenc
preval
sepsi
time
admiss
vs
group
includ
patient
prior
bone
marrow
transplant
vs
note
icu
surviv
respect
valu
lower
report
literatur
date
conclus
icu
mortal
respect
patient
haematolog
malign
stand
benefi
intens
care
ere
admiss
base
clinic
need
introduct
mani
evidencebas
intervent
deliv
patient
may
due
clinician
intent
decis
aim
project
compar
use
starch
remov
option
eprescrib
templat
method
eprescrib
softwar
enabl
user
prescrib
intraven
fl
uid
seri
menu
one
templat
sever
fl
uid
avail
use
bolu
instruct
clinician
remov
starch
option
templat
april
starch
could
still
prescrib
elsewher
prescrib
system
data
use
starch
novemb
novemb
analys
mean
volum
starch
infus
per
patient
per
month
mean
set
paramet
compar
use
student
test
result
mean
volum
starch
per
patient
administ
electron
prescript
option
alter
ml
ml
respect
p
see
figur
conclus
despit
clinician
intend
reduc
use
starch
still
regularli
administ
icu
remov
default
prescrib
option
dramat
reduc
volum
starch
use
whilst
restrict
abil
make
consciou
choic
prescrib
adjust
default
option
potenti
infl
uenc
clinic
decis
ensur
reliabl
evidencebas
care
introduct
earli
detect
sepsi
import
suffi
cient
treatment
reduc
mortal
hypothes
use
modifi
ed
system
infl
ammatori
respons
syndrom
criteria
hour
use
electron
softwar
program
facilit
clinic
diagnosi
sepsi
method
irb
approv
inform
consent
enrol
prospect
observ
singlecent
studi
consecut
patient
age
femalemal
admit
period
surgic
icu
total
met
modifi
ed
system
infl
ammatori
respons
criteria
patient
monitor
electron
softwar
program
use
live
data
laboratori
bedsid
monitor
detect
modifi
ed
system
infl
ammatori
respons
syndrom
criteria
persist
hour
physician
blind
softwar
program
alert
notifi
ed
real
time
modifi
ed
system
infl
ammatori
respons
syndrom
criteria
detect
persist
hour
provid
treatment
recommend
result
total
modifi
ed
system
infl
ammatori
respons
syndrom
criteria
alert
seventyfour
confi
rmed
true
sepsi
case
physician
overal
incid
sepsi
patient
categor
length
stay
hour
hour
hour
overal
sensit
system
detect
sepsi
specifi
citi
posit
predict
valu
neg
predict
valu
conclus
realtim
alert
use
autom
electron
monitor
modifi
ed
system
infl
ammatori
respons
syndrom
criteria
facilit
clinic
diagnosi
sepsi
bed
intent
round
proactiv
patient
round
recognis
royal
colleg
physician
royal
colleg
nurs
structur
evidencebas
process
nurs
carri
regular
check
individu
patient
set
interv
senior
nurs
team
decid
adapt
initi
intens
care
set
order
address
clinic
challeng
provid
guidanc
shift
leader
focu
key
element
care
method
intent
round
perform
per
shift
twice
daili
includ
two
compon
first
pressur
area
care
compon
involv
shift
leader
check
whether
key
element
pressur
sore
prevent
perform
includ
complet
waterlow
risk
assess
tool
note
frequenc
reposit
use
later
posit
pressurereliev
pad
second
renal
replac
therapi
rate
element
identifi
ed
area
focu
establish
haemofi
ltration
fl
uid
use
per
hour
therapi
twice
near
ident
clinic
set
pattern
continu
even
adopt
similar
therapi
guidelin
shift
leader
guid
check
whether
therapi
rate
adjust
line
latest
biochem
result
incid
pressur
ulcer
month
sinc
initi
began
averag
per
month
compar
per
month
prior
commenc
intent
round
ad
round
tool
end
septemb
rrt
rate
preced
month
averag
mlkghour
hour
reduct
previou
averag
mlkghour
pattern
rrt
continu
could
equat
cost
save
per
annum
conclus
use
modifi
ed
target
intent
round
tool
nurs
shift
leader
help
ensur
best
practic
guidelin
adher
strategi
improv
patient
outcom
provid
potenti
signifi
cant
fi
scal
benefi
ts
refer
introduct
handov
often
associ
poor
communi
cation
icu
patient
multipl
complex
problem
ideal
studi
natur
occur
handov
howev
studi
conduct
icu
method
conduct
questionnair
physician
nurs
involv
observ
handov
real
time
medic
icu
patient
month
interview
physician
nurs
involv
observ
realtim
handov
patient
patient
mean
durat
handov
second
face
face
distract
per
handov
note
persontoperson
call
commonest
mode
distract
nurs
receiv
train
induct
signifi
cantli
higher
number
cover
alli
specialti
review
patient
earli
p
percept
rel
import
diff
erent
compon
handov
vari
signifi
cantli
donor
recipi
physician
nurs
physician
nurs
seldom
review
avail
electron
past
medic
record
patient
handov
addit
train
handov
overal
confi
denc
level
manag
follow
handov
signifi
cantli
associ
better
satisfact
univari
analysi
confi
denc
level
patient
manag
remain
signifi
cant
multivari
analysi
howev
agreement
donor
recipi
overal
satisfact
poor
p
nurs
handov
signifi
cantli
longer
physician
vs
second
p
also
associ
higher
distract
particularli
even
shift
conclus
higher
percentag
nurs
receiv
handov
train
nurs
handov
longer
inclus
compon
patient
manag
perceiv
import
compon
handov
vari
among
healthcar
profession
distract
common
handov
associ
longer
durat
nurs
even
shift
higher
confi
denc
level
patient
manag
follow
handov
associ
better
satisfact
use
telemedicin
provid
acut
burn
critic
care
consult
pediatr
adult
burn
patient
lviv
ukrain
well
triag
transport
critic
ill
patient
lviv
tertiarycar
facil
usa
manag
method
use
new
telemedicin
learn
center
establish
citi
hospit
lviv
ukrain
consult
regard
acut
injur
burn
victim
occur
physician
ukrain
physician
shriner
hospit
massachusett
gener
hospit
boston
initi
present
patient
review
daili
basi
physician
boston
skype
internetbas
commun
tool
use
commun
burn
center
lviv
radiograph
imag
scan
digit
use
electron
scanner
jpeg
imag
compress
use
facilit
transmiss
radiograph
imag
patient
chart
inform
consent
hippa
guidelin
follow
transmit
patientrel
inform
result
sinc
provid
consult
patient
lviv
ukrain
rang
age
month
year
patient
averag
six
consult
present
two
case
exampl
capabl
telemedicin
program
fi
rst
case
involv
femal
tbsa
scald
injuri
telemedicin
instrument
primari
assess
well
arrang
direct
assess
nearbi
burn
surgeon
second
case
result
hous
fi
multipl
casualti
physician
boston
abl
util
telemedicin
guid
initi
resuscit
airway
manag
three
critic
burn
children
well
arrang
transport
one
victim
male
tbsa
ukrain
usa
acut
manag
multipl
diffi
culti
overcom
implement
system
two
countri
includ
time
zone
diff
erenc
languag
barrier
diff
erent
approach
patient
care
conclus
establish
telemedicin
program
link
physician
boston
usa
citi
hospit
lviv
ukrain
improv
care
pediatr
adult
burn
patient
program
provid
consult
patient
sinc
highlight
capabl
telemedicin
acut
consult
well
triag
transport
critic
ill
patient
tertiarycar
facil
introduct
last
year
frequenc
endoflif
decis
eold
signifi
cantli
increas
icu
method
nurs
involv
make
eold
diff
erent
worldwid
purpos
studi
analyz
opinion
nurs
therapi
restrict
examin
multicent
studi
opinion
medic
stuff
endoflif
care
hungarian
icu
method
perform
questionnair
evalu
among
physician
nurs
icu
infl
uenc
factor
therapi
restrict
method
decisionmak
process
frequenc
diff
erent
eold
questionnair
contain
question
deliv
electron
hungarian
icu
analyz
respons
anonym
retriev
answer
physician
nurs
analys
use
nonparametr
student
test
result
total
nurs
respond
work
univers
clinic
region
centrum
municip
hospit
icu
nurs
found
human
vs
materi
vs
resourc
restrict
factor
patient
admiss
physician
p
p
nurs
work
municip
hospit
strongli
infl
uenc
lack
materi
human
resourc
nurs
work
univers
clinic
p
p
younger
nurs
work
year
interest
patient
surrog
wish
older
nurs
work
year
religion
infl
uenc
patient
admiss
forego
therapi
howev
religi
nurs
compar
atheist
nonpract
believ
prefer
prolong
therapi
patient
p
nurs
felt
physician
slightli
involv
endoflif
decisionmak
process
vs
p
conclus
found
workplac
level
medic
attend
godli
work
experi
posit
medic
staff
strongli
infl
uenc
make
eold
limit
therapi
team
work
nurs
felt
opinion
hardli
taken
consider
although
nurs
seem
realist
decisionmak
process
introduct
one
fi
peopl
admit
icu
die
research
highlight
concern
support
patient
famili
decisionmak
context
describ
develop
evalu
tool
improv
palli
care
gener
icu
central
london
teach
hospit
method
medic
research
council
guidanc
complex
intervent
phase
compris
literatur
review
theoret
model
observ
qualit
interview
focu
group
staff
famili
explor
concern
view
intervent
identifi
ed
literatur
review
phase
ii
compris
intervent
develop
implement
evalu
tool
feasibl
eff
ect
use
staff
survey
observ
audit
record
rel
survey
result
phase
staff
famili
member
interview
short
time
decis
treatment
withdraw
death
plu
concern
support
manag
commun
decisionmak
highlight
need
ensur
excel
psychosoci
assess
phase
ii
part
integr
care
guidelin
develop
king
psychosoci
assess
care
tool
kpace
kpace
use
patient
enter
icu
complet
within
hour
admiss
contain
psychosoci
assess
famili
patient
need
identifi
es
key
individu
contact
educ
train
support
kpace
implement
two
wave
postimplement
survey
icu
staff
found
awar
kpace
eightytwo
per
cent
nurs
doctor
complet
tool
total
famili
member
respond
survey
addit
three
patient
respond
high
level
satisfact
symptom
control
psychosoci
care
concern
continu
regard
explan
treatment
care
conclus
kpace
feasibl
tool
improv
palli
care
patient
famili
icu
refi
nement
need
plan
consider
rollout
wider
medic
centr
concern
involv
famili
especi
stop
withdraw
therapi
quit
diffi
cult
oper
japan
legal
issu
hypothesi
diff
erenc
exist
thought
physician
nurs
termin
patient
icu
aim
studi
know
real
thought
method
questionnair
survey
perform
physician
nurs
medicosurg
icu
questionnair
consist
question
fi
option
answer
relat
thought
particip
treatment
hopeless
brain
death
patient
concret
question
whether
withhold
therapi
whether
accept
withdraw
therapi
famili
whether
accept
immedi
stop
therapi
famili
whether
posit
donat
organ
brain
death
patient
necess
icu
care
brain
death
patient
feel
guilti
stress
stop
withdraw
therapi
option
answer
fi
gradat
ye
question
particip
ask
answer
questionnair
express
without
regard
legal
issu
consensu
guarante
anonym
data
analysi
answer
compar
physician
nurs
mannwhitney
u
test
use
statist
analysi
p
consid
statist
signifi
cant
result
total
particip
respons
rate
physician
nurs
withdraw
therapi
signifi
cantli
accept
nurs
physician
vs
p
famili
well
understood
withhold
therapi
oper
brain
death
patient
physician
seem
diffi
cult
judgement
nurs
p
icu
care
brain
death
patient
less
necessari
physician
nurs
vs
p
signifi
cant
diff
erenc
question
physician
nurs
feel
guilti
stress
stop
withdraw
therapi
conclus
endoflif
thought
icu
show
diff
erenc
physician
nurs
introduct
optim
patient
evalu
icu
rehabilit
therapi
remain
unclear
method
one
hundr
icu
patient
acut
respiratori
failur
random
receiv
earli
rehabilit
er
usualcar
uc
cohort
n
receiv
er
one
physic
therapi
pt
sessionday
versu
uc
cohort
n
receiv
er
ptday
second
session
resist
train
versu
uc
uc
without
er
blood
drawn
cytokin
day
cohort
underw
strength
physic
function
assess
use
short
physic
perform
batteri
sppb
valid
reliabl
measur
physic
function
consist
walk
speed
balanc
repeat
chair
stand
wellstudi
composit
measur
older
person
use
icu
survivor
small
chang
point
sppb
shown
clinic
meaning
conclus
pilot
studi
earli
icu
rehabilit
safe
associ
numer
although
statist
shorter
hospit
stay
greater
strength
improv
function
score
particularli
sppb
demonstr
discriminatori
abil
group
icu
survivor
low
physic
function
futur
earli
icu
rehabilit
studi
consid
icu
survivor
assess
use
sppb
due
eas
reproduc
discriminatori
abil
follow
icu
hospit
discharg
demograph
variabl
sex
age
educ
race
length
stay
eff
ect
perceiv
qualiti
care
conclus
cqi
ricu
turn
valid
reliabl
sensit
feasibl
instrument
largescal
implement
recommend
